Gene	Variant_Classification	Alteration	Tumor_allele	Reference_allele	dbSNP_RS	bin	Score_bin	Chromosome	Start_position	End_position	Coverage	Allelic_fraction	Number_of_Probes	Segment_Mean	In_Segment	Pathways	COSMIC_overlapping_mutations	COSMIC_total_alterations_in_gene	UniProt_Region	Rationale	Tumor_Sample_Barcode	Clinical_trials	mutation.assessor
BRAF	Missense_Mutation	p.D594N	C	C	rs397516896	0.75	Investigate Actionability	7	140453155	140453155	324	0.058641975308642	NA	NA	NA		p.D594N(9)|p.D594H(2)	27380	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.	Mutations predict sensitivity to RAF inhibitors. Amplification may predict resistance to MEK inhibitors.	MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BRAF&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,140453155,C,C&fts=all">p.D594N</a>
ALK	Missense_Mutation	p.P254S	G	G		2	High Priority	2	29940471	29940471	290	0.113793103448276	NA	NA	NA			340		Translocations predict sensitivity to ALK-inhibitors such as crizotinib.  Secondary mutations can cause resistance.  Amplification and activating mutations may also be sensitive to these agents.	MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ALK&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,29940471,G,G&fts=all">p.P254S</a>
ERBB4	Missense_Mutation	p.G1217E	C	C		2	High Priority	2	212248617	212248617	548	0.0364963503649635	NA	NA	NA			179		Mutations may predict sensitivity to Lapatinib and other anti-EGF family inhibitors	MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ERBB4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,212248617,C,C&fts=all">p.G1217E</a>
MTOR	Missense_Mutation	p.P1167L	G	G		2	High Priority	1	11272430	11272430	255	0.0431372549019608	NA	NA	NA			149		Activating mutations may predict sensitivity to MTOR inhibitors. Secondary mutations may predict resistance to MTOR inhibitors	MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MTOR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,11272430,G,G&fts=all">p.P1167L</a>
NTRK3	Missense_Mutation	p.D401N	C	C	rs368708129	2	High Priority	15	88576178	88576178	150	0.06	NA	NA	NA			119		Fusion with ETS factors (in secretory breast cancer, for example) may predict sensitivity to PI3K pathway inhibitors, SRC inhibitors, and/or IGF1-R inhibitors	MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NTRK3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,88576178,C,C&fts=all">p.D401N</a>
ROS1	Missense_Mutation	p.P696L	G	G		2	High Priority	6	117708090	117708090	359	0.0222841225626741	NA	NA	NA			162		Translocations predict sensitivity to  crizotinib.	MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ROS1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,117708090,G,G&fts=all">p.P696L</a>
EP300	Splice_Site		G	G		3	Investigate Actionability	22	41526008	41526008	243	0.0205761316872428	NA	NA	NA			171			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EP300&recr=Open">Click here</a>	
CBLB	Missense_Mutation	p.P855L	G	G		3.16666666666667	Cancer Pathway Linked to: MTOR; BRAF; EP300	3	105397280	105397280	321	0.0685358255451713	NA	NA	NA	 KEGG_PATHWAYS_IN_CANCER  | 		49	Pro-rich.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CBLB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,105397280,G,G&fts=all">p.P855L</a>
CBLB	Missense_Mutation	p.P855S	G	G		3.16666666666667	Cancer Pathway Linked to: MTOR; BRAF; EP300	3	105397281	105397281	320	0.06875	NA	NA	NA	 KEGG_PATHWAYS_IN_CANCER  | 		49	Pro-rich.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CBLB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,105397281,G,G&fts=all">p.P855S</a>
MECOM	Missense_Mutation	p.S814L	G	G	rs540158912	3.16666666666667	Cancer Pathway Linked to: MTOR; BRAF; EP300	3	168810878	168810878	552	0.135869565217391	NA	NA	NA	 KEGG_PATHWAYS_IN_CANCER  | 		85			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MECOM&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,168810878,G,G&fts=all">p.S814L</a>
JAK1	Missense_Mutation	p.H106Y	G	G		3.5	Cancer Pathway Linked to: BRAF	1	65344721	65344721	100	0.05	NA	NA	NA	 BIOCARTA_EGF_PATHWAY  |  KEGG_PANCREATIC_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		120	FERM. {ECO:0000255|PROSITE- ProRule:PRU00084}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+JAK1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,65344721,G,G&fts=all">p.H106Y</a>
CDK12	Missense_Mutation	p.K757R	A	A		3.75	Cancer Gene Census	17	37650798	37650798	136	0.0514705882352941	NA	NA	NA			70	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDK12&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,37650798,A,A&fts=all">p.K757R</a>
ACSL3	Missense_Mutation	p.T37A	A	A		4	Cancer Gene Census	2	223773599	223773599	568	0.0387323943661972	NA	NA	NA			22			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACSL3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,223773599,A,A&fts=all">p.T37A</a>
AKAP9	Missense_Mutation	p.G1062R	G	G		4	Cancer Gene Census	7	91632415	91632415	230	0.0652173913043478	NA	NA	NA			155			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AKAP9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,91632415,G,G&fts=all">p.G1062R</a>
AKAP9	Missense_Mutation	p.Q3002R	A	A		4	Cancer Gene Census	7	91714981	91714981	196	0.0663265306122449	NA	NA	NA			155			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AKAP9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,91714981,A,A&fts=all">p.Q3002R</a>
ARID2	Missense_Mutation	p.R623C	C	C	rs140086050	4	Cancer Gene Census	12	46243514	46243514	868	0.0748847926267281	NA	NA	NA			116			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARID2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,46243514,C,C&fts=all">p.R623C</a>
BCL11B	Missense_Mutation	p.P136S	G	G		4	Cancer Gene Census	14	99723829	99723829	236	0.0254237288135593	NA	NA	NA			34			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BCL11B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,99723829,G,G&fts=all">p.P136S</a>
CDX2	Missense_Mutation	p.P297L	G	G		4	Cancer Gene Census	13	28537304	28537304	111	0.108108108108108	NA	NA	NA			9			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDX2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,28537304,G,G&fts=all">p.P297L</a>
ELF4	Missense_Mutation	p.T581I	G	G		4	Cancer Gene Census	X	129200946	129200946	194	0.139175257731959	NA	NA	NA			22			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ELF4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,129200946,G,G&fts=all">p.T581I</a>
GATA3	Missense_Mutation	p.R367Q	G	G		4	Cancer Gene Census	10	8115751	8115751	111	0.0630630630630631	NA	NA	NA		p.R367L(1)	87			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GATA3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,8115751,G,G&fts=all">p.R367Q</a>
KIAA1549	Missense_Mutation	p.S202F	G	G		4	Cancer Gene Census	7	138603767	138603767	204	0.0784313725490196	NA	NA	NA			7			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA1549&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,138603767,G,G&fts=all">p.S202F</a>
LIFR	Missense_Mutation	p.H291Y	G	G		4	Cancer Gene Census	5	38510686	38510686	284	0.028169014084507	NA	NA	NA			78			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LIFR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,38510686,G,G&fts=all">p.H291Y</a>
MKL1	Missense_Mutation	p.S612F	G	G		4	Cancer Gene Census	22	40814457	40814457	218	0.0779816513761468	NA	NA	NA			30	Pro-rich.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MKL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,40814457,G,G&fts=all">p.S612F</a>
MLF1	Missense_Mutation	p.E179K	G	G		4	Cancer Gene Census	3	158317959	158317959	251	0.171314741035857	NA	NA	NA		p.E189*(1)|p.E220*(1)	3			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MLF1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,158317959,G,G&fts=all">p.E179K</a>
PBRM1	Missense_Mutation	p.P1094L	G	G		4	Cancer Gene Census	3	52620592	52620592	206	0.16504854368932	NA	NA	NA			335			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PBRM1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,52620592,G,G&fts=all">p.P1094L</a>
PBRM1	Missense_Mutation	p.P1094S	G	G		4	Cancer Gene Census	3	52620593	52620593	203	0.16256157635468	NA	NA	NA			335			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PBRM1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,52620593,G,G&fts=all">p.P1094S</a>
PRDM16	Missense_Mutation	p.S521F	C	C		4	Cancer Gene Census	1	3328323	3328323	232	0.0344827586206897	NA	NA	NA			59	Pro-rich.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRDM16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,3328323,C,C&fts=all">p.S521F</a>
RNF213	Missense_Mutation	p.P354S	C	C		4	Cancer Gene Census	17	78262534	78262534	164	0.0731707317073171	NA	NA	NA			130			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RNF213&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,78262534,C,C&fts=all">p.P354S</a>
RNF213	Missense_Mutation	p.P354L	C	C		4	Cancer Gene Census	17	78262535	78262535	163	0.0736196319018405	NA	NA	NA			130			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RNF213&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,78262535,C,C&fts=all">p.P354L</a>
C6	Missense_Mutation	p.E871K	C	C		4.16666666666667	Cancer Pathway Linked to: MTOR; BRAF; EP300	5	41149355	41149355	687	0.0669577874818049	NA	NA	NA	 KEGG_THYROID_CANCER  |  REACTOME_CELL_CYCLE_CHECKPOINTS  |  KEGG_PATHWAYS_IN_CANCER  | 	p.E871K(1)	96	C5b-binding domain.|Factor I module (FIM) 2.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,41149355,C,C&fts=all">p.E871K</a>
COL4A4	Missense_Mutation	p.G631R	C	C		4.16666666666667	Cancer Pathway Linked to: MTOR; BRAF; EP300	2	227942706	227942706	92	0.0543478260869565	NA	NA	NA	 KEGG_SMALL_CELL_LUNG_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		98	Triple-helical region.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL4A4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,227942706,C,C&fts=all">p.G631R</a>
FGF16	Missense_Mutation	p.L102F	C	C		4.16666666666667	Cancer Pathway Linked to: MTOR; BRAF; EP300	X	76711967	76711967	183	0.103825136612022	NA	NA	NA	 KEGG_PATHWAYS_IN_CANCER  | 		4			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FGF16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,76711967,C,C&fts=all">p.L102F</a>
HHIP	Missense_Mutation	p.L537F	C	C		4.16666666666667	Cancer Pathway Linked to: MTOR; BRAF; EP300	4	145636513	145636513	514	0.0778210116731518	NA	NA	NA	 KEGG_PATHWAYS_IN_CANCER  | 		33			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HHIP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,145636513,C,C&fts=all">p.L537F</a>
ITGA6	Missense_Mutation	p.H201Y	C	C		4.16666666666667	Cancer Pathway Linked to: MTOR; BRAF; EP300	2	173334066	173334066	323	0.0990712074303406	NA	NA	NA	 KEGG_SMALL_CELL_LUNG_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		44			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITGA6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,173334066,C,C&fts=all">p.H201Y</a>
LAMB3	Missense_Mutation	p.V1058I	C	C		4.16666666666667	Cancer Pathway Linked to: MTOR; BRAF; EP300	1	209790811	209790811	170	0.0529411764705882	NA	NA	NA	 KEGG_SMALL_CELL_LUNG_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		45	Domain I.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LAMB3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,209790811,C,C&fts=all">p.V1058I</a>
LAMB4	Missense_Mutation	p.R961K	C	C		4.16666666666667	Cancer Pathway Linked to: MTOR; BRAF; EP300	7	107704385	107704385	255	0.0627450980392157	NA	NA	NA	 KEGG_SMALL_CELL_LUNG_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		97	Laminin EGF-like 9. {ECO:0000255|PROSITE- ProRule:PRU00460}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LAMB4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,107704385,C,C&fts=all">p.R961K</a>
PDGFD	Missense_Mutation	p.R275K	C	C		4.16666666666667	Cancer Pathway Linked to: MTOR; BRAF; EP300	11	103797803	103797803	178	0.0337078651685393	NA	NA	NA	 KEGG_PROSTATE_CANCER  | 		23			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDGFD&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,103797803,C,C&fts=all">p.R275K</a>
PAK7	Missense_Mutation	p.H22Y	G	G		4.25	Cancer Pathway Linked to: BRAF; EP300	20	9624913	9624913	331	0.0392749244712991	NA	NA	NA	 KEGG_RENAL_CELL_CARCINOMA  | 		81	CRIB. {ECO:0000255|PROSITE- ProRule:PRU00057}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PAK7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,9624913,G,G&fts=all">p.H22Y</a>
SOS1	Missense_Mutation	p.R310C	G	G		4.25	Cancer Pathway Linked to: ERBB4; EP300	2	39262578	39262578	401	0.0748129675810474	NA	NA	NA	 BIOCARTA_GLEEVEC_PATHWAY  |  BIOCARTA_HER2_PATHWAY  |  BIOCARTA_IGF1R_PATHWAY  |  BIOCARTA_EGF_PATHWAY  |  BIOCARTA_MET_PATHWAY  |  KEGG_ENDOMETRIAL_CANCER  |  KEGG_NON_SMALL_CELL_LUNG_CANCER  |  KEGG_RENAL_CELL_CARCINOMA  |  KEGG_PROSTATE_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		75	DH. {ECO:0000255|PROSITE- ProRule:PRU00062}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SOS1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,39262578,G,G&fts=all">p.R310C</a>
SMAD3	Missense_Mutation	p.P274L	C	C		4.5	Cancer Pathway Linked to: EP300	15	67477146	67477146	162	0.0864197530864197	NA	NA	NA	 BIOCARTA_TGFB_PATHWAY  |  KEGG_COLORECTAL_CANCER  |  KEGG_PANCREATIC_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		31	MH2. {ECO:0000255|PROSITE- ProRule:PRU00439}.|Sufficient for interaction with XPO4.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SMAD3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,67477146,C,C&fts=all">p.P274L</a>
TG	Missense_Mutation	p.R2177C	C	C	rs555719562	4.5	Cancer Pathway Linked to: EP300	8	134025976	134025976	86	0.0465116279069767	NA	NA	NA	 BIOCARTA_TGFB_PATHWAY  |  BIOCARTA_MET_PATHWAY  |  KEGG_SMALL_CELL_LUNG_CANCER  |  KEGG_NON_SMALL_CELL_LUNG_CANCER  |  KEGG_COLORECTAL_CANCER  |  KEGG_PANCREATIC_CANCER  |  KEGG_RENAL_CELL_CARCINOMA  |  REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL  |  KEGG_PROSTATE_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 	p.R2177C(1)	168			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TG&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,134025976,C,C&fts=all">p.R2177C</a>
TNN	Missense_Mutation	p.S366F	C	C		4.5	Cancer Pathway Linked to: BRAF	1	175052934	175052934	115	0.0434782608695652	NA	NA	NA	 KEGG_THYROID_CANCER  |  BIOCARTA_CELL2CELL_PATHWAY  |  KEGG_ENDOMETRIAL_CANCER  |  KEGG_COLORECTAL_CANCER  |  KEGG_PROSTATE_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		156	Fibronectin type-III 2. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,175052934,C,C&fts=all">p.S366F</a>
ACTN2	Missense_Mutation	p.E414K	G	G		5	Cancer Pathway	1	236906328	236906328	113	0.0707964601769911	NA	NA	NA	 BIOCARTA_CELL2CELL_PATHWAY  | 		86			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACTN2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,236906328,G,G&fts=all">p.E414K</a>
GH1	Splice_Site		C	C		5	Cancer Pathway	17	61995285	61995285	137	0.0510948905109489	NA	NA	NA	 BIOCARTA_LONGEVITY_PATHWAY  | 		19			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GH1&recr=Open">Click here</a>	
GHR	Missense_Mutation	p.F141I	T	T		5	Cancer Pathway	5	42695173	42695173	191	0.0680628272251309	NA	NA	NA	 BIOCARTA_LONGEVITY_PATHWAY  | 		39			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GHR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,42695173,T,T&fts=all">p.F141I</a>
LILRB1	Missense_Mutation	p.G51E	G	G		5	Cancer Pathway	19	55143032	55143032	207	0.0241545893719807	NA	NA	NA	 REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL  | 		74	Ig-like C2-type 1.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LILRB1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,55143032,G,G&fts=all">p.G51E</a>
MAP3K5	Missense_Mutation	p.E679K	C	C		5	Cancer Pathway	6	136944101	136944101	556	0.0665467625899281	NA	NA	NA	 BIOCARTA_41BB_PATHWAY  | 		58			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAP3K5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,136944101,C,C&fts=all">p.E679K</a>
PSMA2	Missense_Mutation	p.E3K	C	C		5	Cancer Pathway	7	42971751	42971751	242	0.0454545454545455	NA	NA	NA	 REACTOME_CELL_CYCLE_CHECKPOINTS  | 		10			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PSMA2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,42971751,C,C&fts=all">p.E3K</a>
RAD54L	Missense_Mutation	p.S274F	C	C		5	Cancer Pathway	1	46726987	46726987	260	0.0384615384615385	NA	NA	NA	 KEGG_HOMOLOGOUS_RECOMBINATION  | 		25	Helicase ATP-binding. {ECO:0000255|PROSITE-ProRule:PRU00541}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RAD54L&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,46726987,C,C&fts=all">p.S274F</a>
CAMK4	Missense_Mutation	p.R139Q	G	G	rs371085970	5.75	Cancer Pathway	5	110730437	110730437	323	0.0185758513931889	NA	NA	NA	 BIOCARTA_STATHMIN_PATHWAY  | 		30	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CAMK4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,110730437,G,G&fts=all">p.R139Q</a>
CAMKV	Nonsense_Mutation	p.W252*	C	C		6.75	Cancer Module	3	49898168	49898168	223	0.121076233183857	NA	NA	NA			7	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CAMKV&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,49898168,C,C&fts=all">p.W252*</a>
ROR2	Missense_Mutation	p.L595F	G	G		6.75	Cancer Module	9	94486993	94486993	80	0.1125	NA	NA	NA			71	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ROR2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,94486993,G,G&fts=all">p.L595F</a>
STK31	Missense_Mutation	p.H942Y	C	C		6.75	Cancer Module	7	23854826	23854826	211	0.0568720379146919	NA	NA	NA			67	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STK31&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,23854826,C,C&fts=all">p.H942Y</a>
A1CF	Splice_Site	p.E34K	C	C		7	Cancer Module	10	52603882	52603882	139	0.0935251798561151	NA	NA	NA		p.E42K(2)|p.E34K(2)	29			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+A1CF&recr=Open">Click here</a>	
ABCA4	Missense_Mutation	p.P2180S	G	G		7	Cancer Module	1	94463608	94463608	177	0.0677966101694915	NA	NA	NA			147			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCA4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,94463608,G,G&fts=all">p.P2180S</a>
ABCA4	Splice_Site	p.D453N	C	C		7	Cancer Module	1	94543443	94543443	229	0.0524017467248908	NA	NA	NA			147			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCA4&recr=Open">Click here</a>	
ABCC3	Missense_Mutation	p.P234L	C	C		7	Cancer Module	17	48736624	48736624	175	0.108571428571429	NA	NA	NA			33			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCC3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,48736624,C,C&fts=all">p.P234L</a>
ABLIM3	Splice_Site	p.D193N	G	G		7	Cancer Module	5	148590290	148590290	233	0.0257510729613734	NA	NA	NA			34	LIM zinc-binding 3. {ECO:0000255|PROSITE- ProRule:PRU00125}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABLIM3&recr=Open">Click here</a>	
ADAM28	Missense_Mutation	p.M171I	G	G		7	Cancer Module	8	24171030	24171030	501	0.0838323353293413	NA	NA	NA			42			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAM28&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,24171030,G,G&fts=all">p.M171I</a>
ADAMTSL4	Missense_Mutation	p.P195L	C	C	rs139990606	7	Cancer Module	1	150526051	150526051	242	0.0991735537190083	NA	NA	NA			32			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAMTSL4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,150526051,C,C&fts=all">p.P195L</a>
ADAMTSL4	Missense_Mutation	p.G473S	G	G		7	Cancer Module	1	150528683	150528683	298	0.0671140939597315	NA	NA	NA			32			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAMTSL4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,150528683,G,G&fts=all">p.G473S</a>
ADH1B	Missense_Mutation	p.S55R	A	A		7	Cancer Module	4	100239297	100239297	413	0.0290556900726392	NA	NA	NA			33			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADH1B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,100239297,A,A&fts=all">p.S55R</a>
AGL	Missense_Mutation	p.L525F	C	C		7	Cancer Module	1	100343346	100343346	401	0.057356608478803	NA	NA	NA			69			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AGL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,100343346,C,C&fts=all">p.L525F</a>
AGR3	Missense_Mutation	p.T127R	G	G	rs201269935	7	Cancer Module	7	16900195	16900195	270	0.0296296296296296	NA	NA	NA			13			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AGR3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,16900195,G,G&fts=all">p.T127R</a>
AIM1	Missense_Mutation	p.H658Y	C	C		7	Cancer Module	6	106968279	106968279	266	0.056390977443609	NA	NA	NA			69			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AIM1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,106968279,C,C&fts=all">p.H658Y</a>
AIM2	Start_Codon_SNP	p.M1I	C	C		7	Cancer Module	1	159043287	159043287	568	0.109154929577465	NA	NA	NA			16	DAPIN. {ECO:0000255|PROSITE- ProRule:PRU00061}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AIM2&recr=Open">Click here</a>	
AKAP6	Missense_Mutation	p.G2257E	G	G		7	Cancer Module	14	33293789	33293789	113	0.0619469026548673	NA	NA	NA			122			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AKAP6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,33293789,G,G&fts=all">p.G2257E</a>
AKR1C4	Missense_Mutation	p.V165M	G	G		7	Cancer Module	10	5248283	5248283	242	0.0537190082644628	NA	NA	NA			18			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AKR1C4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,5248283,G,G&fts=all">p.V165M</a>
ALOX15	Missense_Mutation	p.P329S	G	G		7	Cancer Module	17	4539230	4539230	148	0.0472972972972973	NA	NA	NA			20	Lipoxygenase. {ECO:0000255|PROSITE- ProRule:PRU00726}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ALOX15&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,4539230,G,G&fts=all">p.P329S</a>
ANK3	Missense_Mutation	p.S3987N	C	C		7	Cancer Module	10	61828679	61828679	266	0.0789473684210526	NA	NA	NA			196			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANK3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,61828679,C,C&fts=all">p.S3987N</a>
ANK3	Missense_Mutation	p.G3606E	C	C		7	Cancer Module	10	61829822	61829822	227	0.0616740088105727	NA	NA	NA			196			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANK3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,61829822,C,C&fts=all">p.G3606E</a>
ANK3	Missense_Mutation	p.E3321K	C	C	rs372719095	7	Cancer Module	10	61830678	61830678	322	0.0683229813664596	NA	NA	NA			196			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANK3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,61830678,C,C&fts=all">p.E3321K</a>
APOB	Missense_Mutation	p.S2136L	G	G		7	Cancer Module	2	21233333	21233333	257	0.0778210116731518	NA	NA	NA			305	Heparin-binding.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+APOB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,21233333,G,G&fts=all">p.S2136L</a>
ASGR1	Missense_Mutation	p.P207S	G	G		7	Cancer Module	17	7077362	7077362	116	0.0948275862068965	NA	NA	NA			10	C-type lectin. {ECO:0000255|PROSITE- ProRule:PRU00040}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ASGR1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,7077362,G,G&fts=all">p.P207S</a>
ATG2A	Missense_Mutation	p.A1636V	G	G		7	Cancer Module	11	64665398	64665398	142	0.0915492957746479	NA	NA	NA			55			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATG2A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,64665398,G,G&fts=all">p.A1636V</a>
ATP5B	Missense_Mutation	p.R281W	G	G		7	Cancer Module	12	57036567	57036567	205	0.0731707317073171	NA	NA	NA			19			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATP5B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,57036567,G,G&fts=all">p.R281W</a>
ATP9A	Missense_Mutation	p.S221L	G	G		7	Cancer Module	20	50307339	50307339	506	0.0454545454545455	NA	NA	NA		p.S221L(1)	48			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATP9A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,50307339,G,G&fts=all">p.S221L</a>
AUTS2	Missense_Mutation	p.L158F	C	C		7	Cancer Module	7	69364434	69364434	205	0.0634146341463415	NA	NA	NA			50			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AUTS2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,69364434,C,C&fts=all">p.L158F</a>
BCL2L13	Nonsense_Mutation	p.R161*	C	C		7	Cancer Module	22	18185033	18185033	717	0.0111576011157601	NA	NA	NA			15			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BCL2L13&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,18185033,C,C&fts=all">p.R161*</a>
BMP5	Missense_Mutation	p.S130F	G	G	rs200167972	7	Cancer Module	6	55739275	55739275	202	0.0495049504950495	NA	NA	NA			45			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BMP5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,55739275,G,G&fts=all">p.S130F</a>
BMP6	Missense_Mutation	p.P246S	C	C		7	Cancer Module	6	7845444	7845444	352	0.0539772727272727	NA	NA	NA			23			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BMP6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,7845444,C,C&fts=all">p.P246S</a>
BZRAP1	Missense_Mutation	p.P668S	G	G	rs148890695	7	Cancer Module	17	56390000	56390000	134	0.0895522388059701	NA	NA	NA		p.P728S(1)	54	SH3 1. {ECO:0000255|PROSITE- ProRule:PRU00192}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BZRAP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,56390000,G,G&fts=all">p.P668S</a>
CASR	Missense_Mutation	p.R716C	C	C		7	Cancer Module	3	122002947	122002947	70	0.1	NA	NA	NA			84			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CASR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,122002947,C,C&fts=all">p.R716C</a>
CCDC135	Missense_Mutation	p.E484G	A	A		7	Cancer Module	16	57756956	57756956	235	0.0936170212765957	NA	NA	NA			30			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC135&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,57756956,A,A&fts=all">p.E484G</a>
CCDC28A	Missense_Mutation	p.P163S	C	C		7	Cancer Module	6	139101017	139101017	260	0.0692307692307692	NA	NA	NA			13			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC28A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,139101017,C,C&fts=all">p.P163S</a>
CCR4	Missense_Mutation	p.G56R	G	G		7	Cancer Module	3	32995080	32995080	326	0.110429447852761	NA	NA	NA			16			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCR4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,32995080,G,G&fts=all">p.G56R</a>
CD1B	Nonsense_Mutation	p.W259*	C	C		7	Cancer Module	1	158299270	158299270	204	0.0637254901960784	NA	NA	NA		p.W259*(1)	30	Ig-like.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CD1B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,158299270,C,C&fts=all">p.W259*</a>
CD69	Missense_Mutation	p.F175L	A	A		7	Cancer Module	12	9906154	9906154	329	0.106382978723404	NA	NA	NA			10	C-type lectin. {ECO:0000255|PROSITE- ProRule:PRU00040}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CD69&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,9906154,A,A&fts=all">p.F175L</a>
CECR1	Missense_Mutation	p.H219Y	G	G		7	Cancer Module	22	17684551	17684551	153	0.117647058823529	NA	NA	NA			25			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CECR1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,17684551,G,G&fts=all">p.H219Y</a>
CELSR1	Nonsense_Mutation	p.Q1048*	G	G		7	Cancer Module	22	46929926	46929926	48	0.0833333333333333	NA	NA	NA			95	Cadherin 8. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CELSR1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,46929926,G,G&fts=all">p.Q1048*</a>
CFI	Missense_Mutation	p.R347Q	C	C		7	Cancer Module	4	110670683	110670683	355	0.0225352112676056	NA	NA	NA			27	Peptidase S1. {ECO:0000255|PROSITE- ProRule:PRU00274}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CFI&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,110670683,C,C&fts=all">p.R347Q</a>
CHGB	Missense_Mutation	p.G240R	G	G		7	Cancer Module	20	5903508	5903508	66	0.136363636363636	NA	NA	NA			47			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHGB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,5903508,G,G&fts=all">p.G240R</a>
CHRND	Missense_Mutation	p.G204R	G	G		7	Cancer Module	2	233393672	233393672	83	0.0602409638554217	NA	NA	NA			34			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHRND&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,233393672,G,G&fts=all">p.G204R</a>
CKAP2	Missense_Mutation	p.P102S	C	C		7	Cancer Module	13	53035262	53035262	283	0.0848056537102474	NA	NA	NA			20			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CKAP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,53035262,C,C&fts=all">p.P102S</a>
CLCA2	Missense_Mutation	p.S746L	C	C		7	Cancer Module	1	86919133	86919133	180	0.0555555555555556	NA	NA	NA			42			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLCA2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,86919133,C,C&fts=all">p.S746L</a>
CLCN3	Missense_Mutation	p.R490H	G	G	rs553052405	7	Cancer Module	4	170618791	170618791	364	0.0164835164835165	NA	NA	NA			29			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLCN3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,170618791,G,G&fts=all">p.R490H</a>
CLCN6	Missense_Mutation	p.S424R	T	T		7	Cancer Module	1	11893595	11893595	221	0.0497737556561086	NA	NA	NA			36			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLCN6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,11893595,T,T&fts=all">p.S424R</a>
CNTNAP2	Missense_Mutation	p.E149K	G	G		7	Cancer Module	7	146741041	146741041	589	0.0390492359932088	NA	NA	NA			188	F5/8 type C. {ECO:0000255|PROSITE- ProRule:PRU00081}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNTNAP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,146741041,G,G&fts=all">p.E149K</a>
CNTNAP2	Missense_Mutation	p.E713K	G	G	rs201178948	7	Cancer Module	7	147600695	147600695	99	0.0606060606060606	NA	NA	NA			188	Fibrinogen C-terminal. {ECO:0000255|PROSITE-ProRule:PRU00739}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNTNAP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,147600695,G,G&fts=all">p.E713K</a>
COL15A1	Missense_Mutation	p.R910Q	G	G	rs138040776	7	Cancer Module	9	101810117	101810117	435	0.0804597701149425	NA	NA	NA		p.R910L(1)	107	Collagen-like 4.|Triple-helical region 5 (COL5).		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL15A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,101810117,G,G&fts=all">p.R910Q</a>
COL19A1	Missense_Mutation	p.E99K	G	G		7	Cancer Module	6	70637829	70637829	558	0.0591397849462366	NA	NA	NA		p.E99*(1)	109	Laminin G-like.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL19A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,70637829,G,G&fts=all">p.E99K</a>
COL19A1	Missense_Mutation	p.E199K	G	G		7	Cancer Module	6	70639521	70639521	371	0.0700808625336927	NA	NA	NA			109	Laminin G-like.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL19A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,70639521,G,G&fts=all">p.E199K</a>
COL2A1	Splice_Site	p.G684S	C	C		7	Cancer Module	12	48376920	48376920	39	0.128205128205128	NA	NA	NA			64	Triple-helical region.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL2A1&recr=Open">Click here</a>	
COL2A1	Missense_Mutation	p.P163L	G	G		7	Cancer Module	12	48391432	48391432	94	0.074468085106383	NA	NA	NA			64			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL2A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,48391432,G,G&fts=all">p.P163L</a>
COL3A1	Missense_Mutation	p.R271Q	G	G	rs112185887	7	Cancer Module	2	189855743	189855743	573	0.0523560209424084	NA	NA	NA		p.R271Q(1)	126	Triple-helical region.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL3A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,189855743,G,G&fts=all">p.R271Q</a>
COL5A1	Missense_Mutation	p.P693S	C	C		7	Cancer Module	9	137657569	137657569	194	0.0721649484536082	NA	NA	NA			115	Triple-helical region.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL5A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,137657569,C,C&fts=all">p.P693S</a>
CPZ	Missense_Mutation	p.R312Q	G	G	rs538634471	7	Cancer Module	4	8608525	8608525	113	0.0707964601769911	NA	NA	NA			46			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CPZ&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,8608525,G,G&fts=all">p.R312Q</a>
CR1	Missense_Mutation	p.G2E	G	G		7	Cancer Module	1	207669617	207669617	127	0.094488188976378	NA	NA	NA			82			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CR1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,207669617,G,G&fts=all">p.G2E</a>
CRYBA4	Missense_Mutation	p.R25Q	G	G		7	Cancer Module	22	27019232	27019232	251	0.107569721115538	NA	NA	NA		p.R25L(1)	18	Beta/gamma crystallin 'Greek key' 1. {ECO:0000255|PROSITE-ProRule:PRU00028}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CRYBA4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,27019232,G,G&fts=all">p.R25Q</a>
CRYGC	Nonsense_Mutation	p.W69*	C	C	rs373451856	7	Cancer Module	2	208994210	208994210	212	0.0943396226415094	NA	NA	NA			9	Beta/gamma crystallin 'Greek key' 2. {ECO:0000255|PROSITE-ProRule:PRU00028}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CRYGC&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,208994210,C,C&fts=all">p.W69*</a>
CRYGD	Nonsense_Mutation	p.Q101*	G	G		7	Cancer Module	2	208986621	208986621	462	0.0151515151515152	NA	NA	NA			5	Beta/gamma crystallin 'Greek key' 3. {ECO:0000255|PROSITE-ProRule:PRU00028}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CRYGD&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,208986621,G,G&fts=all">p.Q101*</a>
CRYZ	Missense_Mutation	p.P63L	G	G		7	Cancer Module	1	75188878	75188878	347	0.0662824207492795	NA	NA	NA			10			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CRYZ&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,75188878,G,G&fts=all">p.P63L</a>
CSMD2	Missense_Mutation	p.G332E	C	C		7	Cancer Module	1	34123617	34123617	212	0.0943396226415094	NA	NA	NA			246			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSMD2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,34123617,C,C&fts=all">p.G332E</a>
CSMD3	Missense_Mutation	p.P3464S	G	G	rs141126792	7	Cancer Module	8	113256635	113256635	272	0.0257352941176471	NA	NA	NA		p.P3464S(1)	646	Sushi 28. {ECO:0000255|PROSITE- ProRule:PRU00302}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSMD3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,113256635,G,G&fts=all">p.P3464S</a>
CTNS	Missense_Mutation	p.P29L	C	C		7	Cancer Module	17	3550762	3550762	134	0.119402985074627	NA	NA	NA			10			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CTNS&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,3550762,C,C&fts=all">p.P29L</a>
CTTNBP2	Missense_Mutation	p.S629L	G	G		7	Cancer Module	7	117431364	117431364	90	0.0777777777777778	NA	NA	NA			83			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CTTNBP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,117431364,G,G&fts=all">p.S629L</a>
CYP11A1	Missense_Mutation	p.S233F	G	G		7	Cancer Module	15	74631642	74631642	127	0.031496062992126	NA	NA	NA			20			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP11A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,74631642,G,G&fts=all">p.S233F</a>
DECR1	Missense_Mutation	p.V198A	T	T		7	Cancer Module	8	91049123	91049123	419	0.0405727923627685	NA	NA	NA			15			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DECR1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,91049123,T,T&fts=all">p.V198A</a>
DEF6	Missense_Mutation	p.R104W	C	C		7	Cancer Module	6	35278308	35278308	292	0.0479452054794521	NA	NA	NA			15			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DEF6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,35278308,C,C&fts=all">p.R104W</a>
DHRS9	Missense_Mutation	p.P87S	C	C		7	Cancer Module	2	169938350	169938350	153	0.065359477124183	NA	NA	NA			13			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DHRS9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,169938350,C,C&fts=all">p.P87S</a>
DLEC1	Missense_Mutation	p.P334S	C	C		7	Cancer Module	3	38104198	38104198	176	0.0738636363636364	NA	NA	NA			51			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DLEC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,38104198,C,C&fts=all">p.P334S</a>
DLX3	Missense_Mutation	p.S198N	C	C		7	Cancer Module	17	48069152	48069152	289	0.0519031141868512	NA	NA	NA			12			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DLX3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,48069152,C,C&fts=all">p.S198N</a>
DLX4	Missense_Mutation	p.E91K	G	G		7	Cancer Module	17	48047103	48047103	149	0.114093959731544	NA	NA	NA			10			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DLX4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,48047103,G,G&fts=all">p.E91K</a>
DNAH11	Missense_Mutation	p.R2997W	C	C	rs371680752	7	Cancer Module	7	21805094	21805094	342	0.043859649122807	NA	NA	NA			230	AAA 4. {ECO:0000250}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,21805094,C,C&fts=all">p.R2997W</a>
DNAH3	Missense_Mutation	p.S3603N	C	C		7	Cancer Module	16	20970519	20970519	157	0.0318471337579618	NA	NA	NA			202	AAA 6. {ECO:0000250}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,20970519,C,C&fts=all">p.S3603N</a>
DNAH3	Missense_Mutation	p.S2582L	G	G		7	Cancer Module	16	20994157	20994157	235	0.0936170212765957	NA	NA	NA			202	AAA 4. {ECO:0000250}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,20994157,G,G&fts=all">p.S2582L</a>
DNAH5	Missense_Mutation	p.D1898N	C	C	rs149834171	7	Cancer Module	5	13841032	13841032	223	0.0448430493273543	NA	NA	NA			378	Stem. {ECO:0000250}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,13841032,C,C&fts=all">p.D1898N</a>
DNAH7	Nonsense_Mutation	p.Q2553*	G	G	rs555618371	7	Cancer Module	2	196726520	196726520	265	0.0641509433962264	NA	NA	NA			205	AAA 4. {ECO:0000250}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,196726520,G,G&fts=all">p.Q2553*</a>
DNAH7	Nonsense_Mutation	p.R2293*	G	G		7	Cancer Module	2	196729502	196729502	434	0.043778801843318	NA	NA	NA			205			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,196729502,G,G&fts=all">p.R2293*</a>
DNAH7	Missense_Mutation	p.T384R	G	G		7	Cancer Module	2	196866421	196866421	294	0.0612244897959184	NA	NA	NA			205	Stem. {ECO:0000250}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,196866421,G,G&fts=all">p.T384R</a>
DNAH9	Missense_Mutation	p.S2163F	C	C		7	Cancer Module	17	11650961	11650961	182	0.0714285714285714	NA	NA	NA			290	AAA 2. {ECO:0000250}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,11650961,C,C&fts=all">p.S2163F</a>
DNAJC10	Missense_Mutation	p.H690Y	C	C		7	Cancer Module	2	183623957	183623957	362	0.0718232044198895	NA	NA	NA			32	Thioredoxin 4. {ECO:0000255|PROSITE- ProRule:PRU00691}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAJC10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,183623957,C,C&fts=all">p.H690Y</a>
DNAJC7	Missense_Mutation	p.A54V	G	G		7	Cancer Module	17	40152505	40152505	175	0.0342857142857143	NA	NA	NA			9			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAJC7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,40152505,G,G&fts=all">p.A54V</a>
DPEP2	Missense_Mutation	p.S425F	G	G		7	Cancer Module	16	68021596	68021596	187	0.0374331550802139	NA	NA	NA			17			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DPEP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,68021596,G,G&fts=all">p.S425F</a>
DPYD	Missense_Mutation	p.D529N	C	C		7	Cancer Module	1	97981437	97981437	286	0.0384615384615385	NA	NA	NA			83			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DPYD&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,97981437,C,C&fts=all">p.D529N</a>
DPYD	Missense_Mutation	p.L80P	A	A		7	Cancer Module	1	98206030	98206030	552	0.0742753623188406	NA	NA	NA			83	4Fe-4S ferredoxin-type 1. {ECO:0000255|PROSITE-ProRule:PRU00711}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DPYD&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,98206030,A,A&fts=all">p.L80P</a>
DYX1C1	Missense_Mutation	p.R233C	G	G	rs530669133	7	Cancer Module	15	55742506	55742506	326	0.0736196319018405	NA	NA	NA			18			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DYX1C1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,55742506,G,G&fts=all">p.R233C</a>
DYX1C1	Missense_Mutation	p.S216L	G	G		7	Cancer Module	15	55742556	55742556	228	0.0657894736842105	NA	NA	NA			18			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DYX1C1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,55742556,G,G&fts=all">p.S216L</a>
DZIP1	Missense_Mutation	p.V856I	C	C		7	Cancer Module	13	96234526	96234526	395	0.0126582278481013	NA	NA	NA			38			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DZIP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,96234526,C,C&fts=all">p.V856I</a>
DZIP1	Missense_Mutation	p.H361Y	G	G		7	Cancer Module	13	96274626	96274626	176	0.0965909090909091	NA	NA	NA		p.H361Y(4)	38			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DZIP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,96274626,G,G&fts=all">p.H361Y</a>
ECEL1	Missense_Mutation	p.E475K	C	C		7	Cancer Module	2	233348209	233348209	66	0.0757575757575758	NA	NA	NA			23			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ECEL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,233348209,C,C&fts=all">p.E475K</a>
EDC4	Missense_Mutation	p.S301I	G	G		7	Cancer Module	16	67912076	67912076	116	0.0431034482758621	NA	NA	NA			41			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EDC4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,67912076,G,G&fts=all">p.S301I</a>
EDEM3	Nonsense_Mutation	p.R85*	G	G		7	Cancer Module	1	184706797	184706797	298	0.0738255033557047	NA	NA	NA			30			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EDEM3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,184706797,G,G&fts=all">p.R85*</a>
EDN1	Missense_Mutation	p.S189F	C	C		7	Cancer Module	6	12296227	12296227	642	0.105919003115265	NA	NA	NA			13			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EDN1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,12296227,C,C&fts=all">p.S189F</a>
EFCAB6	Missense_Mutation	p.G1341R	C	C	rs3833393	7	Cancer Module	22	43933284	43933284	328	0.0609756097560976	NA	NA	NA			68	Interaction with PARK7.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EFCAB6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,43933284,C,C&fts=all">p.G1341R</a>
EFHC2	Missense_Mutation	p.R522C	G	G		7	Cancer Module	X	44091783	44091783	30	0.133333333333333	NA	NA	NA			29	DM10 3. {ECO:0000255|PROSITE- ProRule:PRU00665}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EFHC2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,44091783,G,G&fts=all">p.R522C</a>
EGR1	Missense_Mutation	p.Y235C	A	A		7	Cancer Module	5	137802842	137802842	215	0.0418604651162791	NA	NA	NA			6			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EGR1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,137802842,A,A&fts=all">p.Y235C</a>
EHBP1	Missense_Mutation	p.H801Y	C	C		7	Cancer Module	2	63176277	63176277	207	0.0628019323671498	NA	NA	NA			47			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EHBP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,63176277,C,C&fts=all">p.H801Y</a>
EPB41L4A	Missense_Mutation	p.E268K	C	C	rs200997940	7	Cancer Module	5	111576501	111576501	433	0.0323325635103926	NA	NA	NA		p.E268K(1)	34	FERM. {ECO:0000255|PROSITE- ProRule:PRU00084}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EPB41L4A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,111576501,C,C&fts=all">p.E268K</a>
EPHA7	Missense_Mutation	p.P554S	G	G		7	Cancer Module	6	93974394	93974394	326	0.0460122699386503	NA	NA	NA			112			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EPHA7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,93974394,G,G&fts=all">p.P554S</a>
ETAA1	Missense_Mutation	p.S405F	C	C		7	Cancer Module	2	67631028	67631028	375	0.0746666666666667	NA	NA	NA			33			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ETAA1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,67631028,C,C&fts=all">p.S405F</a>
FABP2	Missense_Mutation	p.E102K	C	C	rs375920710	7	Cancer Module	4	120240735	120240735	717	0.0460251046025105	NA	NA	NA		p.E102K(1)	8			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FABP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,120240735,C,C&fts=all">p.E102K</a>
FBN2	Missense_Mutation	p.G2282R	C	C		7	Cancer Module	5	127623036	127623036	420	0.0690476190476191	NA	NA	NA			197	EGF-like 38; calcium-binding. {ECO:0000255|PROSITE-ProRule:PRU00076}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FBN2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,127623036,C,C&fts=all">p.G2282R</a>
FBN2	Missense_Mutation	p.V723A	A	A		7	Cancer Module	5	127704955	127704955	221	0.0452488687782805	NA	NA	NA			197	TB 3.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FBN2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,127704955,A,A&fts=all">p.V723A</a>
FGL1	Splice_Site	p.S21L	G	G		7	Cancer Module	8	17743002	17743002	294	0.0272108843537415	NA	NA	NA		p.S21L(1)	13			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FGL1&recr=Open">Click here</a>	
FMNL1	Missense_Mutation	p.R98Q	G	G		7	Cancer Module	17	43309813	43309813	138	0.072463768115942	NA	NA	NA			33	GBD/FH3. {ECO:0000255|PROSITE- ProRule:PRU00579}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FMNL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,43309813,G,G&fts=all">p.R98Q</a>
FUBP3	Missense_Mutation	p.D246N	G	G		7	Cancer Module	9	133495810	133495810	270	0.0333333333333333	NA	NA	NA			21			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FUBP3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,133495810,G,G&fts=all">p.D246N</a>
FUT9	Missense_Mutation	p.G7E	G	G	rs146406553	7	Cancer Module	6	96651051	96651051	645	0.0186046511627907	NA	NA	NA		p.G7E(2)	34			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FUT9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,96651051,G,G&fts=all">p.G7E</a>
GABBR1	Missense_Mutation	p.Y228F	T	T		7	Cancer Module	6	29591776	29591776	110	0.0454545454545455	NA	NA	NA			47			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GABBR1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,29591776,T,T&fts=all">p.Y228F</a>
GNB5	Nonsense_Mutation	p.W394*	C	C		7	Cancer Module	15	52414960	52414960	370	0.0621621621621622	NA	NA	NA			2			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GNB5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,52414960,C,C&fts=all">p.W394*</a>
GON4L	Missense_Mutation	p.E614K	C	C		7	Cancer Module	1	155753829	155753829	392	0.0892857142857143	NA	NA	NA			45			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GON4L&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,155753829,C,C&fts=all">p.E614K</a>
GPR17	Missense_Mutation	p.A304V	C	C		7	Cancer Module	2	128409136	128409136	76	0.105263157894737	NA	NA	NA			19			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR17&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,128409136,C,C&fts=all">p.A304V</a>
GPR98	Missense_Mutation	p.K2484N	A	A	rs397517437	7	Cancer Module	5	89990025	89990025	128	0.1015625	NA	NA	NA			269	Calx-beta 17. {ECO:0000305|PubMed:11606593}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR98&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,89990025,A,A&fts=all">p.K2484N</a>
GPR98	Missense_Mutation	p.N3906Y	A	A		7	Cancer Module	5	90052406	90052406	117	0.0512820512820513	NA	NA	NA			269	Calx-beta 26. {ECO:0000255}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR98&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,90052406,A,A&fts=all">p.N3906Y</a>
GPR98	Missense_Mutation	p.S5625L	C	C	rs373862154	7	Cancer Module	5	90136657	90136657	160	0.09375	NA	NA	NA			269			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR98&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,90136657,C,C&fts=all">p.S5625L</a>
GRB14	Missense_Mutation	p.G269R	C	C		7	Cancer Module	2	165378501	165378501	349	0.0401146131805158	NA	NA	NA			32	PH. {ECO:0000255|PROSITE- ProRule:PRU00145}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRB14&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,165378501,C,C&fts=all">p.G269R</a>
GREB1	Missense_Mutation	p.S369F	C	C		7	Cancer Module	2	11725978	11725978	182	0.0824175824175824	NA	NA	NA			30			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GREB1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,11725978,C,C&fts=all">p.S369F</a>
GRIA4	Missense_Mutation	p.D212N	G	G		7	Cancer Module	11	105732896	105732896	165	0.0424242424242424	NA	NA	NA			82			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRIA4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,105732896,G,G&fts=all">p.D212N</a>
GRIK2	Missense_Mutation	p.R431C	C	C		7	Cancer Module	6	102266332	102266332	191	0.0418848167539267	NA	NA	NA			83			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRIK2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,102266332,C,C&fts=all">p.R431C</a>
GSTA4	Missense_Mutation	p.F133C	A	A		7	Cancer Module	6	52849278	52849278	458	0.0414847161572052	NA	NA	NA			7	GST C-terminal.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GSTA4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,52849278,A,A&fts=all">p.F133C</a>
GTF3C1	Missense_Mutation	p.E1366K	C	C		7	Cancer Module	16	27492500	27492500	218	0.0596330275229358	NA	NA	NA			80			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GTF3C1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,27492500,C,C&fts=all">p.E1366K</a>
GUCY2C	Missense_Mutation	p.L331F	G	G		7	Cancer Module	12	14827652	14827652	290	0.0482758620689655	NA	NA	NA			51			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GUCY2C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,14827652,G,G&fts=all">p.L331F</a>
HAO1	Missense_Mutation	p.E197K	C	C		7	Cancer Module	20	7886933	7886933	219	0.0273972602739726	NA	NA	NA			36	FMN hydroxy acid dehydrogenase. {ECO:0000255|PROSITE-ProRule:PRU00683}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HAO1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,7886933,C,C&fts=all">p.E197K</a>
HBG2	Missense_Mutation	p.E91K	C	C		7	Cancer Module	11	5275566	5275566	609	0.0377668308702791	NA	NA	NA			13			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HBG2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,5275566,C,C&fts=all">p.E91K</a>
HDAC9	Missense_Mutation	p.R183Q	G	G		7	Cancer Module	7	18633644	18633644	210	0.0857142857142857	NA	NA	NA			82	Interaction with MAPK10. {ECO:0000250}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HDAC9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,18633644,G,G&fts=all">p.R183Q</a>
HMG20B	Missense_Mutation	p.E307K	G	G		7	Cancer Module	19	3578089	3578089	87	0.0804597701149425	NA	NA	NA			1			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HMG20B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,3578089,G,G&fts=all">p.E307K</a>
HRH1	Missense_Mutation	p.D247N	G	G	rs201469326	7	Cancer Module	3	11301462	11301462	59	0.135593220338983	NA	NA	NA			25			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HRH1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,11301462,G,G&fts=all">p.D247N</a>
HSD11B1	Missense_Mutation	p.G47E	G	G		7	Cancer Module	1	209879207	209879207	165	0.0424242424242424	NA	NA	NA			16			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HSD11B1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,209879207,G,G&fts=all">p.G47E</a>
HSD11B1	Missense_Mutation	p.P271L	C	C		7	Cancer Module	1	209907799	209907799	398	0.0301507537688442	NA	NA	NA			16			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HSD11B1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,209907799,C,C&fts=all">p.P271L</a>
HTATIP2	Missense_Mutation	p.R109Q	G	G		7	Cancer Module	11	20398148	20398148	375	0.0746666666666667	NA	NA	NA			8			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HTATIP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,20398148,G,G&fts=all">p.R109Q</a>
IGSF1	Missense_Mutation	p.E1096K	C	C		7	Cancer Module	X	130409132	130409132	306	0.107843137254902	NA	NA	NA			78	Ig-like C2-type 11.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGSF1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,130409132,C,C&fts=all">p.E1096K</a>
IHH	Missense_Mutation	p.P205S	G	G		7	Cancer Module	2	219920552	219920552	55	0.0909090909090909	NA	NA	NA			14			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IHH&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,219920552,G,G&fts=all">p.P205S</a>
IL1B	Nonsense_Mutation	p.Q232*	G	G		7	Cancer Module	2	113588054	113588054	378	0.0793650793650794	NA	NA	NA			12			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IL1B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,113588054,G,G&fts=all">p.Q232*</a>
IL1RL2	Missense_Mutation	p.G124D	G	G		7	Cancer Module	2	102808462	102808462	214	0.0280373831775701	NA	NA	NA			26			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IL1RL2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,102808462,G,G&fts=all">p.G124D</a>
INMT	Missense_Mutation	p.E95K	G	G		7	Cancer Module	7	30793475	30793475	374	0.0320855614973262	NA	NA	NA			23			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+INMT&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,30793475,G,G&fts=all">p.E95K</a>
INPP5A	Splice_Site		G	G		7	Cancer Module	10	134421418	134421418	528	0.0965909090909091	NA	NA	NA			15			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+INPP5A&recr=Open">Click here</a>	
INTS9	Missense_Mutation	p.G413E	C	C		7	Cancer Module	8	28638372	28638372	291	0.0756013745704467	NA	NA	NA			19			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+INTS9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,28638372,C,C&fts=all">p.G413E</a>
IPO11	Missense_Mutation	p.T840I	C	C		7	Cancer Module	5	61857021	61857021	255	0.0784313725490196	NA	NA	NA			30			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IPO11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,61857021,C,C&fts=all">p.T840I</a>
ITPR1	Missense_Mutation	p.A943T	G	G		7	Cancer Module	3	4718390	4718390	75	0.106666666666667	NA	NA	NA			106			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITPR1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,4718390,G,G&fts=all">p.A943T</a>
ITPR1	Missense_Mutation	p.G1131V	G	G		7	Cancer Module	3	4725421	4725421	129	0.124031007751938	NA	NA	NA			106			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITPR1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,4725421,G,G&fts=all">p.G1131V</a>
ITPR2	Missense_Mutation	p.R265C	G	G		7	Cancer Module	12	26868294	26868294	555	0.0810810810810811	NA	NA	NA			125	Inositol 1,4,5-trisphosphate binding. {ECO:0000250}.|MIR 3. {ECO:0000255|PROSITE- ProRule:PRU00131}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITPR2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,26868294,G,G&fts=all">p.R265C</a>
KARS	Missense_Mutation	p.H148Y	G	G		7	Cancer Module	16	75674112	75674112	276	0.0579710144927536	NA	NA	NA			18			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KARS&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,75674112,G,G&fts=all">p.H148Y</a>
KCNC4	Missense_Mutation	p.R535K	G	G		7	Cancer Module	1	110766511	110766511	55	0.163636363636364	NA	NA	NA			32			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNC4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,110766511,G,G&fts=all">p.R535K</a>
KCNJ3	Missense_Mutation	p.S18L	C	C		7	Cancer Module	2	155555340	155555340	136	0.0808823529411765	NA	NA	NA			54			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNJ3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,155555340,C,C&fts=all">p.S18L</a>
KCNJ8	Missense_Mutation	p.G417E	C	C		7	Cancer Module	12	21918682	21918682	407	0.0614250614250614	NA	NA	NA			28			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNJ8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,21918682,C,C&fts=all">p.G417E</a>
KCNQ3	Missense_Mutation	p.P513L	G	G		7	Cancer Module	8	133152353	133152353	109	0.0825688073394495	NA	NA	NA			70			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNQ3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,133152353,G,G&fts=all">p.P513L</a>
KCNQ5	Missense_Mutation	p.S280L	C	C		7	Cancer Module	6	73787531	73787531	323	0.0557275541795666	NA	NA	NA		p.S280L(1)	57			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNQ5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,73787531,C,C&fts=all">p.S280L</a>
KLHL32	Missense_Mutation	p.H54Y	C	C		7	Cancer Module	6	97424009	97424009	199	0.0552763819095477	NA	NA	NA			38	BTB. {ECO:0000255|PROSITE- ProRule:PRU00037}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KLHL32&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,97424009,C,C&fts=all">p.H54Y</a>
KRT14	Missense_Mutation	p.G99D	C	C		7	Cancer Module	17	39742791	39742791	98	0.112244897959184	NA	NA	NA			25	Head.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KRT14&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,39742791,C,C&fts=all">p.G99D</a>
KYNU	Missense_Mutation	p.P49L	C	C		7	Cancer Module	2	143643082	143643082	83	0.0843373493975904	NA	NA	NA			36			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KYNU&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,143643082,C,C&fts=all">p.P49L</a>
KYNU	Missense_Mutation	p.V414I	G	G		7	Cancer Module	2	143798195	143798195	145	0.0551724137931034	NA	NA	NA			36			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KYNU&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,143798195,G,G&fts=all">p.V414I</a>
LIF	Missense_Mutation	p.G20E	C	C		7	Cancer Module	22	30640883	30640883	108	0.148148148148148	NA	NA	NA			7			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LIF&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,30640883,C,C&fts=all">p.G20E</a>
LNPEP	Missense_Mutation	p.F987Y	T	T		7	Cancer Module	5	96364119	96364119	386	0.0673575129533679	NA	NA	NA			34			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LNPEP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,96364119,T,T&fts=all">p.F987Y</a>
LPHN3	Missense_Mutation	p.L376F	C	C		7	Cancer Module	4	62599203	62599203	107	0.0467289719626168	NA	NA	NA			125	Olfactomedin-like. {ECO:0000255|PROSITE- ProRule:PRU00446}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LPHN3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,62599203,C,C&fts=all">p.L376F</a>
LRP1B	Missense_Mutation	p.I439L	T	T		7	Cancer Module	2	141816545	141816545	313	0.073482428115016	NA	NA	NA			606			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRP1B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,141816545,T,T&fts=all">p.I439L</a>
LRRCC1	Missense_Mutation	p.R939K	G	G		7	Cancer Module	8	86050686	86050686	338	0.0532544378698225	NA	NA	NA			43			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRRCC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,86050686,G,G&fts=all">p.R939K</a>
LTBP1	Missense_Mutation	p.A599V	C	C		7	Cancer Module	2	33500931	33500931	290	0.0758620689655172	NA	NA	NA			108	TB 1.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LTBP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,33500931,C,C&fts=all">p.A599V</a>
LTBP1	Missense_Mutation	p.D867N	G	G		7	Cancer Module	2	33567910	33567910	395	0.0759493670886076	NA	NA	NA			108			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LTBP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,33567910,G,G&fts=all">p.D867N</a>
MADD	Missense_Mutation	p.S741F	C	C		7	Cancer Module	11	47306556	47306556	173	0.092485549132948	NA	NA	NA			84			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MADD&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,47306556,C,C&fts=all">p.S741F</a>
MAGEC1	Missense_Mutation	p.S558F	C	C		7	Cancer Module	X	140994863	140994863	384	0.125	NA	NA	NA			127			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAGEC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,140994863,C,C&fts=all">p.S558F</a>
MAGEC1	Missense_Mutation	p.R1066C	C	C		7	Cancer Module	X	140996386	140996386	269	0.107806691449814	NA	NA	NA			127	MAGE. {ECO:0000255|PROSITE- ProRule:PRU00127}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAGEC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,140996386,C,C&fts=all">p.R1066C</a>
MCF2	Missense_Mutation	p.R710Q	C	C	rs370241205	7	Cancer Module	X	138680593	138680593	179	0.134078212290503	NA	NA	NA			62	PH. {ECO:0000255|PROSITE- ProRule:PRU00145}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MCF2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,138680593,C,C&fts=all">p.R710Q</a>
MCF2L2	Missense_Mutation	p.G258E	C	C		7	Cancer Module	3	183029541	183029541	156	0.102564102564103	NA	NA	NA			72			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MCF2L2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,183029541,C,C&fts=all">p.G258E</a>
MICAL3	Missense_Mutation	p.H497Y	G	G		7	Cancer Module	22	18376631	18376631	29	0.275862068965517	NA	NA	NA			4			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MICAL3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,18376631,G,G&fts=all">p.H497Y</a>
MKKS	Missense_Mutation	p.P519L	G	G		7	Cancer Module	20	10386052	10386052	264	0.0681818181818182	NA	NA	NA			16			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MKKS&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,10386052,G,G&fts=all">p.P519L</a>
MMP16	Missense_Mutation	p.V306M	C	C		7	Cancer Module	8	89128903	89128903	567	0.0652557319223986	NA	NA	NA			81			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MMP16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,89128903,C,C&fts=all">p.V306M</a>
MPP6	Missense_Mutation	p.P335L	C	C		7	Cancer Module	7	24708169	24708169	229	0.0305676855895196	NA	NA	NA			20			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MPP6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,24708169,C,C&fts=all">p.P335L</a>
MRC2	Missense_Mutation	p.E368K	G	G		7	Cancer Module	17	60744879	60744879	144	0.0833333333333333	NA	NA	NA		p.E368K(1)	53			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MRC2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,60744879,G,G&fts=all">p.E368K</a>
MRPL13	Missense_Mutation	p.L138F	G	G		7	Cancer Module	8	121426333	121426333	95	0.0526315789473684	NA	NA	NA			6			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MRPL13&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,121426333,G,G&fts=all">p.L138F</a>
MUC16	Missense_Mutation	p.E8402K	C	C		7	Cancer Module	19	9062242	9062242	139	0.115107913669065	NA	NA	NA			590	Ser-rich.|Thr-rich.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,9062242,C,C&fts=all">p.E8402K</a>
MYO9A	Nonsense_Mutation	p.R2156*	G	G	rs145598484	7	Cancer Module	15	72144482	72144482	228	0.105263157894737	NA	NA	NA			88	Rho-GAP. {ECO:0000255|PROSITE- ProRule:PRU00172}.|Tail.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO9A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,72144482,G,G&fts=all">p.R2156*</a>
NKTR	Missense_Mutation	p.S1346L	C	C		7	Cancer Module	3	42681233	42681233	369	0.127371273712737	NA	NA	NA			41	Arg/Ser tandem repeat-rich.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NKTR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,42681233,C,C&fts=all">p.S1346L</a>
NOS1	Missense_Mutation	p.R1428Q	C	C	rs376113705	7	Cancer Module	12	117655959	117655959	657	0.0624048706240487	NA	NA	NA			117			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NOS1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,117655959,C,C&fts=all">p.R1428Q</a>
NOS1	Missense_Mutation	p.K356I	T	T		7	Cancer Module	12	117725939	117725939	125	0.048	NA	NA	NA			117			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NOS1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,117725939,T,T&fts=all">p.K356I</a>
NOS1	Missense_Mutation	p.G29E	C	C		7	Cancer Module	12	117768789	117768789	115	0.0521739130434783	NA	NA	NA			117			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NOS1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,117768789,C,C&fts=all">p.G29E</a>
NRXN1	Missense_Mutation	p.D77N	C	C		7	Cancer Module	2	51255183	51255183	61	0.0819672131147541	NA	NA	NA			58	Laminin G-like 1. {ECO:0000255|PROSITE- ProRule:PRU00122}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NRXN1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,51255183,C,C&fts=all">p.D77N</a>
NXPH2	Missense_Mutation	p.M77I	C	C		7	Cancer Module	2	139429056	139429056	286	0.0314685314685315	NA	NA	NA			22	II.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NXPH2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,139429056,C,C&fts=all">p.M77I</a>
OAS1	Missense_Mutation	p.R104K	G	G		7	Cancer Module	12	113346471	113346471	108	0.101851851851852	NA	NA	NA			16			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OAS1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,113346471,G,G&fts=all">p.R104K</a>
OASL	Missense_Mutation	p.M264I	C	C		7	Cancer Module	12	121465486	121465486	215	0.0418604651162791	NA	NA	NA			14			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OASL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,121465486,C,C&fts=all">p.M264I</a>
PCLO	Missense_Mutation	p.P3880S	G	G		7	Cancer Module	7	82545664	82545664	1106	0.0307414104882459	NA	NA	NA			259			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCLO&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,82545664,G,G&fts=all">p.P3880S</a>
PDCD1	Missense_Mutation	p.P243S	G	G		7	Cancer Module	2	242793350	242793350	88	0.0454545454545455	NA	NA	NA			8			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDCD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,242793350,G,G&fts=all">p.P243S</a>
PDE6B	Splice_Site	p.E285K	G	G		7	Cancer Module	4	647869	647869	143	0.0559440559440559	NA	NA	NA			30	GAF 2.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDE6B&recr=Open">Click here</a>	
PEG3	Missense_Mutation	p.L70F	G	G	rs535012135	7	Cancer Module	19	57335816	57335816	271	0.0590405904059041	NA	NA	NA			170	SCAN box. {ECO:0000255|PROSITE- ProRule:PRU00187}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PEG3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,57335816,G,G&fts=all">p.L70F</a>
PIF1	Missense_Mutation	p.S412F	G	G		7	Cancer Module	15	65112144	65112144	223	0.0762331838565022	NA	NA	NA			2			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PIF1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,65112144,G,G&fts=all">p.S412F</a>
PITPNB	Missense_Mutation	p.P175S	G	G		7	Cancer Module	22	28269737	28269737	281	0.0676156583629893	NA	NA	NA			8			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PITPNB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,28269737,G,G&fts=all">p.P175S</a>
PLA2G12B	Nonsense_Mutation	p.W170*	C	C		7	Cancer Module	10	74695453	74695453	157	0.0573248407643312	NA	NA	NA			9			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLA2G12B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,74695453,C,C&fts=all">p.W170*</a>
PLA2R1	Nonsense_Mutation	p.Q53*	G	G		7	Cancer Module	2	160901621	160901621	162	0.0308641975308642	NA	NA	NA			60	Ricin B-type lectin. {ECO:0000255|PROSITE-ProRule:PRU00174}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLA2R1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,160901621,G,G&fts=all">p.Q53*</a>
PLCB2	Missense_Mutation	p.P166S	G	G		7	Cancer Module	15	40594347	40594347	340	0.0647058823529412	NA	NA	NA			39			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLCB2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,40594347,G,G&fts=all">p.P166S</a>
PLCL1	Missense_Mutation	p.S762L	C	C		7	Cancer Module	2	198950526	198950526	245	0.0612244897959184	NA	NA	NA			80	C2. {ECO:0000255|PROSITE- ProRule:PRU00041}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLCL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,198950526,C,C&fts=all">p.S762L</a>
PLXDC2	Missense_Mutation	p.P418S	C	C		7	Cancer Module	10	20506484	20506484	152	0.0592105263157895	NA	NA	NA			34	Thr-rich.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLXDC2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,20506484,C,C&fts=all">p.P418S</a>
POU6F2	Missense_Mutation	p.P348S	C	C		7	Cancer Module	7	39472691	39472691	101	0.0495049504950495	NA	NA	NA			42	Gln-rich.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+POU6F2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,39472691,C,C&fts=all">p.P348S</a>
POU6F2	Missense_Mutation	p.P348L	C	C		7	Cancer Module	7	39472692	39472692	102	0.0490196078431373	NA	NA	NA			42	Gln-rich.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+POU6F2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,39472692,C,C&fts=all">p.P348L</a>
PPM1H	Missense_Mutation	p.S184F	G	G		7	Cancer Module	12	63195801	63195801	226	0.0752212389380531	NA	NA	NA			18	PP2C-like.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPM1H&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,63195801,G,G&fts=all">p.S184F</a>
PRX	Splice_Site	p.G62R	C	C		7	Cancer Module	19	40909613	40909613	6	0.5	NA	NA	NA			47	PDZ. {ECO:0000255|PROSITE- ProRule:PRU00143}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRX&recr=Open">Click here</a>	
PTPRT	Missense_Mutation	p.E1019K	C	C		7	Cancer Module	20	40743883	40743883	350	0.0285714285714286	NA	NA	NA			176	Tyrosine-protein phosphatase 1. {ECO:0000255|PROSITE-ProRule:PRU00160}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPRT&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,40743883,C,C&fts=all">p.E1019K</a>
RAB3C	Missense_Mutation	p.D149N	G	G		7	Cancer Module	5	58120938	58120938	307	0.0716612377850163	NA	NA	NA			21			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RAB3C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,58120938,G,G&fts=all">p.D149N</a>
RAG1	Missense_Mutation	p.G933E	G	G		7	Cancer Module	11	36597652	36597652	150	0.0533333333333333	NA	NA	NA			65			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RAG1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,36597652,G,G&fts=all">p.G933E</a>
RBBP6	Missense_Mutation	p.P1565L	C	C		7	Cancer Module	16	24583081	24583081	214	0.0560747663551402	NA	NA	NA			46			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RBBP6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,24583081,C,C&fts=all">p.P1565L</a>
RELN	Nonsense_Mutation	p.W632*	C	C		7	Cancer Module	7	103290828	103290828	196	0.102040816326531	NA	NA	NA			227			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RELN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,103290828,C,C&fts=all">p.W632*</a>
RGS18	Missense_Mutation	p.D121N	G	G		7	Cancer Module	1	192150499	192150499	391	0.132992327365729	NA	NA	NA			24	RGS. {ECO:0000255|PROSITE- ProRule:PRU00171}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RGS18&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,192150499,G,G&fts=all">p.D121N</a>
RIMS1	Missense_Mutation	p.R211Q	G	G		7	Cancer Module	6	72889438	72889438	166	0.036144578313253	NA	NA	NA		p.R211Q(1)	102			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RIMS1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,72889438,G,G&fts=all">p.R211Q</a>
RIMS1	Missense_Mutation	p.S1217L	C	C		7	Cancer Module	6	73000477	73000477	128	0.0625	NA	NA	NA			102			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RIMS1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,73000477,C,C&fts=all">p.S1217L</a>
RIT1	Missense_Mutation	p.R105C	G	G		7	Cancer Module	1	155874218	155874218	297	0.0673400673400673	NA	NA	NA			19			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RIT1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,155874218,G,G&fts=all">p.R105C</a>
RLF	Missense_Mutation	p.S1678F	C	C		7	Cancer Module	1	40705407	40705407	170	0.0882352941176471	NA	NA	NA			68			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RLF&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,40705407,C,C&fts=all">p.S1678F</a>
RNF11	Missense_Mutation	p.G83E	G	G		7	Cancer Module	1	51735752	51735752	279	0.032258064516129	NA	NA	NA		p.0?(2)	1			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RNF11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,51735752,G,G&fts=all">p.G83E</a>
RNF144A	Splice_Site		A	A		7	Cancer Module	2	7170255	7170255	168	0.0773809523809524	NA	NA	NA			25			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RNF144A&recr=Open">Click here</a>	
RP1	Missense_Mutation	p.S28N	G	G		7	Cancer Module	8	55533609	55533609	239	0.0460251046025105	NA	NA	NA			169			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,55533609,G,G&fts=all">p.S28N</a>
RP1	Missense_Mutation	p.R37Q	G	G		7	Cancer Module	8	55533636	55533636	172	0.0465116279069767	NA	NA	NA			169	Doublecortin 1. {ECO:0000255|PROSITE- ProRule:PRU00072}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,55533636,G,G&fts=all">p.R37Q</a>
RP1	Missense_Mutation	p.R396Q	G	G	rs141279458	7	Cancer Module	8	55537629	55537629	120	0.0833333333333333	NA	NA	NA			169			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,55537629,G,G&fts=all">p.R396Q</a>
RP1	Missense_Mutation	p.P1116S	C	C		7	Cancer Module	8	55539788	55539788	279	0.028673835125448	NA	NA	NA			169			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,55539788,C,C&fts=all">p.P1116S</a>
RP1	Missense_Mutation	p.V1215I	G	G		7	Cancer Module	8	55540085	55540085	241	0.0580912863070539	NA	NA	NA			169			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,55540085,G,G&fts=all">p.V1215I</a>
RRP12	Missense_Mutation	p.P161L	G	G	rs147516563	7	Cancer Module	10	99153489	99153489	190	0.068421052631579	NA	NA	NA			37			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RRP12&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,99153489,G,G&fts=all">p.P161L</a>
RYR1	Missense_Mutation	p.P4515S	C	C		7	Cancer Module	19	39058441	39058441	139	0.0575539568345324	NA	NA	NA			285	Pro-rich.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RYR1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,39058441,C,C&fts=all">p.P4515S</a>
RYR2	Missense_Mutation	p.R3227C	C	C		7	Cancer Module	1	237870347	237870347	298	0.11744966442953	NA	NA	NA			586			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RYR2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,237870347,C,C&fts=all">p.R3227C</a>
SAMSN1	Missense_Mutation	p.H254Y	G	G		7	Cancer Module	21	15872858	15872858	328	0.0579268292682927	NA	NA	NA			24	SAM. {ECO:0000255|PROSITE- ProRule:PRU00184}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SAMSN1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,15872858,G,G&fts=all">p.H254Y</a>
SCN4A	Missense_Mutation	p.M138I	C	C		7	Cancer Module	17	62049564	62049564	55	0.0727272727272727	NA	NA	NA			101			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCN4A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,62049564,C,C&fts=all">p.M138I</a>
SELE	Missense_Mutation	p.G416E	C	C	rs140351789	7	Cancer Module	1	169697231	169697231	435	0.0873563218390805	NA	NA	NA			32	Sushi 4. {ECO:0000255|PROSITE- ProRule:PRU00302}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SELE&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,169697231,C,C&fts=all">p.G416E</a>
SEMA6B	Missense_Mutation	p.D577N	C	C		7	Cancer Module	19	4546237	4546237	61	0.114754098360656	NA	NA	NA			21			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEMA6B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,4546237,C,C&fts=all">p.D577N</a>
SFTPD	Missense_Mutation	p.G127R	C	C	rs150839598	7	Cancer Module	10	81702198	81702198	110	0.0636363636363636	NA	NA	NA			17	Collagen-like.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SFTPD&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,81702198,C,C&fts=all">p.G127R</a>
SH3BP1	Missense_Mutation	p.P551L	C	C		7	Cancer Module	22	38049839	38049839	84	0.0595238095238095	NA	NA	NA			13			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SH3BP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,38049839,C,C&fts=all">p.P551L</a>
SH3BP4	Missense_Mutation	p.S543F	C	C		7	Cancer Module	2	235951041	235951041	103	0.087378640776699	NA	NA	NA			44			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SH3BP4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,235951041,C,C&fts=all">p.S543F</a>
SIPA1L2	Missense_Mutation	p.S1472L	G	G	rs150962063	7	Cancer Module	1	232561550	232561550	149	0.087248322147651	NA	NA	NA		p.S1472L(1)	103			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SIPA1L2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,232561550,G,G&fts=all">p.S1472L</a>
SLAMF7	Missense_Mutation	p.G177R	G	G		7	Cancer Module	1	160719763	160719763	172	0.0813953488372093	NA	NA	NA			24	Ig-like C2-type.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLAMF7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,160719763,G,G&fts=all">p.G177R</a>
SLC12A3	Missense_Mutation	p.G439D	G	G		7	Cancer Module	16	56913120	56913120	95	0.0631578947368421	NA	NA	NA			50			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC12A3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,56913120,G,G&fts=all">p.G439D</a>
SLC12A4	Missense_Mutation	p.P230S	G	G		7	Cancer Module	16	67986316	67986316	293	0.037542662116041	NA	NA	NA			29			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC12A4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,67986316,G,G&fts=all">p.P230S</a>
SLC15A2	Missense_Mutation	p.S437F	C	C		7	Cancer Module	3	121647371	121647371	409	0.110024449877751	NA	NA	NA			36			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC15A2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,121647371,C,C&fts=all">p.S437F</a>
SLC4A2	Missense_Mutation	p.S64F	C	C		7	Cancer Module	7	150761628	150761628	113	0.0707964601769911	NA	NA	NA			33	Pro-rich.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC4A2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,150761628,C,C&fts=all">p.S64F</a>
SLC5A2	Missense_Mutation	p.R49K	G	G		7	Cancer Module	16	31496013	31496013	257	0.0272373540856031	NA	NA	NA			25			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC5A2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,31496013,G,G&fts=all">p.R49K</a>
SLCO1A2	Missense_Mutation	p.S49F	G	G		7	Cancer Module	12	21457408	21457408	252	0.0595238095238095	NA	NA	NA		p.S181F(1)	48			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLCO1A2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,21457408,G,G&fts=all">p.S49F</a>
SNX21	Missense_Mutation	p.R171Q	G	G	rs201926135	7	Cancer Module	20	44469369	44469369	232	0.0818965517241379	NA	NA	NA			7	PX. {ECO:0000255|PROSITE- ProRule:PRU00147}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SNX21&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,44469369,G,G&fts=all">p.R171Q</a>
SOAT2	Missense_Mutation	p.R371Q	G	G	rs141175448	7	Cancer Module	12	53514642	53514642	341	0.0469208211143695	NA	NA	NA			18			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SOAT2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,53514642,G,G&fts=all">p.R371Q</a>
SORL1	Missense_Mutation	p.S1116L	C	C		7	Cancer Module	11	121500244	121500244	281	0.0854092526690391	NA	NA	NA			91	LDL-receptor class A 2. {ECO:0000255|PROSITE-ProRule:PRU00124}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SORL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,121500244,C,C&fts=all">p.S1116L</a>
SPEF2	Missense_Mutation	p.R1734K	G	G		7	Cancer Module	5	35807014	35807014	281	0.0533807829181495	NA	NA	NA			37			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPEF2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,35807014,G,G&fts=all">p.R1734K</a>
SPEN	Missense_Mutation	p.P2867L	C	C		7	Cancer Module	1	16261335	16261335	94	0.0638297872340425	NA	NA	NA			149	Interaction with RBPSUH. {ECO:0000250}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPEN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,16261335,C,C&fts=all">p.P2867L</a>
SPON2	Splice_Site	p.S270S	T	T		7	Cancer Module	4	1164191	1164191	479	0.0459290187891441	NA	NA	NA			9			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPON2&recr=Open">Click here</a>	
SYNE2	Missense_Mutation	p.V4119G	T	T		7	Cancer Module	14	64564815	64564815	110	0.0727272727272727	NA	NA	NA			224			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SYNE2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,64564815,T,T&fts=all">p.V4119G</a>
SYNPO2	Nonsense_Mutation	p.R37*	C	C		7	Cancer Module	4	119944588	119944588	164	0.0304878048780488	NA	NA	NA			64	PDZ. {ECO:0000255|PROSITE- ProRule:PRU00143}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SYNPO2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,119944588,C,C&fts=all">p.R37*</a>
TACC2	Missense_Mutation	p.G702S	G	G		7	Cancer Module	10	123987497	123987497	162	0.0617283950617284	NA	NA	NA			83			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TACC2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,123987497,G,G&fts=all">p.G702S</a>
TACC3	Missense_Mutation	p.P217S	C	C		7	Cancer Module	4	1729778	1729778	66	0.0606060606060606	NA	NA	NA			25			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TACC3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,1729778,C,C&fts=all">p.P217S</a>
TACC3	Missense_Mutation	p.P591L	C	C		7	Cancer Module	4	1738991	1738991	86	0.0581395348837209	NA	NA	NA			25			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TACC3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,1738991,C,C&fts=all">p.P591L</a>
TARBP1	Missense_Mutation	p.V1466F	C	C	rs574387954	7	Cancer Module	1	234529431	234529431	352	0.0625	NA	NA	NA			55			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TARBP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,234529431,C,C&fts=all">p.V1466F</a>
TBXAS1	Missense_Mutation	p.I235M	A	A		7	Cancer Module	7	139657449	139657449	178	0.0280898876404494	NA	NA	NA			28			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TBXAS1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,139657449,A,A&fts=all">p.I235M</a>
TCEB3	Missense_Mutation	p.S427L	C	C		7	Cancer Module	1	24078375	24078375	491	0.0346232179226069	NA	NA	NA			19			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TCEB3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,24078375,C,C&fts=all">p.S427L</a>
TEX14	Missense_Mutation	p.L577S	A	A		7	Cancer Module	17	56676994	56676994	168	0.0654761904761905	NA	NA	NA			81			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TEX14&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,56676994,A,A&fts=all">p.L577S</a>
TFAP2B	Missense_Mutation	p.S244L	C	C		7	Cancer Module	6	50803903	50803903	219	0.0867579908675799	NA	NA	NA		p.S244L(1)	40			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TFAP2B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,50803903,C,C&fts=all">p.S244L</a>
THBS3	Missense_Mutation	p.D634N	C	C		7	Cancer Module	1	155168374	155168374	187	0.0962566844919786	NA	NA	NA			48			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+THBS3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,155168374,C,C&fts=all">p.D634N</a>
TLL1	Missense_Mutation	p.R257Q	G	G		7	Cancer Module	4	166924680	166924680	299	0.020066889632107	NA	NA	NA			77	Metalloprotease. {ECO:0000250}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TLL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,166924680,G,G&fts=all">p.R257Q</a>
TLL1	Missense_Mutation	p.D908N	G	G		7	Cancer Module	4	167020494	167020494	444	0.0382882882882883	NA	NA	NA			77	CUB 5. {ECO:0000255|PROSITE- ProRule:PRU00059}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TLL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,167020494,G,G&fts=all">p.D908N</a>
TLR2	Missense_Mutation	p.P668S	C	C	rs531080680	7	Cancer Module	4	154626061	154626061	294	0.0408163265306122	NA	NA	NA			29	TIR. {ECO:0000255|PROSITE- ProRule:PRU00204}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TLR2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,154626061,C,C&fts=all">p.P668S</a>
TMEM200A	Missense_Mutation	p.P330L	C	C		7	Cancer Module	6	130762556	130762556	159	0.0880503144654088	NA	NA	NA			52			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM200A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,130762556,C,C&fts=all">p.P330L</a>
TNC	Splice_Site	p.E1748K	C	C		7	Cancer Module	9	117793964	117793964	220	0.0863636363636364	NA	NA	NA			120	Fibronectin type-III 13. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNC&recr=Open">Click here</a>	
TNR	Missense_Mutation	p.P866S	G	G		7	Cancer Module	1	175332955	175332955	209	0.0430622009569378	NA	NA	NA			177	Fibronectin type-III 7. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,175332955,G,G&fts=all">p.P866S</a>
TPD52	Missense_Mutation	p.E48K	C	C		7	Cancer Module	8	80965659	80965659	471	0.0679405520169851	NA	NA	NA			8			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TPD52&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,80965659,C,C&fts=all">p.E48K</a>
TPTE	Missense_Mutation	p.H207Y	G	G		7	Cancer Module	21	10942968	10942968	354	0.0282485875706215	NA	NA	NA			130			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TPTE&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,10942968,G,G&fts=all">p.H207Y</a>
TRMT1	Missense_Mutation	p.P443S	G	G		7	Cancer Module	19	13220265	13220265	184	0.0815217391304348	NA	NA	NA			14	Trm1 methyltransferase. {ECO:0000255|PROSITE-ProRule:PRU00958}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRMT1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,13220265,G,G&fts=all">p.P443S</a>
TROVE2	Nonsense_Mutation	p.Q101*	C	C		7	Cancer Module	1	193038485	193038485	182	0.0769230769230769	NA	NA	NA			21	TROVE. {ECO:0000255|PROSITE- ProRule:PRU00343}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TROVE2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,193038485,C,C&fts=all">p.Q101*</a>
TRPC3	Nonsense_Mutation	p.E634*	C	C		7	Cancer Module	4	122828615	122828615	505	0.0297029702970297	NA	NA	NA			51			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRPC3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,122828615,C,C&fts=all">p.E634*</a>
TRPC4	Missense_Mutation	p.P13L	G	G		7	Cancer Module	13	38357433	38357433	357	0.0560224089635854	NA	NA	NA			83			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRPC4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,38357433,G,G&fts=all">p.P13L</a>
TRPM1	Missense_Mutation	p.M23I	C	C		7	Cancer Module	15	31369122	31369122	246	0.0650406504065041	NA	NA	NA			99			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRPM1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,31369122,C,C&fts=all">p.M23I</a>
TSPAN2	Missense_Mutation	p.S51F	G	G		7	Cancer Module	1	115615546	115615546	110	0.0636363636363636	NA	NA	NA			10			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TSPAN2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,115615546,G,G&fts=all">p.S51F</a>
TTN	Missense_Mutation	p.E34410K	C	C		7	Cancer Module	2	179398114	179398114	189	0.0582010582010582	NA	NA	NA			1448			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,179398114,C,C&fts=all">p.E34410K</a>
TTN	Missense_Mutation	p.D32769N	C	C	rs564151542	7	Cancer Module	2	179404487	179404487	207	0.0386473429951691	NA	NA	NA			1448	Ig-like 145.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,179404487,C,C&fts=all">p.D32769N</a>
TTN	Missense_Mutation	p.D30251N	C	C		7	Cancer Module	2	179416876	179416876	399	0.0576441102756892	NA	NA	NA			1448	Fibronectin type-III 120. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,179416876,C,C&fts=all">p.D30251N</a>
TTN	Missense_Mutation	p.D18156N	C	C		7	Cancer Module	2	179468948	179468948	77	0.0779220779220779	NA	NA	NA			1448	Ig-like 105.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,179468948,C,C&fts=all">p.D18156N</a>
TTN	Missense_Mutation	p.G14743W	C	C		7	Cancer Module	2	179495022	179495022	319	0.0188087774294671	NA	NA	NA			1448	Fibronectin type-III 6. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,179495022,C,C&fts=all">p.G14743W</a>
TTN	Missense_Mutation	p.G9843R	C	C		7	Cancer Module	2	179569978	179569978	291	0.0515463917525773	NA	NA	NA			1448	Ig-like 79.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,179569978,C,C&fts=all">p.G9843R</a>
TTN	Missense_Mutation	p.E7840K	C	C		7	Cancer Module	2	179584851	179584851	237	0.0421940928270042	NA	NA	NA			1448	Ig-like 60.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,179584851,C,C&fts=all">p.E7840K</a>
TTN	Missense_Mutation	p.L2676F	G	G		7	Cancer Module	2	179636028	179636028	209	0.0239234449760766	NA	NA	NA			1448	Ig-like 15.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,179636028,G,G&fts=all">p.L2676F</a>
USH2A	Missense_Mutation	p.R3119C	G	G	rs576236830	7	Cancer Module	1	216011349	216011349	461	0.0563991323210412	NA	NA	NA			527	Fibronectin type-III 18. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USH2A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,216011349,G,G&fts=all">p.R3119C</a>
UTRN	Missense_Mutation	p.E1976K	G	G		7	Cancer Module	6	144852207	144852207	162	0.0308641975308642	NA	NA	NA			148			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UTRN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,144852207,G,G&fts=all">p.E1976K</a>
VPS13D	Missense_Mutation	p.Q1754R	A	A		7	Cancer Module	1	12343420	12343420	94	0.0531914893617021	NA	NA	NA			130			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VPS13D&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,12343420,A,A&fts=all">p.Q1754R</a>
VPS13D	Missense_Mutation	p.R4228W	C	C		7	Cancer Module	1	12557573	12557573	233	0.0600858369098712	NA	NA	NA			130			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VPS13D&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,12557573,C,C&fts=all">p.R4228W</a>
XRCC1	Missense_Mutation	p.P187S	G	G		7	Cancer Module	19	44057595	44057595	181	0.0552486187845304	NA	NA	NA			19			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XRCC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,44057595,G,G&fts=all">p.P187S</a>
ZBTB4	Missense_Mutation	p.P461L	G	G		7	Cancer Module	17	7366919	7366919	63	0.0952380952380952	NA	NA	NA			36	Pro-rich.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZBTB4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,7366919,G,G&fts=all">p.P461L</a>
ZEB2	Missense_Mutation	p.S851F	G	G		7	Cancer Module	2	145156202	145156202	311	0.0482315112540193	NA	NA	NA			107			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZEB2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,145156202,G,G&fts=all">p.S851F</a>
ZFX	Missense_Mutation	p.V766I	G	G		7	Cancer Module	X	24229371	24229371	289	0.0173010380622837	NA	NA	NA			24			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZFX&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,24229371,G,G&fts=all">p.V766I</a>
ZNF16	Missense_Mutation	p.P175S	G	G		7	Cancer Module	8	146157650	146157650	526	0.0513307984790875	NA	NA	NA			29	Necessary for transcription activation.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,146157650,G,G&fts=all">p.P175S</a>
ZNF177	Missense_Mutation	p.P102S	C	C		7	Cancer Module	19	9490783	9490783	194	0.0824742268041237	NA	NA	NA			13			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF177&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,9490783,C,C&fts=all">p.P102S</a>
ZNF195	Missense_Mutation	p.F531Y	A	A		7	Cancer Module	11	3380646	3380646	416	0.0697115384615385	NA	NA	NA			17			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF195&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,3380646,A,A&fts=all">p.F531Y</a>
ZNF23	Missense_Mutation	p.K427E	T	T		7	Cancer Module	16	71482649	71482649	151	0.0728476821192053	NA	NA	NA			29			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF23&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,71482649,T,T&fts=all">p.K427E</a>
ZNF286A	Missense_Mutation	p.C245W	T	T		7	Cancer Module	17	15619773	15619773	135	0.0666666666666667	NA	NA	NA			24			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF286A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,15619773,T,T&fts=all">p.C245W</a>
ZNF318	Missense_Mutation	p.S1896F	G	G		7	Cancer Module	6	43306049	43306049	289	0.0968858131487889	NA	NA	NA			61			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF318&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,43306049,G,G&fts=all">p.S1896F</a>
ZNF34	Missense_Mutation	p.P299L	G	G		7	Cancer Module	8	145999375	145999375	80	0.0625	NA	NA	NA			11			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF34&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,145999375,G,G&fts=all">p.P299L</a>
ZNF397	Missense_Mutation	p.P16S	C	C		7	Cancer Module	18	32822480	32822480	314	0.0796178343949045	NA	NA	NA			12			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF397&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,32822480,C,C&fts=all">p.P16S</a>
ZP4	Missense_Mutation	p.L217F	G	G		7	Cancer Module	1	238050766	238050766	301	0.0498338870431894	NA	NA	NA			73	ZP. {ECO:0000255|PROSITE- ProRule:PRU00375}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZP4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,238050766,G,G&fts=all">p.L217F</a>
ZYG11B	Frame_Shift_Del	p.LYN698fs	TTATACAA	TTATACAA		7	Cancer Module	1	53287158	53287165	252	0.0317460317460317	NA	NA	NA			30			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZYG11B&recr=Open">Click here</a>	
MAP3K4	Nonsense_Mutation	p.R1375*	C	C		7.75	Cancer Gene	6	161529778	161529778	289	0.0346020761245675	NA	NA	NA			77	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAP3K4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,161529778,C,C&fts=all">p.R1375*</a>
MPP7	Missense_Mutation	p.E436K	C	C		7.75	Cancer Gene	10	28347525	28347525	380	0.0868421052631579	NA	NA	NA			22	Guanylate kinase-like. {ECO:0000255|PROSITE-ProRule:PRU00100}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MPP7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,28347525,C,C&fts=all">p.E436K</a>
VRK3	Missense_Mutation	p.R369C	G	G		7.75	Cancer Gene	19	50491741	50491741	136	0.0588235294117647	NA	NA	NA			23	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VRK3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,50491741,G,G&fts=all">p.R369C</a>
ABCA13	Missense_Mutation	p.D193N	G	G		8	Cancer Gene	7	48266967	48266967	166	0.0421686746987952	NA	NA	NA		p.D138H(1)|p.D193H(1)	270			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCA13&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,48266967,G,G&fts=all">p.D193N</a>
ABCA13	Nonsense_Mutation	p.Q248*	C	C		8	Cancer Gene	7	48269531	48269531	213	0.0610328638497653	NA	NA	NA			270			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCA13&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,48269531,C,C&fts=all">p.Q248*</a>
ABCA13	Missense_Mutation	p.Q248L	A	A		8	Cancer Gene	7	48269532	48269532	212	0.0518867924528302	NA	NA	NA			270			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCA13&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,48269532,A,A&fts=all">p.Q248L</a>
ABCA13	Missense_Mutation	p.Q248H	A	A		8	Cancer Gene	7	48269533	48269533	211	0.0521327014218009	NA	NA	NA			270			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCA13&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,48269533,A,A&fts=all">p.Q248H</a>
ABCA13	Missense_Mutation	p.S293F	C	C		8	Cancer Gene	7	48273729	48273729	255	0.0784313725490196	NA	NA	NA			270			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCA13&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,48273729,C,C&fts=all">p.S293F</a>
ABCA13	Missense_Mutation	p.T1147I	C	C		8	Cancer Gene	7	48312703	48312703	446	0.0358744394618834	NA	NA	NA			270			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCA13&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,48312703,C,C&fts=all">p.T1147I</a>
ABCA13	Missense_Mutation	p.H5017Q	T	T		8	Cancer Gene	7	48684320	48684320	351	0.0313390313390313	NA	NA	NA			270			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCA13&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,48684320,T,T&fts=all">p.H5017Q</a>
ADAMTS19	Splice_Site	p.Q762Q	G	G		8	Cancer Gene	5	128990126	128990126	172	0.0755813953488372	NA	NA	NA			91	Cys-rich.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAMTS19&recr=Open">Click here</a>	
ADAMTS20	Missense_Mutation	p.P1779S	G	G		8	Cancer Gene	12	43769293	43769293	330	0.0545454545454545	NA	NA	NA			95	GON. {ECO:0000255|PROSITE- ProRule:PRU00383}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAMTS20&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,43769293,G,G&fts=all">p.P1779S</a>
ADCY10	Missense_Mutation	p.E1407K	C	C	rs200525715	8	Cancer Gene	1	167791329	167791329	244	0.0614754098360656	NA	NA	NA			63			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADCY10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,167791329,C,C&fts=all">p.E1407K</a>
ADCY10	Missense_Mutation	p.E1032K	C	C		8	Cancer Gene	1	167805762	167805762	237	0.0464135021097046	NA	NA	NA			63			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADCY10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,167805762,C,C&fts=all">p.E1032K</a>
AGPAT9	Nonsense_Mutation	p.W124*	G	G		8	Cancer Gene	4	84502878	84502878	330	0.0454545454545455	NA	NA	NA			13			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AGPAT9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,84502878,G,G&fts=all">p.W124*</a>
AMBRA1	Nonsense_Mutation	p.Q150*	G	G		8	Cancer Gene	11	46567257	46567257	119	0.0840336134453782	NA	NA	NA			39			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AMBRA1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,46567257,G,G&fts=all">p.Q150*</a>
ANO4	Missense_Mutation	p.S291F	C	C		8	Cancer Gene	12	101433812	101433812	573	0.0418848167539267	NA	NA	NA			78			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANO4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,101433812,C,C&fts=all">p.S291F</a>
AP1B1	Missense_Mutation	p.L684F	G	G		8	Cancer Gene	22	29735071	29735071	211	0.0947867298578199	NA	NA	NA			22	Pro-rich (stalk region).		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AP1B1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,29735071,G,G&fts=all">p.L684F</a>
ARHGEF37	Missense_Mutation	p.R664Q	G	G		8	Cancer Gene	5	149011717	149011717	118	0.0423728813559322	NA	NA	NA			17	SH3 2. {ECO:0000255|PROSITE- ProRule:PRU00192}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARHGEF37&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,149011717,G,G&fts=all">p.R664Q</a>
ASPM	Missense_Mutation	p.I1854T	A	A		8	Cancer Gene	1	197072820	197072820	374	0.0748663101604278	NA	NA	NA			165			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ASPM&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,197072820,A,A&fts=all">p.I1854T</a>
ASTN1	Missense_Mutation	p.C712G	A	A		8	Cancer Gene	1	176915177	176915177	173	0.0289017341040462	NA	NA	NA			153			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ASTN1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,176915177,A,A&fts=all">p.C712G</a>
ASXL3	Missense_Mutation	p.L1990F	A	A		8	Cancer Gene	18	31325782	31325782	293	0.0477815699658703	NA	NA	NA			43			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ASXL3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,31325782,A,A&fts=all">p.L1990F</a>
ATAD5	Nonsense_Mutation	p.Q771*	C	C		8	Cancer Gene	17	29171000	29171000	541	0.0646950092421442	NA	NA	NA			51			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATAD5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,29171000,C,C&fts=all">p.Q771*</a>
ATP13A5	Missense_Mutation	p.S783L	G	G		8	Cancer Gene	3	193029702	193029702	279	0.14336917562724	NA	NA	NA			76			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATP13A5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,193029702,G,G&fts=all">p.S783L</a>
ATRNL1	Missense_Mutation	p.R1368Q	G	G		8	Cancer Gene	10	117704253	117704253	556	0.0863309352517986	NA	NA	NA			95			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATRNL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,117704253,G,G&fts=all">p.R1368Q</a>
BCMO1	Missense_Mutation	p.P294L	C	C		8	Cancer Gene	16	81303801	81303801	344	0.0348837209302326	NA	NA	NA			23			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BCMO1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,81303801,C,C&fts=all">p.P294L</a>
BTBD11	Splice_Site	p.G699E	G	G	rs267603282	8	Cancer Gene	12	108011078	108011078	356	0.0758426966292135	NA	NA	NA			53			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BTBD11&recr=Open">Click here</a>	
BTBD11	Missense_Mutation	p.L764M	C	C		8	Cancer Gene	12	108011993	108011993	96	0.0625	NA	NA	NA			53			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BTBD11&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,108011993,C,C&fts=all">p.L764M</a>
C12orf54	Missense_Mutation	p.E59K	G	G		8	Cancer Gene	12	48884601	48884601	325	0.0646153846153846	NA	NA	NA			5			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C12orf54&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,48884601,G,G&fts=all">p.E59K</a>
C15orf39	Missense_Mutation	p.P688L	C	C		8	Cancer Gene	15	75500452	75500452	117	0.094017094017094	NA	NA	NA			16			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C15orf39&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,75500452,C,C&fts=all">p.P688L</a>
C17orf53	Missense_Mutation	p.S224F	C	C		8	Cancer Gene	17	42225842	42225842	397	0.0554156171284635	NA	NA	NA			22			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C17orf53&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,42225842,C,C&fts=all">p.S224F</a>
C18orf21	Missense_Mutation	p.R58C	C	C		8	Cancer Gene	18	33554930	33554930	492	0.0365853658536585	NA	NA	NA			5			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C18orf21&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,33554930,C,C&fts=all">p.R58C</a>
C1orf162	Missense_Mutation	p.S117L	C	C		8	Cancer Gene	1	112020627	112020627	311	0.067524115755627	NA	NA	NA			5			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C1orf162&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,112020627,C,C&fts=all">p.S117L</a>
C1orf173	Missense_Mutation	p.E622K	C	C		8	Cancer Gene	1	75055627	75055627	350	0.0457142857142857	NA	NA	NA			184	Glu-rich.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C1orf173&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,75055627,C,C&fts=all">p.E622K</a>
C20orf26	Missense_Mutation	p.E63K	G	G		8	Cancer Gene	20	20051541	20051541	193	0.0569948186528497	NA	NA	NA			77			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C20orf26&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,20051541,G,G&fts=all">p.E63K</a>
C2orf53	Missense_Mutation	p.S94F	G	G		8	Cancer Gene	2	27360917	27360917	77	0.12987012987013	NA	NA	NA			20	Pro-rich.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C2orf53&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,27360917,G,G&fts=all">p.S94F</a>
CADM2	Missense_Mutation	p.Q215H	G	G		8	Cancer Gene	3	85961665	85961665	199	0.0251256281407035	NA	NA	NA			38	Ig-like C2-type 1.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CADM2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,85961665,G,G&fts=all">p.Q215H</a>
CD101	Nonsense_Mutation	p.W998*	G	G		8	Cancer Gene	1	117576650	117576650	229	0.0436681222707424	NA	NA	NA			49			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CD101&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,117576650,G,G&fts=all">p.W998*</a>
CD163L1	Missense_Mutation	p.E875K	C	C		8	Cancer Gene	12	7528389	7528389	271	0.0811808118081181	NA	NA	NA			96	SRCR 8. {ECO:0000255|PROSITE- ProRule:PRU00196}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CD163L1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,7528389,C,C&fts=all">p.E875K</a>
CD300LG	Missense_Mutation	p.E110K	G	G		8	Cancer Gene	17	41926210	41926210	194	0.0412371134020619	NA	NA	NA		p.E110K(3)	19	Ig-like V-type.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CD300LG&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,41926210,G,G&fts=all">p.E110K</a>
CDC42BPG	Missense_Mutation	p.P814L	G	G		8	Cancer Gene	11	64601422	64601422	454	0.0638766519823789	NA	NA	NA			4			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDC42BPG&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,64601422,G,G&fts=all">p.P814L</a>
CDCP1	Missense_Mutation	p.P824S	G	G		8	Cancer Gene	3	45127171	45127171	398	0.153266331658291	NA	NA	NA			29			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDCP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,45127171,G,G&fts=all">p.P824S</a>
CDHR3	Missense_Mutation	p.E545K	G	G		8	Cancer Gene	7	105658498	105658498	114	0.0526315789473684	NA	NA	NA			23	Cadherin 5. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDHR3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,105658498,G,G&fts=all">p.E545K</a>
CDK5RAP2	Missense_Mutation	p.S1434F	G	G		8	Cancer Gene	9	123173749	123173749	144	0.0486111111111111	NA	NA	NA			58			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDK5RAP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,123173749,G,G&fts=all">p.S1434F</a>
CDX4	Missense_Mutation	p.R224C	C	C		8	Cancer Gene	X	72674236	72674236	45	0.177777777777778	NA	NA	NA			18			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDX4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,72674236,C,C&fts=all">p.R224C</a>
CMBL	Missense_Mutation	p.R217W	G	G		8	Cancer Gene	5	10280654	10280654	320	0.096875	NA	NA	NA			13			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CMBL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,10280654,G,G&fts=all">p.R217W</a>
CMYA5	Missense_Mutation	p.E584K	G	G		8	Cancer Gene	5	79026338	79026338	808	0.0321782178217822	NA	NA	NA			128	Glu-rich.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CMYA5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,79026338,G,G&fts=all">p.E584K</a>
CNGB3	Missense_Mutation	p.G743R	C	C		8	Cancer Gene	8	87588235	87588235	258	0.062015503875969	NA	NA	NA			80			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNGB3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,87588235,C,C&fts=all">p.G743R</a>
COL4A3	Missense_Mutation	p.G619E	G	G		8	Cancer Gene	2	228137762	228137762	139	0.0359712230215827	NA	NA	NA			55	Triple-helical region.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL4A3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,228137762,G,G&fts=all">p.G619E</a>
CPA4	Missense_Mutation	p.D35N	G	G		8	Cancer Gene	7	129938620	129938620	268	0.0485074626865672	NA	NA	NA			21			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CPA4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,129938620,G,G&fts=all">p.D35N</a>
CPT1C	Missense_Mutation	p.S34F	C	C		8	Cancer Gene	19	50195610	50195610	78	0.0512820512820513	NA	NA	NA			27			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CPT1C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,50195610,C,C&fts=all">p.S34F</a>
CRISP2	Missense_Mutation	p.G186R	C	C		8	Cancer Gene	6	49663597	49663597	527	0.0531309297912713	NA	NA	NA			19			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CRISP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,49663597,C,C&fts=all">p.G186R</a>
CRISP3	Missense_Mutation	p.E54K	C	C		8	Cancer Gene	6	49704172	49704172	658	0.0729483282674772	NA	NA	NA			27	SCP.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CRISP3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,49704172,C,C&fts=all">p.E54K</a>
CSMD1	Missense_Mutation	p.E2084K	C	C		8	Cancer Gene	8	2976104	2976104	213	0.0610328638497653	NA	NA	NA			25			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSMD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,2976104,C,C&fts=all">p.E2084K</a>
CTNND2	Missense_Mutation	p.S1170F	G	G		8	Cancer Gene	5	10973734	10973734	163	0.0736196319018405	NA	NA	NA			136			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CTNND2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,10973734,G,G&fts=all">p.S1170F</a>
CTNND2	Missense_Mutation	p.E969K	C	C		8	Cancer Gene	5	11022975	11022975	216	0.101851851851852	NA	NA	NA			136			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CTNND2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,11022975,C,C&fts=all">p.E969K</a>
CXorf22	Missense_Mutation	p.E916K	G	G		8	Cancer Gene	X	36007468	36007468	138	0.115942028985507	NA	NA	NA			44			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CXorf22&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,36007468,G,G&fts=all">p.E916K</a>
CXorf36	Missense_Mutation	p.R419K	C	C		8	Cancer Gene	X	45010943	45010943	190	0.110526315789474	NA	NA	NA			7			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CXorf36&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,45010943,C,C&fts=all">p.R419K</a>
CXorf48	Missense_Mutation	p.E81K	C	C	rs150387330	8	Cancer Gene	X	134303556	134303556	59	0.0847457627118644	NA	NA	NA			5			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CXorf48&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,134303556,C,C&fts=all">p.E81K</a>
CYSLTR2	Missense_Mutation	p.R226W	C	C		8	Cancer Gene	13	49281629	49281629	278	0.0179856115107914	NA	NA	NA			20			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYSLTR2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,49281629,C,C&fts=all">p.R226W</a>
DAAM1	Missense_Mutation	p.L980F	C	C		8	Cancer Gene	14	59834228	59834228	244	0.0245901639344262	NA	NA	NA			37	FH2. {ECO:0000255|PROSITE- ProRule:PRU00774}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DAAM1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,59834228,C,C&fts=all">p.L980F</a>
DCAF4L2	Missense_Mutation	p.G256E	C	C		8	Cancer Gene	8	88885433	88885433	196	0.0612244897959184	NA	NA	NA			83			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DCAF4L2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,88885433,C,C&fts=all">p.G256E</a>
DCDC1	Missense_Mutation	p.P634S	G	G		8	Cancer Gene	11	31123807	31123807	48	0.104166666666667	NA	NA	NA			31			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DCDC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,31123807,G,G&fts=all">p.P634S</a>
DCHS2	Missense_Mutation	p.G219E	C	C		8	Cancer Gene	4	155287400	155287400	149	0.0604026845637584	NA	NA	NA			176	Cadherin 2. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DCHS2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,155287400,C,C&fts=all">p.G219E</a>
DCLK3	Missense_Mutation	p.D263E	G	G		8	Cancer Gene	3	36779362	36779362	158	0.107594936708861	NA	NA	NA			48			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DCLK3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,36779362,G,G&fts=all">p.D263E</a>
DDX27	Missense_Mutation	p.P420L	C	C		8	Cancer Gene	20	47850139	47850139	337	0.103857566765579	NA	NA	NA			45	Helicase ATP-binding. {ECO:0000255|PROSITE-ProRule:PRU00541}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DDX27&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,47850139,C,C&fts=all">p.P420L</a>
DDX58	Splice_Site		C	C		8	Cancer Gene	9	32466287	32466287	503	0.0457256461232604	NA	NA	NA			27			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DDX58&recr=Open">Click here</a>	
DDX60	Nonsense_Mutation	p.W601*	C	C		8	Cancer Gene	4	169201662	169201662	163	0.0797546012269939	NA	NA	NA			63			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DDX60&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,169201662,C,C&fts=all">p.W601*</a>
DEPDC4	Missense_Mutation	p.P219Q	G	G		8	Cancer Gene	12	100656086	100656086	278	0.0215827338129496	NA	NA	NA			15			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DEPDC4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,100656086,G,G&fts=all">p.P219Q</a>
DNAH2	Splice_Site	p.I3462I	C	C		8	Cancer Gene	17	7721413	7721413	86	0.0813953488372093	NA	NA	NA			189	AAA 5. {ECO:0000250}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH2&recr=Open">Click here</a>	
DNAJC16	Missense_Mutation	p.S743F	C	C		8	Cancer Gene	1	15894551	15894551	170	0.0411764705882353	NA	NA	NA			18			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAJC16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,15894551,C,C&fts=all">p.S743F</a>
DSC1	Missense_Mutation	p.S849L	G	G		8	Cancer Gene	18	28710616	28710616	377	0.0742705570291777	NA	NA	NA			53			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DSC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,28710616,G,G&fts=all">p.S849L</a>
ECT2L	Splice_Site		G	G		8	Cancer Gene	6	139164115	139164115	368	0.0489130434782609	NA	NA	NA			30			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ECT2L&recr=Open">Click here</a>	
ECT2L	Splice_Site	p.D115N	G	G		8	Cancer Gene	6	139164116	139164116	368	0.0516304347826087	NA	NA	NA			30	F-box.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ECT2L&recr=Open">Click here</a>	
ERN2	Missense_Mutation	p.A720V	G	G		8	Cancer Gene	16	23703345	23703345	389	0.0154241645244216	NA	NA	NA			6			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ERN2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,23703345,G,G&fts=all">p.A720V</a>
ERN2	Missense_Mutation	p.L276F	G	G		8	Cancer Gene	16	23716232	23716232	163	0.049079754601227	NA	NA	NA			6			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ERN2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,23716232,G,G&fts=all">p.L276F</a>
ESF1	Missense_Mutation	p.F47L	A	A		8	Cancer Gene	20	13763648	13763648	568	0.0457746478873239	NA	NA	NA			31			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ESF1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,13763648,A,A&fts=all">p.F47L</a>
EVC2	Missense_Mutation	p.G353V	C	C		8	Cancer Gene	4	5664921	5664921	269	0.0408921933085502	NA	NA	NA			81			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EVC2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,5664921,C,C&fts=all">p.G353V</a>
FAM120B	Missense_Mutation	p.L305I	C	C		8	Cancer Gene	6	170627391	170627391	232	0.0862068965517241	NA	NA	NA			44			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM120B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,170627391,C,C&fts=all">p.L305I</a>
FAM170A	Missense_Mutation	p.M224I	G	G		8	Cancer Gene	5	118970115	118970115	259	0.0424710424710425	NA	NA	NA			24			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM170A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,118970115,G,G&fts=all">p.M224I</a>
FAM47C	Missense_Mutation	p.S12F	C	C		8	Cancer Gene	X	37026518	37026518	21	0.285714285714286	NA	NA	NA		p.S12Y(2)	120			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM47C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,37026518,C,C&fts=all">p.S12F</a>
FAM47C	Missense_Mutation	p.L750R	T	T		8	Cancer Gene	X	37028732	37028732	88	0.147727272727273	NA	NA	NA			120			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM47C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,37028732,T,T&fts=all">p.L750R</a>
FAM65C	Missense_Mutation	p.N713H	T	T		8	Cancer Gene	20	49211153	49211153	184	0.0434782608695652	NA	NA	NA			29			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM65C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,49211153,T,T&fts=all">p.N713H</a>
FAM71B	Missense_Mutation	p.P250L	G	G		8	Cancer Gene	5	156590527	156590527	155	0.032258064516129	NA	NA	NA			68	Ala-rich.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM71B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,156590527,G,G&fts=all">p.P250L</a>
FAM71F1	Missense_Mutation	p.D128N	G	G		8	Cancer Gene	7	128359129	128359129	246	0.134146341463415	NA	NA	NA			18			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM71F1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,128359129,G,G&fts=all">p.D128N</a>
FAM81B	Missense_Mutation	p.R15K	G	G		8	Cancer Gene	5	94727137	94727137	181	0.0552486187845304	NA	NA	NA			22			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM81B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,94727137,G,G&fts=all">p.R15K</a>
FAM83B	Missense_Mutation	p.H504Y	C	C	rs115872183	8	Cancer Gene	6	54805279	54805279	295	0.0271186440677966	NA	NA	NA			71			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM83B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,54805279,C,C&fts=all">p.H504Y</a>
FAM83B	Missense_Mutation	p.R960C	C	C	rs145623856	8	Cancer Gene	6	54806647	54806647	323	0.0526315789473684	NA	NA	NA		p.R960C(1)	71			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM83B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,54806647,C,C&fts=all">p.R960C</a>
FAM83G	Missense_Mutation	p.G239E	C	C		8	Cancer Gene	17	18882961	18882961	258	0.104651162790698	NA	NA	NA			22			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM83G&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,18882961,C,C&fts=all">p.G239E</a>
FAT4	Missense_Mutation	p.E2009K	G	G		8	Cancer Gene	4	126336143	126336143	564	0.0656028368794326	NA	NA	NA			355	Cadherin 19. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAT4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,126336143,G,G&fts=all">p.E2009K</a>
FAT4	Missense_Mutation	p.P2374S	C	C		8	Cancer Gene	4	126355501	126355501	481	0.0665280665280665	NA	NA	NA			355	Cadherin 23. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAT4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,126355501,C,C&fts=all">p.P2374S</a>
FAT4	Missense_Mutation	p.D3037N	G	G		8	Cancer Gene	4	126371280	126371280	202	0.0544554455445545	NA	NA	NA			355	Cadherin 29. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAT4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,126371280,G,G&fts=all">p.D3037N</a>
FBXO36	Missense_Mutation	p.G58D	G	G		8	Cancer Gene	2	230861527	230861527	320	0.05625	NA	NA	NA			7			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FBXO36&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,230861527,G,G&fts=all">p.G58D</a>
FBXO8	Missense_Mutation	p.H222Y	G	G		8	Cancer Gene	4	175160253	175160253	291	0.0412371134020619	NA	NA	NA			14	SEC7. {ECO:0000255|PROSITE- ProRule:PRU00189}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FBXO8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,175160253,G,G&fts=all">p.H222Y</a>
FERMT1	Missense_Mutation	p.G584E	C	C		8	Cancer Gene	20	6060192	6060192	234	0.0341880341880342	NA	NA	NA			17	FERM.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FERMT1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,6060192,C,C&fts=all">p.G584E</a>
FHL5	Missense_Mutation	p.D283N	G	G		8	Cancer Gene	6	97063640	97063640	193	0.0466321243523316	NA	NA	NA			27	LIM zinc-binding 4. {ECO:0000255|PROSITE- ProRule:PRU00125}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FHL5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,97063640,G,G&fts=all">p.D283N</a>
FLG2	Missense_Mutation	p.E397K	C	C		8	Cancer Gene	1	152329073	152329073	221	0.0723981900452489	NA	NA	NA			188	Ser-rich.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FLG2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,152329073,C,C&fts=all">p.E397K</a>
FMN1	Missense_Mutation	p.G1188R	C	C		8	Cancer Gene	15	33192272	33192272	345	0.0898550724637681	NA	NA	NA			29	FH2. {ECO:0000255|PROSITE- ProRule:PRU00774}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FMN1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,33192272,C,C&fts=all">p.G1188R</a>
FMO2	Missense_Mutation	p.E308K	G	G		8	Cancer Gene	1	171174512	171174512	203	0.108374384236453	NA	NA	NA			22			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FMO2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,171174512,G,G&fts=all">p.E308K</a>
FOXR2	Missense_Mutation	p.P111S	C	C		8	Cancer Gene	X	55650475	55650475	45	0.133333333333333	NA	NA	NA			19			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FOXR2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,55650475,C,C&fts=all">p.P111S</a>
FPR2	Missense_Mutation	p.G222E	G	G		8	Cancer Gene	19	52272576	52272576	192	0.0572916666666667	NA	NA	NA			33			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FPR2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,52272576,G,G&fts=all">p.G222E</a>
FREM1	Missense_Mutation	p.S1526F	G	G		8	Cancer Gene	9	14776067	14776067	263	0.0874524714828897	NA	NA	NA			100			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FREM1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,14776067,G,G&fts=all">p.S1526F</a>
FRMD7	Missense_Mutation	p.S286L	G	G		8	Cancer Gene	X	131216439	131216439	567	0.119929453262787	NA	NA	NA			24			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FRMD7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,131216439,G,G&fts=all">p.S286L</a>
FRMPD3	Missense_Mutation	p.P1491L	C	C		8	Cancer Gene	X	106845642	106845642	71	0.140845070422535	NA	NA	NA			28			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FRMPD3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,106845642,C,C&fts=all">p.P1491L</a>
FRY	Missense_Mutation	p.L1482F	G	G		8	Cancer Gene	13	32785026	32785026	183	0.0273224043715847	NA	NA	NA			132			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FRY&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,32785026,G,G&fts=all">p.L1482F</a>
GALNT8	Missense_Mutation	p.P290L	C	C		8	Cancer Gene	12	4854603	4854603	242	0.0702479338842975	NA	NA	NA			35	Catalytic subdomain A.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GALNT8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,4854603,C,C&fts=all">p.P290L</a>
GBP4	Nonsense_Mutation	p.W129*	C	C		8	Cancer Gene	1	89659072	89659072	288	0.0416666666666667	NA	NA	NA			33	GB1/RHD3-type G.|GTPase domain (Globular). {ECO:0000250}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GBP4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,89659072,C,C&fts=all">p.W129*</a>
GIMAP1	Missense_Mutation	p.D164N	G	G	rs145115862	8	Cancer Gene	7	150417582	150417582	159	0.0566037735849057	NA	NA	NA			28	AIG1-type G.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GIMAP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,150417582,G,G&fts=all">p.D164N</a>
GIMAP8	Missense_Mutation	p.G238E	G	G		8	Cancer Gene	7	150171130	150171130	251	0.0438247011952191	NA	NA	NA			62			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GIMAP8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,150171130,G,G&fts=all">p.G238E</a>
GLIS3	Missense_Mutation	p.R720Q	C	C	rs200316055	8	Cancer Gene	9	3879565	3879565	92	0.0760869565217391	NA	NA	NA			26			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GLIS3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,3879565,C,C&fts=all">p.R720Q</a>
GOLGA3	Missense_Mutation	p.E680K	C	C		8	Cancer Gene	12	133373187	133373187	442	0.0361990950226244	NA	NA	NA		p.E680*(1)	64	Gln-rich.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GOLGA3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,133373187,C,C&fts=all">p.E680K</a>
GPR119	Missense_Mutation	p.L94F	G	G		8	Cancer Gene	X	129519142	129519142	194	0.11340206185567	NA	NA	NA			11			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR119&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,129519142,G,G&fts=all">p.L94F</a>
GPR124	Missense_Mutation	p.P870L	C	C		8	Cancer Gene	8	37697736	37697736	123	0.0650406504065041	NA	NA	NA			37			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR124&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,37697736,C,C&fts=all">p.P870L</a>
GPR52	Missense_Mutation	p.R139C	C	C		8	Cancer Gene	1	174417664	174417664	614	0.0700325732899023	NA	NA	NA			20			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR52&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,174417664,C,C&fts=all">p.R139C</a>
GPR84	Missense_Mutation	p.L338F	G	G		8	Cancer Gene	12	54756624	54756624	252	0.119047619047619	NA	NA	NA			18			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR84&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,54756624,G,G&fts=all">p.L338F</a>
GRAMD4	Nonsense_Mutation	p.Q184*	C	C		8	Cancer Gene	22	47059020	47059020	219	0.0776255707762557	NA	NA	NA			12			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRAMD4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,47059020,C,C&fts=all">p.Q184*</a>
GRIN2B	Missense_Mutation	p.L229F	G	G		8	Cancer Gene	12	13906576	13906576	320	0.046875	NA	NA	NA			143			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRIN2B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,13906576,G,G&fts=all">p.L229F</a>
GSDMC	Missense_Mutation	p.D44N	C	C		8	Cancer Gene	8	130789704	130789704	260	0.0384615384615385	NA	NA	NA			26			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GSDMC&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,130789704,C,C&fts=all">p.D44N</a>
GTSF1L	Missense_Mutation	p.D12N	C	C		8	Cancer Gene	20	42355301	42355301	267	0.0224719101123595	NA	NA	NA			5			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GTSF1L&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,42355301,C,C&fts=all">p.D12N</a>
HAUS3	Nonsense_Mutation	p.Q410*	G	G		8	Cancer Gene	4	2240452	2240452	271	0.040590405904059	NA	NA	NA			22			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HAUS3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,2240452,G,G&fts=all">p.Q410*</a>
HCAR3	Missense_Mutation	p.M109I	C	C		8	Cancer Gene	12	123200958	123200958	162	0.0493827160493827	NA	NA	NA			9			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HCAR3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,123200958,C,C&fts=all">p.M109I</a>
HCN1	Missense_Mutation	p.E810K	C	C		8	Cancer Gene	5	45262268	45262268	44	0.0909090909090909	NA	NA	NA			156			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HCN1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,45262268,C,C&fts=all">p.E810K</a>
HEATR4	Missense_Mutation	p.E454K	C	C		8	Cancer Gene	14	73980789	73980789	175	0.0628571428571429	NA	NA	NA			28			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HEATR4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,73980789,C,C&fts=all">p.E454K</a>
HEMGN	Missense_Mutation	p.E331K	C	C		8	Cancer Gene	9	100692686	100692686	416	0.0673076923076923	NA	NA	NA			27			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HEMGN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,100692686,C,C&fts=all">p.E331K</a>
HEMGN	Missense_Mutation	p.R78K	C	C		8	Cancer Gene	9	100693444	100693444	337	0.029673590504451	NA	NA	NA			27	Necessary for nuclear localization.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HEMGN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,100693444,C,C&fts=all">p.R78K</a>
HERC1	Missense_Mutation	p.G3682E	C	C		8	Cancer Gene	15	63937715	63937715	107	0.0654205607476635	NA	NA	NA			132			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HERC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,63937715,C,C&fts=all">p.G3682E</a>
HHLA2	Missense_Mutation	p.T328P	A	A		8	Cancer Gene	3	108076987	108076987	119	0.0672268907563025	NA	NA	NA			18	Ig-like V-type 2.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HHLA2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,108076987,A,A&fts=all">p.T328P</a>
HMG20A	Missense_Mutation	p.R240C	C	C		8	Cancer Gene	15	77770663	77770663	160	0.05625	NA	NA	NA			18			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HMG20A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,77770663,C,C&fts=all">p.R240C</a>
HTN1	Missense_Mutation	p.F43Y	T	T		8	Cancer Gene	4	70921240	70921240	188	0.0585106382978723	NA	NA	NA			6			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HTN1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,70921240,T,T&fts=all">p.F43Y</a>
IDO2	Missense_Mutation	p.E117K	G	G	rs573611998	8	Cancer Gene	8	39840204	39840204	65	0.0615384615384615	NA	NA	NA			18			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IDO2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,39840204,G,G&fts=all">p.E117K</a>
IDO2	Missense_Mutation	p.L391F	C	C		8	Cancer Gene	8	39873068	39873068	358	0.0307262569832402	NA	NA	NA			18			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IDO2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,39873068,C,C&fts=all">p.L391F</a>
IFNA16	Missense_Mutation	p.Q63P	T	T		8	Cancer Gene	9	21217117	21217117	392	0.0510204081632653	NA	NA	NA			13			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IFNA16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,21217117,T,T&fts=all">p.Q63P</a>
IFNB1	Nonsense_Mutation	p.Q39*	G	G		8	Cancer Gene	9	21077754	21077754	135	0.133333333333333	NA	NA	NA			12			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IFNB1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,21077754,G,G&fts=all">p.Q39*</a>
IGDCC4	Missense_Mutation	p.S602L	G	G	rs372210828	8	Cancer Gene	15	65685779	65685779	140	0.0571428571428571	NA	NA	NA			44	Fibronectin type-III 2. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGDCC4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,65685779,G,G&fts=all">p.S602L</a>
IGF2BP1	Missense_Mutation	p.E307K	G	G		8	Cancer Gene	17	47118840	47118840	134	0.082089552238806	NA	NA	NA			31	KH 2. {ECO:0000255|PROSITE- ProRule:PRU00117}.|Necessary for interaction with ELAVL4 and binding to TAU mRNA. {ECO:0000250}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGF2BP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,47118840,G,G&fts=all">p.E307K</a>
IL20RA	Missense_Mutation	p.L97F	G	G		8	Cancer Gene	6	137332525	137332525	474	0.040084388185654	NA	NA	NA			27	Fibronectin type-III 1. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IL20RA&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,137332525,G,G&fts=all">p.L97F</a>
INADL	Missense_Mutation	p.G1477E	G	G		8	Cancer Gene	1	62574161	62574161	158	0.069620253164557	NA	NA	NA			103	PDZ 8. {ECO:0000255|PROSITE- ProRule:PRU00143}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+INADL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,62574161,G,G&fts=all">p.G1477E</a>
INADL	Missense_Mutation	p.P1698L	C	C		8	Cancer Gene	1	62593693	62593693	241	0.045643153526971	NA	NA	NA			103	PDZ 10. {ECO:0000255|PROSITE- ProRule:PRU00143}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+INADL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,62593693,C,C&fts=all">p.P1698L</a>
INTS10	Missense_Mutation	p.R138H	G	G		8	Cancer Gene	8	19678001	19678001	426	0.0140845070422535	NA	NA	NA			20			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+INTS10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,19678001,G,G&fts=all">p.R138H</a>
IPO4	Missense_Mutation	p.P520S	G	G		8	Cancer Gene	14	24653934	24653934	43	0.0930232558139535	NA	NA	NA			33			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IPO4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,24653934,G,G&fts=all">p.P520S</a>
IPO9	Missense_Mutation	p.V276M	G	G		8	Cancer Gene	1	201823966	201823966	230	0.0608695652173913	NA	NA	NA			38			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IPO9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,201823966,G,G&fts=all">p.V276M</a>
KANK4	Missense_Mutation	p.H244R	T	T		8	Cancer Gene	1	62740045	62740045	66	0.0757575757575758	NA	NA	NA			81	Pro-rich.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KANK4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,62740045,T,T&fts=all">p.H244R</a>
KCNH5	Missense_Mutation	p.E977K	C	C		8	Cancer Gene	14	63174264	63174264	366	0.0327868852459016	NA	NA	NA			99			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNH5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,63174264,C,C&fts=all">p.E977K</a>
KCNS3	Missense_Mutation	p.E15K	G	G		8	Cancer Gene	2	18112318	18112318	267	0.0374531835205993	NA	NA	NA			32			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNS3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,18112318,G,G&fts=all">p.E15K</a>
KCTD2	Missense_Mutation	p.S261L	C	C		8	Cancer Gene	17	73059132	73059132	251	0.0717131474103586	NA	NA	NA			3			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCTD2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,73059132,C,C&fts=all">p.S261L</a>
KCTD8	Missense_Mutation	p.R306C	G	G		8	Cancer Gene	4	44449625	44449625	63	0.0952380952380952	NA	NA	NA			41			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCTD8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,44449625,G,G&fts=all">p.R306C</a>
KDM5B	Missense_Mutation	p.G1249V	C	C		8	Cancer Gene	1	202702692	202702692	255	0.0549019607843137	NA	NA	NA			6			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KDM5B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,202702692,C,C&fts=all">p.G1249V</a>
KIAA1024	Missense_Mutation	p.D457N	G	G		8	Cancer Gene	15	79749858	79749858	138	0.115942028985507	NA	NA	NA			49			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA1024&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,79749858,G,G&fts=all">p.D457N</a>
KIAA1033	Missense_Mutation	p.H210Y	C	C		8	Cancer Gene	12	105514945	105514945	224	0.0535714285714286	NA	NA	NA			41			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA1033&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,105514945,C,C&fts=all">p.H210Y</a>
KIAA1109	Missense_Mutation	p.E4401K	G	G		8	Cancer Gene	4	123269793	123269793	243	0.065843621399177	NA	NA	NA			172			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA1109&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,123269793,G,G&fts=all">p.E4401K</a>
KIRREL2	Missense_Mutation	p.K538E	A	A		8	Cancer Gene	19	36353496	36353496	132	0.128787878787879	NA	NA	NA			48			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIRREL2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,36353496,A,A&fts=all">p.K538E</a>
KLB	Nonsense_Mutation	p.W100*	G	G		8	Cancer Gene	4	39408869	39408869	187	0.0427807486631016	NA	NA	NA			29	Glycosyl hydrolase-1 1.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KLB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,39408869,G,G&fts=all">p.W100*</a>
KLF17	Missense_Mutation	p.R366W	C	C	rs369271264	8	Cancer Gene	1	44596354	44596354	186	0.102150537634409	NA	NA	NA			18			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KLF17&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,44596354,C,C&fts=all">p.R366W</a>
KLHL26	Missense_Mutation	p.R546W	C	C		8	Cancer Gene	19	18779843	18779843	112	0.0357142857142857	NA	NA	NA			17			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KLHL26&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,18779843,C,C&fts=all">p.R546W</a>
KNDC1	Missense_Mutation	p.P422S	C	C		8	Cancer Gene	10	135000116	135000116	87	0.103448275862069	NA	NA	NA			60			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KNDC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,135000116,C,C&fts=all">p.P422S</a>
KRT84	Missense_Mutation	p.E304K	C	C		8	Cancer Gene	12	52776223	52776223	186	0.0591397849462366	NA	NA	NA			27	Coil 1B.|Rod.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KRT84&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,52776223,C,C&fts=all">p.E304K</a>
KRTAP13-4	Missense_Mutation	p.S104L	C	C		8	Cancer Gene	21	31802904	31802904	91	0.0989010989010989	NA	NA	NA		p.S104*(1)	15			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KRTAP13-4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,31802904,C,C&fts=all">p.S104L</a>
KRTCAP2	Missense_Mutation	p.P12S	G	G		8	Cancer Gene	1	155145745	155145745	123	0.0731707317073171	NA	NA	NA			4			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KRTCAP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,155145745,G,G&fts=all">p.P12S</a>
LCT	Missense_Mutation	p.M757T	A	A		8	Cancer Gene	2	136569964	136569964	237	0.0464135021097046	NA	NA	NA			124	4 X approximate repeats.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LCT&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,136569964,A,A&fts=all">p.M757T</a>
LETMD1	Missense_Mutation	p.L217F	C	C		8	Cancer Gene	12	51449754	51449754	323	0.0464396284829721	NA	NA	NA			16	LETM1.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LETMD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,51449754,C,C&fts=all">p.L217F</a>
LMF2	Splice_Site	p.E606K	C	C		8	Cancer Gene	22	50942128	50942128	21	0.19047619047619	NA	NA	NA			10			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LMF2&recr=Open">Click here</a>	
LPAR4	Missense_Mutation	p.R147C	C	C		8	Cancer Gene	X	78010805	78010805	114	0.131578947368421	NA	NA	NA			38			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LPAR4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,78010805,C,C&fts=all">p.R147C</a>
LRFN5	Missense_Mutation	p.D338N	G	G		8	Cancer Gene	14	42356840	42356840	308	0.0357142857142857	NA	NA	NA			120	Ig-like.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRFN5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,42356840,G,G&fts=all">p.D338N</a>
LRRC20	Missense_Mutation	p.E131K	C	C		8	Cancer Gene	10	72083628	72083628	89	0.112359550561798	NA	NA	NA			9			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRRC20&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,72083628,C,C&fts=all">p.E131K</a>
LRRC7	Missense_Mutation	p.P1417S	C	C		8	Cancer Gene	1	70541892	70541892	280	0.0857142857142857	NA	NA	NA			162			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRRC7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,70541892,C,C&fts=all">p.P1417S</a>
LRRIQ1	Missense_Mutation	p.K1559R	A	A		8	Cancer Gene	12	85547828	85547828	190	0.068421052631579	NA	NA	NA			83			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRRIQ1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,85547828,A,A&fts=all">p.K1559R</a>
LYVE1	Missense_Mutation	p.E175K	C	C	rs117443264	8	Cancer Gene	11	10580792	10580792	215	0.0558139534883721	NA	NA	NA			8			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LYVE1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,10580792,C,C&fts=all">p.E175K</a>
MAGEC3	Missense_Mutation	p.D438N	G	G		8	Cancer Gene	X	140984856	140984856	39	0.128205128205128	NA	NA	NA			69			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAGEC3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,140984856,G,G&fts=all">p.D438N</a>
MAGI3	Missense_Mutation	p.P1021S	C	C		8	Cancer Gene	1	114215959	114215959	219	0.0684931506849315	NA	NA	NA			41			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAGI3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,114215959,C,C&fts=all">p.P1021S</a>
MANBA	Missense_Mutation	p.S570L	G	G	rs542071291	8	Cancer Gene	4	103571854	103571854	197	0.050761421319797	NA	NA	NA			42			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MANBA&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,103571854,G,G&fts=all">p.S570L</a>
MBD3L1	Missense_Mutation	p.G176R	G	G		8	Cancer Gene	19	8953880	8953880	51	0.0784313725490196	NA	NA	NA			12			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MBD3L1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,8953880,G,G&fts=all">p.G176R</a>
MCTP1	Missense_Mutation	p.P432L	G	G		8	Cancer Gene	5	94253656	94253656	324	0.0432098765432099	NA	NA	NA			41			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MCTP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,94253656,G,G&fts=all">p.P432L</a>
MCTP2	Missense_Mutation	p.N224I	A	A		8	Cancer Gene	15	94882552	94882552	462	0.0800865800865801	NA	NA	NA			49	C2 1. {ECO:0000255|PROSITE- ProRule:PRU00041}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MCTP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,94882552,A,A&fts=all">p.N224I</a>
MCTP2	Missense_Mutation	p.D569N	G	G		8	Cancer Gene	15	94928671	94928671	539	0.0723562152133581	NA	NA	NA			49	C2 3. {ECO:0000255|PROSITE- ProRule:PRU00041}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MCTP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,94928671,G,G&fts=all">p.D569N</a>
MEGF10	Missense_Mutation	p.E100K	G	G		8	Cancer Gene	5	126676301	126676301	248	0.0483870967741935	NA	NA	NA			68	EMI. {ECO:0000255|PROSITE- ProRule:PRU00384}.|Necessary for interaction with AP2M1, self-assembly and formation of the irregular, mosaic-like adhesion pattern.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MEGF10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,126676301,G,G&fts=all">p.E100K</a>
MGAT4C	Missense_Mutation	p.E415K	C	C		8	Cancer Gene	12	86373261	86373261	408	0.0245098039215686	NA	NA	NA			41			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MGAT4C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,86373261,C,C&fts=all">p.E415K</a>
MORC1	Splice_Site		C	C		8	Cancer Gene	3	108688570	108688570	248	0.0967741935483871	NA	NA	NA			105			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MORC1&recr=Open">Click here</a>	
MRPL45	Missense_Mutation	p.S98L	C	C		8	Cancer Gene	17	36455365	36455365	525	0.0819047619047619	NA	NA	NA			13			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MRPL45&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,36455365,C,C&fts=all">p.S98L</a>
MUC17	Missense_Mutation	p.T766P	A	A		8	Cancer Gene	7	100676993	100676993	703	0.0369843527738265	NA	NA	NA			343	59 X approximate tandem repeats.|Ser-rich.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC17&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,100676993,A,A&fts=all">p.T766P</a>
MUC17	Missense_Mutation	p.S3733L	C	C		8	Cancer Gene	7	100685895	100685895	362	0.0469613259668508	NA	NA	NA		p.S3733*(1)	343	Ser-rich.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC17&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,100685895,C,C&fts=all">p.S3733L</a>
MYOCD	Missense_Mutation	p.S63F	C	C	rs201202686	8	Cancer Gene	17	12620673	12620673	103	0.0679611650485437	NA	NA	NA			70			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYOCD&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,12620673,C,C&fts=all">p.S63F</a>
NAP1L2	Missense_Mutation	p.G322E	C	C	rs397896767	8	Cancer Gene	X	72433364	72433364	291	0.134020618556701	NA	NA	NA			29			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NAP1L2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,72433364,C,C&fts=all">p.G322E</a>
NDUFB9	Missense_Mutation	p.D95N	G	G		8	Cancer Gene	8	125555509	125555509	141	0.0354609929078014	NA	NA	NA			8			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NDUFB9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,125555509,G,G&fts=all">p.D95N</a>
NEDD9	Missense_Mutation	p.S395F	G	G		8	Cancer Gene	6	11190918	11190918	130	0.0461538461538462	NA	NA	NA		p.S395F(2)	26			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NEDD9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,11190918,G,G&fts=all">p.S395F</a>
NEK9	Splice_Site		C	C		8	Cancer Gene	14	75570544	75570544	385	0.0363636363636364	NA	NA	NA			31			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NEK9&recr=Open">Click here</a>	
NEUROD4	Missense_Mutation	p.S8F	C	C		8	Cancer Gene	12	55420246	55420246	197	0.0558375634517767	NA	NA	NA		p.S8F(1)	41			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NEUROD4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,55420246,C,C&fts=all">p.S8F</a>
NFASC	Missense_Mutation	p.P460L	C	C		8	Cancer Gene	1	204943406	204943406	69	0.0579710144927536	NA	NA	NA			81	Ig-like C2-type 5.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NFASC&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,204943406,C,C&fts=all">p.P460L</a>
NFASC	Missense_Mutation	p.E1156K	G	G		8	Cancer Gene	1	204981969	204981969	190	0.0578947368421053	NA	NA	NA			81	Fibronectin type-III 5. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NFASC&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,204981969,G,G&fts=all">p.E1156K</a>
NFS1	Missense_Mutation	p.S389F	G	G		8	Cancer Gene	20	34261577	34261577	190	0.068421052631579	NA	NA	NA			18			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NFS1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,34261577,G,G&fts=all">p.S389F</a>
NLRP10	Missense_Mutation	p.P42S	G	G		8	Cancer Gene	11	7984919	7984919	193	0.0725388601036269	NA	NA	NA			58	DAPIN. {ECO:0000255|PROSITE- ProRule:PRU00061}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLRP10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,7984919,G,G&fts=all">p.P42S</a>
NLRP13	Missense_Mutation	p.E211K	C	C		8	Cancer Gene	19	56424552	56424552	364	0.0796703296703297	NA	NA	NA			109			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLRP13&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,56424552,C,C&fts=all">p.E211K</a>
NLRP4	Missense_Mutation	p.R255Q	G	G	rs145432163	8	Cancer Gene	19	56369523	56369523	212	0.0566037735849057	NA	NA	NA			42	NACHT. {ECO:0000255|PROSITE- ProRule:PRU00136}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLRP4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,56369523,G,G&fts=all">p.R255Q</a>
NOTCH4	Missense_Mutation	p.R1362K	C	C		8	Cancer Gene	6	32168948	32168948	232	0.0474137931034483	NA	NA	NA			100			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NOTCH4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,32168948,C,C&fts=all">p.R1362K</a>
NPNT	Missense_Mutation	p.G493E	G	G		8	Cancer Gene	4	106888387	106888387	118	0.0423728813559322	NA	NA	NA			21	MAM. {ECO:0000255|PROSITE- ProRule:PRU00128}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NPNT&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,106888387,G,G&fts=all">p.G493E</a>
OBSCN	Missense_Mutation	p.S4820F	C	C		8	Cancer Gene	1	228493016	228493016	384	0.0911458333333333	NA	NA	NA			223			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OBSCN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,228493016,C,C&fts=all">p.S4820F</a>
OPALIN	Splice_Site	p.E65K	C	C		8	Cancer Gene	10	98108102	98108102	121	0.0578512396694215	NA	NA	NA			9			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OPALIN&recr=Open">Click here</a>	
OPN1LW	Missense_Mutation	p.E265K	G	G		8	Cancer Gene	X	153421817	153421817	196	0.158163265306122	NA	NA	NA			15			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OPN1LW&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,153421817,G,G&fts=all">p.E265K</a>
OR10X1	Missense_Mutation	p.S34F	G	G		8	Cancer Gene	1	158549589	158549589	414	0.0628019323671498	NA	NA	NA			37			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR10X1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,158549589,G,G&fts=all">p.S34F</a>
OR12D3	Missense_Mutation	p.D178N	C	C		8	Cancer Gene	6	29342533	29342533	226	0.0442477876106195	NA	NA	NA			23			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR12D3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,29342533,C,C&fts=all">p.D178N</a>
OR13C3	Missense_Mutation	p.S97F	G	G		8	Cancer Gene	9	107298805	107298805	181	0.0386740331491713	NA	NA	NA			19			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR13C3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,107298805,G,G&fts=all">p.S97F</a>
OR14J1	Missense_Mutation	p.V2I	G	G		8	Cancer Gene	6	29274470	29274470	435	0.0436781609195402	NA	NA	NA			17			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR14J1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,29274470,G,G&fts=all">p.V2I</a>
OR1D2	Missense_Mutation	p.S243F	G	G		8	Cancer Gene	17	2995563	2995563	188	0.0585106382978723	NA	NA	NA			15			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR1D2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,2995563,G,G&fts=all">p.S243F</a>
OR2B2	Start_Codon_SNP	p.M1I	C	C		8	Cancer Gene	6	27880095	27880095	148	0.0472972972972973	NA	NA	NA			22			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR2B2&recr=Open">Click here</a>	
OR2Z1	Missense_Mutation	p.H56Y	C	C		8	Cancer Gene	19	8841556	8841556	204	0.053921568627451	NA	NA	NA			18			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR2Z1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,8841556,C,C&fts=all">p.H56Y</a>
OR51B5	Missense_Mutation	p.P267S	G	G		8	Cancer Gene	11	5363956	5363956	147	0.054421768707483	NA	NA	NA			28			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR51B5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,5363956,G,G&fts=all">p.P267S</a>
OR51F2	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	11	4825849	4904115	NA	NA	3	-1.17657670931474	TRUE		NA	NA	NA		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR51F2&recr=Open">Click here</a>	
OR51S1	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	11	4825849	4904115	NA	NA	3	-1.17657670931474	TRUE		NA	NA	NA		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR51S1&recr=Open">Click here</a>	
OR51T1	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	11	4825849	4904115	NA	NA	3	-1.17657670931474	TRUE		NA	NA	NA		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR51T1&recr=Open">Click here</a>	
OR52J3	Missense_Mutation	p.P255L	C	C		8	Cancer Gene	11	5068519	5068519	462	0.0844155844155844	NA	NA	NA			36			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR52J3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,5068519,C,C&fts=all">p.P255L</a>
OR52M1	Missense_Mutation	p.P292S	C	C		8	Cancer Gene	11	4567294	4567294	181	0.0441988950276243	NA	NA	NA			18			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR52M1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,4567294,C,C&fts=all">p.P292S</a>
OR52R1	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	11	4825849	4904115	NA	NA	3	-1.17657670931474	FALSE		NA	NA	NA		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR52R1&recr=Open">Click here</a>	
OR7G2	Missense_Mutation	p.R111W	G	G	rs367685139	8	Cancer Gene	19	9213652	9213652	253	0.0948616600790514	NA	NA	NA			16			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR7G2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,9213652,G,G&fts=all">p.R111W</a>
OR9A2	Missense_Mutation	p.G40E	C	C		8	Cancer Gene	7	142724101	142724101	235	0.025531914893617	NA	NA	NA			25			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR9A2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,142724101,C,C&fts=all">p.G40E</a>
OSTM1	Missense_Mutation	p.P296L	G	G		8	Cancer Gene	6	108370519	108370519	247	0.048582995951417	NA	NA	NA			8			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OSTM1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,108370519,G,G&fts=all">p.P296L</a>
OTOGL	Missense_Mutation	p.S430F	C	C		8	Cancer Gene	12	80647276	80647276	229	0.091703056768559	NA	NA	NA			23	TIL 1.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OTOGL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,80647276,C,C&fts=all">p.S430F</a>
OTOP3	Missense_Mutation	p.E299K	G	G		8	Cancer Gene	17	72942845	72942845	450	0.102222222222222	NA	NA	NA			23			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OTOP3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,72942845,G,G&fts=all">p.E299K</a>
OTOP3	Missense_Mutation	p.P327L	C	C		8	Cancer Gene	17	72942930	72942930	344	0.061046511627907	NA	NA	NA			23			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OTOP3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,72942930,C,C&fts=all">p.P327L</a>
PAPPA2	Missense_Mutation	p.R825Q	G	G	rs564617754	8	Cancer Gene	1	176661304	176661304	292	0.0616438356164384	NA	NA	NA			226			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PAPPA2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,176661304,G,G&fts=all">p.R825Q</a>
PAPPA2	Missense_Mutation	p.P1289S	C	C		8	Cancer Gene	1	176708828	176708828	230	0.0695652173913043	NA	NA	NA			226			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PAPPA2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,176708828,C,C&fts=all">p.P1289S</a>
PCDH10	Missense_Mutation	p.E69G	A	A		8	Cancer Gene	4	134071501	134071501	204	0.0637254901960784	NA	NA	NA			136	Cadherin 1. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDH10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,134071501,A,A&fts=all">p.E69G</a>
PCDH15	Missense_Mutation	p.E1467K	C	C		8	Cancer Gene	10	55570420	55570420	421	0.0688836104513064	NA	NA	NA			237			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDH15&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,55570420,C,C&fts=all">p.E1467K</a>
PCDH15	Missense_Mutation	p.D1598N	C	C		8	Cancer Gene	10	55582700	55582700	328	0.0640243902439024	NA	NA	NA		p.D1596Y(1)	237			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDH15&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,55582700,C,C&fts=all">p.D1598N</a>
PCDH15	Missense_Mutation	p.G801R	C	C	rs138805682	8	Cancer Gene	10	55782798	55782798	312	0.0769230769230769	NA	NA	NA			237	Cadherin 7. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDH15&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,55782798,C,C&fts=all">p.G801R</a>
PCDHA10	Missense_Mutation	p.E338K	G	G		8	Cancer Gene	5	140236645	140236645	252	0.0198412698412698	NA	NA	NA		p.V337_L339delVEL(2)|p.L336fs*4(2)|p.L336fs*11(2)|p.L336fs*10(2)	79	Cadherin 3. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHA10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,140236645,G,G&fts=all">p.E338K</a>
PCDHA12	Missense_Mutation	p.G746E	G	G		8	Cancer Gene	5	140257294	140257294	79	0.0886075949367089	NA	NA	NA			78	5 X 4 AA repeats of P-X-X-P.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHA12&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,140257294,G,G&fts=all">p.G746E</a>
PCDHA4	Missense_Mutation	p.S601L	C	C		8	Cancer Gene	5	140188574	140188574	154	0.051948051948052	NA	NA	NA			78	Cadherin 6. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHA4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,140188574,C,C&fts=all">p.S601L</a>
PCDHA6	Nonsense_Mutation	p.R297*	C	C		8	Cancer Gene	5	140208565	140208565	313	0.0319488817891374	NA	NA	NA			89	Cadherin 3. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHA6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,140208565,C,C&fts=all">p.R297*</a>
PCDHA6	Missense_Mutation	p.R757K	G	G	rs147693617	8	Cancer Gene	5	140209946	140209946	245	0.0489795918367347	NA	NA	NA			89			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHA6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,140209946,G,G&fts=all">p.R757K</a>
PCDHB12	Missense_Mutation	p.D388N	G	G		8	Cancer Gene	5	140589641	140589641	109	0.055045871559633	NA	NA	NA			83	Cadherin 4. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHB12&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,140589641,G,G&fts=all">p.D388N</a>
PCDHB14	Missense_Mutation	p.T146I	C	C		8	Cancer Gene	5	140603514	140603514	270	0.037037037037037	NA	NA	NA			49	Cadherin 2. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHB14&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,140603514,C,C&fts=all">p.T146I</a>
PCDHB4	Missense_Mutation	p.E309K	G	G		8	Cancer Gene	5	140502505	140502505	356	0.0449438202247191	NA	NA	NA			67	Cadherin 3. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHB4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,140502505,G,G&fts=all">p.E309K</a>
PCDHGA5	Missense_Mutation	p.D570N	G	G		8	Cancer Gene	5	140745605	140745605	363	0.0633608815426997	NA	NA	NA			18	Cadherin 6. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHGA5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,140745605,G,G&fts=all">p.D570N</a>
PCNXL2	Missense_Mutation	p.E411K	C	C		8	Cancer Gene	1	233394377	233394377	281	0.0747330960854092	NA	NA	NA			86			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCNXL2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,233394377,C,C&fts=all">p.E411K</a>
PER3	Missense_Mutation	p.A797V	C	C		8	Cancer Gene	1	7887379	7887379	99	0.0909090909090909	NA	NA	NA			39	Pro-rich.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PER3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,7887379,C,C&fts=all">p.A797V</a>
PI4KA	Missense_Mutation	p.R2050C	G	G		8	Cancer Gene	22	21064221	21064221	122	0.0491803278688525	NA	NA	NA			79			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PI4KA&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,21064221,G,G&fts=all">p.R2050C</a>
PIWIL3	Missense_Mutation	p.K317N	T	T		8	Cancer Gene	22	25150007	25150007	308	0.0779220779220779	NA	NA	NA			50	PAZ. {ECO:0000255|PROSITE- ProRule:PRU00142}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PIWIL3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,25150007,T,T&fts=all">p.K317N</a>
PLB1	Nonsense_Mutation	p.W261*	G	G		8	Cancer Gene	2	28764582	28764582	79	0.113924050632911	NA	NA	NA			69	4 X 308-326 AA approximate repeats.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLB1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,28764582,G,G&fts=all">p.W261*</a>
PLCH1	Missense_Mutation	p.E793D	T	T		8	Cancer Gene	3	155206573	155206573	154	0.123376623376623	NA	NA	NA			107	C2. {ECO:0000255|PROSITE- ProRule:PRU00041}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLCH1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,155206573,T,T&fts=all">p.E793D</a>
PLCZ1	Missense_Mutation	p.S288L	G	G		8	Cancer Gene	12	18841097	18841097	482	0.0497925311203319	NA	NA	NA			31			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLCZ1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,18841097,G,G&fts=all">p.S288L</a>
PLEK2	Splice_Site	p.G312R	C	C		8	Cancer Gene	14	67854941	67854941	133	0.0902255639097744	NA	NA	NA			15	PH 2. {ECO:0000255|PROSITE- ProRule:PRU00145}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLEK2&recr=Open">Click here</a>	
PLEKHH2	Missense_Mutation	p.G1182E	G	G		8	Cancer Gene	2	43971118	43971118	237	0.0843881856540084	NA	NA	NA			56	FERM. {ECO:0000255|PROSITE- ProRule:PRU00084}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLEKHH2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,43971118,G,G&fts=all">p.G1182E</a>
PMFBP1	Start_Codon_SNP	p.M1I	C	C		8	Cancer Gene	16	72205105	72205105	494	0.0526315789473684	NA	NA	NA			45			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PMFBP1&recr=Open">Click here</a>	
POGZ	Nonsense_Mutation	p.Q101*	G	G		8	Cancer Gene	1	151403300	151403300	79	0.0759493670886076	NA	NA	NA			47			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+POGZ&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,151403300,G,G&fts=all">p.Q101*</a>
PPP2R2B	Missense_Mutation	p.Y67C	T	T		8	Cancer Gene	5	146077676	146077676	718	0.0417827298050139	NA	NA	NA			32			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPP2R2B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,146077676,T,T&fts=all">p.Y67C</a>
PPP2R5E	Missense_Mutation	p.L83P	A	A		8	Cancer Gene	14	63920513	63920513	269	0.0855018587360595	NA	NA	NA			15			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPP2R5E&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,63920513,A,A&fts=all">p.L83P</a>
PREX2	Missense_Mutation	p.R297C	C	C		8	Cancer Gene	8	68956771	68956771	410	0.0365853658536585	NA	NA	NA			178	PH. {ECO:0000255|PROSITE- ProRule:PRU00145}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PREX2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,68956771,C,C&fts=all">p.R297C</a>
PREX2	Missense_Mutation	p.R1105S	A	A		8	Cancer Gene	8	69028156	69028156	337	0.0504451038575668	NA	NA	NA			178			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PREX2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,69028156,A,A&fts=all">p.R1105S</a>
PROKR2	Missense_Mutation	p.E308K	C	C		8	Cancer Gene	20	5282919	5282919	192	0.0625	NA	NA	NA			53			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PROKR2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,5282919,C,C&fts=all">p.E308K</a>
PROX2	Missense_Mutation	p.G190D	C	C		8	Cancer Gene	14	75329969	75329969	113	0.0442477876106195	NA	NA	NA			6			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PROX2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,75329969,C,C&fts=all">p.G190D</a>
PRRC2A	Missense_Mutation	p.P842S	C	C		8	Cancer Gene	6	31598974	31598974	192	0.078125	NA	NA	NA			70	4 X 57 AA type A repeats.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRRC2A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,31598974,C,C&fts=all">p.P842S</a>
PRSS37	Missense_Mutation	p.K182I	T	T		8	Cancer Gene	7	141536934	141536934	289	0.0449826989619377	NA	NA	NA			15	Peptidase S1. {ECO:0000255|PROSITE- ProRule:PRU00274}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRSS37&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,141536934,T,T&fts=all">p.K182I</a>
PRUNE2	Missense_Mutation	p.S958L	G	G		8	Cancer Gene	9	79324317	79324317	237	0.0548523206751055	NA	NA	NA			16			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRUNE2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,79324317,G,G&fts=all">p.S958L</a>
PSG2	Missense_Mutation	p.G297E	C	C		8	Cancer Gene	19	43575926	43575926	616	0.0746753246753247	NA	NA	NA			49	Ig-like C2-type 2.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PSG2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,43575926,C,C&fts=all">p.G297E</a>
PTCHD2	Nonsense_Mutation	p.W1228*	G	G		8	Cancer Gene	1	11595569	11595569	131	0.0534351145038168	NA	NA	NA			76			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTCHD2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,11595569,G,G&fts=all">p.W1228*</a>
RAG2	Missense_Mutation	p.M443I	C	C		8	Cancer Gene	11	36614390	36614390	172	0.104651162790698	NA	NA	NA			32			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RAG2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,36614390,C,C&fts=all">p.M443I</a>
RAG2	Missense_Mutation	p.I142F	T	T		8	Cancer Gene	11	36615295	36615295	411	0.10705596107056	NA	NA	NA			32			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RAG2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,36615295,T,T&fts=all">p.I142F</a>
RBM25	Missense_Mutation	p.L518P	T	T		8	Cancer Gene	14	73576061	73576061	264	0.0189393939393939	NA	NA	NA			31	Arg-rich.|Glu-rich.|Necessary for nuclear speckle localization.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RBM25&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,73576061,T,T&fts=all">p.L518P</a>
RBM44	Missense_Mutation	p.G894E	G	G		8	Cancer Gene	2	238737937	238737937	112	0.0982142857142857	NA	NA	NA			33	RRM. {ECO:0000255|PROSITE- ProRule:PRU00176}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RBM44&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,238737937,G,G&fts=all">p.G894E</a>
RBM46	Nonsense_Mutation	p.R16*	C	C	rs144494582	8	Cancer Gene	4	155717950	155717950	225	0.0622222222222222	NA	NA	NA		p.R16*(1)	26			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RBM46&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,155717950,C,C&fts=all">p.R16*</a>
RBPJL	Splice_Site	p.E149K	G	G		8	Cancer Gene	20	43940861	43940861	147	0.054421768707483	NA	NA	NA			19			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RBPJL&recr=Open">Click here</a>	
RDH12	Splice_Site	p.G63E	G	G		8	Cancer Gene	14	68191816	68191816	515	0.0349514563106796	NA	NA	NA			12			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RDH12&recr=Open">Click here</a>	
REP15	Missense_Mutation	p.P45L	C	C		8	Cancer Gene	12	27849629	27849629	169	0.0473372781065089	NA	NA	NA			9			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+REP15&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,27849629,C,C&fts=all">p.P45L</a>
RFX6	Missense_Mutation	p.P879S	C	C		8	Cancer Gene	6	117252517	117252517	566	0.0247349823321555	NA	NA	NA			59			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RFX6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,117252517,C,C&fts=all">p.P879S</a>
RHOBTB2	Missense_Mutation	p.P330S	C	C		8	Cancer Gene	8	22864680	22864680	141	0.0851063829787234	NA	NA	NA			31	BTB 1. {ECO:0000255|PROSITE- ProRule:PRU00037}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RHOBTB2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,22864680,C,C&fts=all">p.P330S</a>
RIMBP3	Missense_Mutation	p.G1070E	C	C		8	Cancer Gene	22	20458093	20458093	102	0.0588235294117647	NA	NA	NA			13	Fibronectin type-III 1. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RIMBP3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,20458093,C,C&fts=all">p.G1070E</a>
RIMBP3	Missense_Mutation	p.G1070R	C	C		8	Cancer Gene	22	20458094	20458094	103	0.0485436893203883	NA	NA	NA			13	Fibronectin type-III 1. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RIMBP3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,20458094,C,C&fts=all">p.G1070R</a>
RNF180	Missense_Mutation	p.E350K	G	G		8	Cancer Gene	5	63510201	63510201	162	0.037037037037037	NA	NA	NA			20	Interaction with ZIC2. {ECO:0000250}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RNF180&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,63510201,G,G&fts=all">p.E350K</a>
RP1L1	Missense_Mutation	p.R328S	G	G	rs374588944	8	Cancer Gene	8	10470626	10470626	203	0.0344827586206897	NA	NA	NA		p.R328C(1)	148			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP1L1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,10470626,G,G&fts=all">p.R328S</a>
RSPO4	Missense_Mutation	p.S159L	G	G		8	Cancer Gene	20	944697	944697	60	0.0666666666666667	NA	NA	NA			7	TSP type-1. {ECO:0000255|PROSITE- ProRule:PRU00210}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RSPO4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,944697,G,G&fts=all">p.S159L</a>
S1PR1	Missense_Mutation	p.R320W	C	C		8	Cancer Gene	1	101705498	101705498	693	0.0303030303030303	NA	NA	NA			43			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+S1PR1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,101705498,C,C&fts=all">p.R320W</a>
SCAND3	Missense_Mutation	p.M771I	C	C		8	Cancer Gene	6	28541353	28541353	73	0.0547945205479452	NA	NA	NA			71			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCAND3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,28541353,C,C&fts=all">p.M771I</a>
SCAND3	Missense_Mutation	p.M176I	C	C		8	Cancer Gene	6	28547089	28547089	613	0.032626427406199	NA	NA	NA			71			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCAND3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,28547089,C,C&fts=all">p.M176I</a>
SCN3A	Missense_Mutation	p.G1054R	C	C		8	Cancer Gene	2	165984374	165984374	245	0.0612244897959184	NA	NA	NA			120			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCN3A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,165984374,C,C&fts=all">p.G1054R</a>
SDAD1	Missense_Mutation	p.H437Y	G	G		8	Cancer Gene	4	76882228	76882228	376	0.0345744680851064	NA	NA	NA			19			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SDAD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,76882228,G,G&fts=all">p.H437Y</a>
SDAD1	Missense_Mutation	p.P293S	G	G		8	Cancer Gene	4	76891468	76891468	256	0.0390625	NA	NA	NA			19			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SDAD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,76891468,G,G&fts=all">p.P293S</a>
SDK2	Missense_Mutation	p.G1019E	C	C		8	Cancer Gene	17	71395344	71395344	88	0.0681818181818182	NA	NA	NA			86	Fibronectin type-III 5. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SDK2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,71395344,C,C&fts=all">p.G1019E</a>
SETX	Missense_Mutation	p.L554F	G	G		8	Cancer Gene	9	135205325	135205325	276	0.0978260869565217	NA	NA	NA			97			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SETX&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,135205325,G,G&fts=all">p.L554F</a>
SHANK3	Missense_Mutation	p.R526Q	G	G		8	Cancer Gene	22	51142294	51142294	39	0.153846153846154	NA	NA	NA			8	SH3. {ECO:0000255|PROSITE- ProRule:PRU00192}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SHANK3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,51142294,G,G&fts=all">p.R526Q</a>
SLC13A5	Missense_Mutation	p.M437I	C	C		8	Cancer Gene	17	6594224	6594224	154	0.0909090909090909	NA	NA	NA			26			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC13A5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,6594224,C,C&fts=all">p.M437I</a>
SLC17A6	Missense_Mutation	p.G567E	G	G		8	Cancer Gene	11	22399237	22399237	140	0.1	NA	NA	NA			50			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC17A6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,22399237,G,G&fts=all">p.G567E</a>
SLC22A25	Missense_Mutation	p.G14E	C	C	rs376474135	8	Cancer Gene	11	62997084	62997084	229	0.0436681222707424	NA	NA	NA			34			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC22A25&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,62997084,C,C&fts=all">p.G14E</a>
SLC2A7	Missense_Mutation	p.E492K	C	C		8	Cancer Gene	1	9063424	9063424	241	0.0539419087136929	NA	NA	NA			24			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC2A7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,9063424,C,C&fts=all">p.E492K</a>
SLC44A2	Missense_Mutation	p.A441V	C	C		8	Cancer Gene	19	10747087	10747087	189	0.0582010582010582	NA	NA	NA			27			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC44A2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,10747087,C,C&fts=all">p.A441V</a>
SLFN13	Missense_Mutation	p.D251N	C	C		8	Cancer Gene	17	33771949	33771949	536	0.0634328358208955	NA	NA	NA			31			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLFN13&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,33771949,C,C&fts=all">p.D251N</a>
SMG9	Missense_Mutation	p.P296L	G	G		8	Cancer Gene	19	44242296	44242296	176	0.0568181818181818	NA	NA	NA			19			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SMG9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,44242296,G,G&fts=all">p.P296L</a>
SNCAIP	Missense_Mutation	p.E11K	G	G		8	Cancer Gene	5	121726860	121726860	326	0.0552147239263804	NA	NA	NA			39			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SNCAIP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,121726860,G,G&fts=all">p.E11K</a>
SNCAIP	Missense_Mutation	p.E538K	G	G		8	Cancer Gene	5	121780306	121780306	261	0.0459770114942529	NA	NA	NA			39			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SNCAIP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,121780306,G,G&fts=all">p.E538K</a>
SPAG17	Nonsense_Mutation	p.W558*	C	C		8	Cancer Gene	1	118628633	118628633	377	0.103448275862069	NA	NA	NA			123			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPAG17&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,118628633,C,C&fts=all">p.W558*</a>
SPECC1L	Nonsense_Mutation	p.R461*	C	C		8	Cancer Gene	22	24718329	24718329	331	0.0725075528700906	NA	NA	NA			27			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPECC1L&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,24718329,C,C&fts=all">p.R461*</a>
SPIN1	Nonsense_Mutation	p.R122*	C	C	rs11142308	8	Cancer Gene	9	91083295	91083295	80	0.0625	NA	NA	NA			4			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPIN1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,91083295,C,C&fts=all">p.R122*</a>
SPTLC3	Missense_Mutation	p.S315F	C	C		8	Cancer Gene	20	13098164	13098164	378	0.0899470899470899	NA	NA	NA			25			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPTLC3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,13098164,C,C&fts=all">p.S315F</a>
ST6GALNAC3	Missense_Mutation	p.G259R	G	G		8	Cancer Gene	1	77094348	77094348	177	0.0338983050847458	NA	NA	NA			36			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ST6GALNAC3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,77094348,G,G&fts=all">p.G259R</a>
STAB2	Missense_Mutation	p.G932S	G	G		8	Cancer Gene	12	104071378	104071378	167	0.0359281437125748	NA	NA	NA			174			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STAB2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,104071378,G,G&fts=all">p.G932S</a>
STARD13	Missense_Mutation	p.L710F	G	G		8	Cancer Gene	13	33692355	33692355	326	0.0644171779141104	NA	NA	NA			40	Rho-GAP. {ECO:0000255|PROSITE- ProRule:PRU00172}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STARD13&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,33692355,G,G&fts=all">p.L710F</a>
STEAP2	Nonsense_Mutation	p.Q339*	C	C		8	Cancer Gene	7	89856807	89856807	320	0.028125	NA	NA	NA			15	Ferric oxidoreductase.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STEAP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,89856807,C,C&fts=all">p.Q339*</a>
SULT1C4	Missense_Mutation	p.P87S	C	C		8	Cancer Gene	2	108998307	108998307	354	0.0395480225988701	NA	NA	NA		p.P87S(1)	12			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SULT1C4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,108998307,C,C&fts=all">p.P87S</a>
SUPT3H	Missense_Mutation	p.E158K	C	C		8	Cancer Gene	6	44971422	44971422	313	0.0862619808306709	NA	NA	NA			12			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SUPT3H&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,44971422,C,C&fts=all">p.E158K</a>
SYCP3	Missense_Mutation	p.I166L	T	T	rs140320814	8	Cancer Gene	12	102125402	102125402	201	0.0298507462686567	NA	NA	NA			11	Gln-rich.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SYCP3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,102125402,T,T&fts=all">p.I166L</a>
SYNM	Missense_Mutation	p.G116R	G	G		8	Cancer Gene	15	99669769	99669769	491	0.0936863543788187	NA	NA	NA			29	Coil 1B.|Interaction with DMD and UTRN.|Rod.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SYNM&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,99669769,G,G&fts=all">p.G116R</a>
TAF8	Missense_Mutation	p.P93L	C	C		8	Cancer Gene	6	42025229	42025229	171	0.064327485380117	NA	NA	NA			6	Histone-fold.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TAF8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,42025229,C,C&fts=all">p.P93L</a>
TARS2	Missense_Mutation	p.R346C	C	C		8	Cancer Gene	1	150470021	150470021	207	0.0628019323671498	NA	NA	NA			35			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TARS2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,150470021,C,C&fts=all">p.R346C</a>
TAS2R38	Missense_Mutation	p.L249F	G	G		8	Cancer Gene	7	141672745	141672745	116	0.0431034482758621	NA	NA	NA			21			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TAS2R38&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,141672745,G,G&fts=all">p.L249F</a>
TBL1X	Missense_Mutation	p.S198F	C	C		8	Cancer Gene	X	9659748	9659748	117	0.11965811965812	NA	NA	NA			20			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TBL1X&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,9659748,C,C&fts=all">p.S198F</a>
TCEAL7	Missense_Mutation	p.Y54C	A	A		8	Cancer Gene	X	102586492	102586492	137	0.116788321167883	NA	NA	NA			2			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TCEAL7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,102586492,A,A&fts=all">p.Y54C</a>
TCF23	Missense_Mutation	p.E76K	G	G	rs138049932	8	Cancer Gene	2	27372994	27372994	93	0.0537634408602151	NA	NA	NA			14	bHLH. {ECO:0000255|PROSITE- ProRule:PRU00981}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TCF23&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,27372994,G,G&fts=all">p.E76K</a>
TDRD6	Splice_Site		G	G		8	Cancer Gene	6	46661912	46661912	234	0.0555555555555556	NA	NA	NA			80			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TDRD6&recr=Open">Click here</a>	
TENC1	Missense_Mutation	p.H392N	C	C		8	Cancer Gene	12	53452178	53452178	142	0.0563380281690141	NA	NA	NA			34	C2 tensin-type. {ECO:0000255|PROSITE- ProRule:PRU00589}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TENC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,53452178,C,C&fts=all">p.H392N</a>
TENC1	Missense_Mutation	p.E762K	G	G		8	Cancer Gene	12	53453709	53453709	52	0.0769230769230769	NA	NA	NA			34	Pro-rich.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TENC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,53453709,G,G&fts=all">p.E762K</a>
TMEM106B	Missense_Mutation	p.S244F	C	C		8	Cancer Gene	7	12271507	12271507	353	0.0509915014164306	NA	NA	NA			18			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM106B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,12271507,C,C&fts=all">p.S244F</a>
TMEM214	Missense_Mutation	p.P292S	C	C		8	Cancer Gene	2	27259620	27259620	297	0.0572390572390572	NA	NA	NA			18			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM214&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,27259620,C,C&fts=all">p.P292S</a>
TMEM57	Missense_Mutation	p.S637F	C	C		8	Cancer Gene	1	25824872	25824872	290	0.096551724137931	NA	NA	NA			27			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM57&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,25824872,C,C&fts=all">p.S637F</a>
TMOD1	Missense_Mutation	p.S261T	T	T		8	Cancer Gene	9	100331230	100331230	247	0.0890688259109312	NA	NA	NA			11			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMOD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,100331230,T,T&fts=all">p.S261T</a>
TMOD1	Missense_Mutation	p.S261F	C	C		8	Cancer Gene	9	100331231	100331231	246	0.0934959349593496	NA	NA	NA			11			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMOD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,100331231,C,C&fts=all">p.S261F</a>
TMPRSS6	Missense_Mutation	p.S358F	G	G		8	Cancer Gene	22	37480780	37480780	17	0.235294117647059	NA	NA	NA			40	CUB 2. {ECO:0000255|PROSITE- ProRule:PRU00059}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMPRSS6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,37480780,G,G&fts=all">p.S358F</a>
TMPRSS9	Missense_Mutation	p.E351K	G	G	rs558960490	8	Cancer Gene	19	2410291	2410291	248	0.0887096774193548	NA	NA	NA			29	Peptidase S1 1. {ECO:0000255|PROSITE- ProRule:PRU00274}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMPRSS9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,2410291,G,G&fts=all">p.E351K</a>
TNFSF15	Missense_Mutation	p.Q62L	T	T		8	Cancer Gene	9	117568108	117568108	123	0.0650406504065041	NA	NA	NA			11			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNFSF15&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,117568108,T,T&fts=all">p.Q62L</a>
TNFSF8	Missense_Mutation	p.S67F	G	G		8	Cancer Gene	9	117680414	117680414	166	0.0903614457831325	NA	NA	NA			12			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNFSF8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,117680414,G,G&fts=all">p.S67F</a>
TNIK	Missense_Mutation	p.D589N	C	C		8	Cancer Gene	3	170846511	170846511	84	0.19047619047619	NA	NA	NA			62	Mediates interaction with NEDD4.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNIK&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,170846511,C,C&fts=all">p.D589N</a>
TNNI3K	Missense_Mutation	p.S789A	T	T		8	Cancer Gene	1	75005931	75005931	251	0.0557768924302789	NA	NA	NA			76			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNNI3K&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,75005931,T,T&fts=all">p.S789A</a>
TNS4	Missense_Mutation	p.G177D	C	C		8	Cancer Gene	17	38645131	38645131	295	0.0610169491525424	NA	NA	NA			30	Ser-rich.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNS4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,38645131,C,C&fts=all">p.G177D</a>
TOPORS	Missense_Mutation	p.S718L	G	G		8	Cancer Gene	9	32542370	32542370	457	0.0853391684901532	NA	NA	NA			12	Arg-rich.|Interaction with TOP1.|Interaction with p53/TP53.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TOPORS&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,32542370,G,G&fts=all">p.S718L</a>
TPRG1L	Missense_Mutation	p.S174F	C	C		8	Cancer Gene	1	3544114	3544114	518	0.0463320463320463	NA	NA	NA			8			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TPRG1L&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,3544114,C,C&fts=all">p.S174F</a>
TRERF1	Missense_Mutation	p.M464I	C	C		8	Cancer Gene	6	42235937	42235937	179	0.0893854748603352	NA	NA	NA			45	Interacts with CREBBP.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRERF1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,42235937,C,C&fts=all">p.M464I</a>
TRIOBP	Missense_Mutation	p.S136F	C	C		8	Cancer Gene	22	38109369	38109369	350	0.08	NA	NA	NA			12			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRIOBP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,38109369,C,C&fts=all">p.S136F</a>
TRIOBP	Missense_Mutation	p.S1185F	C	C		8	Cancer Gene	22	38122117	38122117	126	0.111111111111111	NA	NA	NA			12			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRIOBP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,38122117,C,C&fts=all">p.S1185F</a>
TRMT61B	Start_Codon_SNP	p.M1T	A	A		8	Cancer Gene	2	29093142	29093142	36	0.166666666666667	NA	NA	NA			13			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRMT61B&recr=Open">Click here</a>	
TTC38	Splice_Site		T	T		8	Cancer Gene	22	46669968	46669968	67	0.0746268656716418	NA	NA	NA			12			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTC38&recr=Open">Click here</a>	
TTLL7	Missense_Mutation	p.R227Q	C	C		8	Cancer Gene	1	84408189	84408189	293	0.0341296928327645	NA	NA	NA			29	TTL. {ECO:0000255|PROSITE- ProRule:PRU00568}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTLL7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,84408189,C,C&fts=all">p.R227Q</a>
UGT3A1	Missense_Mutation	p.K94M	T	T		8	Cancer Gene	5	35965948	35965948	227	0.0308370044052863	NA	NA	NA			46			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UGT3A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,35965948,T,T&fts=all">p.K94M</a>
UNC93A	Missense_Mutation	p.R343C	C	C	rs267600893	8	Cancer Gene	6	167721317	167721317	230	0.0478260869565217	NA	NA	NA			40			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UNC93A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,167721317,C,C&fts=all">p.R343C</a>
UROC1	Missense_Mutation	p.D457N	C	C		8	Cancer Gene	3	126216963	126216963	449	0.0579064587973274	NA	NA	NA			39			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UROC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,126216963,C,C&fts=all">p.D457N</a>
USP31	Missense_Mutation	p.P941S	G	G	rs371536399	8	Cancer Gene	16	23080605	23080605	255	0.0392156862745098	NA	NA	NA			57	Ubiquitin-like. {ECO:0000255|PROSITE- ProRule:PRU00214}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USP31&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,23080605,G,G&fts=all">p.P941S</a>
USP38	Missense_Mutation	p.L331H	T	T		8	Cancer Gene	4	144119019	144119019	598	0.0317725752508361	NA	NA	NA			33			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USP38&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,144119019,T,T&fts=all">p.L331H</a>
USP53	Missense_Mutation	p.G668S	G	G	rs61730004	8	Cancer Gene	4	120193017	120193017	316	0.0411392405063291	NA	NA	NA			27			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USP53&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,120193017,G,G&fts=all">p.G668S</a>
VNN3	Missense_Mutation	p.G82R	C	C		8	Cancer Gene	6	133055492	133055492	298	0.087248322147651	NA	NA	NA			8	CN hydrolase. {ECO:0000255|PROSITE- ProRule:PRU00054}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VNN3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,133055492,C,C&fts=all">p.G82R</a>
VPS13A	Missense_Mutation	p.R161C	C	C		8	Cancer Gene	9	79824434	79824434	184	0.130434782608696	NA	NA	NA			104			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VPS13A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,79824434,C,C&fts=all">p.R161C</a>
WDR17	Missense_Mutation	p.L558P	T	T		8	Cancer Gene	4	177067289	177067289	399	0.0401002506265664	NA	NA	NA			92			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WDR17&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,177067289,T,T&fts=all">p.L558P</a>
WDR27	Missense_Mutation	p.V165G	A	A		8	Cancer Gene	6	170068244	170068244	147	0.0748299319727891	NA	NA	NA			12			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WDR27&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,170068244,A,A&fts=all">p.V165G</a>
YLPM1	Nonsense_Mutation	p.Q401*	C	C		8	Cancer Gene	14	75247198	75247198	325	0.0861538461538462	NA	NA	NA			62	Gln-rich.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+YLPM1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,75247198,C,C&fts=all">p.Q401*</a>
ZFC3H1	Missense_Mutation	p.P1169L	G	G		8	Cancer Gene	12	72024699	72024699	216	0.0648148148148148	NA	NA	NA			69			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZFC3H1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,72024699,G,G&fts=all">p.P1169L</a>
ZHX3	Missense_Mutation	p.E573K	C	C		8	Cancer Gene	20	39831840	39831840	210	0.0476190476190476	NA	NA	NA			31			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZHX3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,39831840,C,C&fts=all">p.E573K</a>
ZNF138	Missense_Mutation	p.P260S	C	C		8	Cancer Gene	7	64292494	64292494	164	0.0670731707317073	NA	NA	NA			7			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF138&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,64292494,C,C&fts=all">p.P260S</a>
ZNF154	Missense_Mutation	p.G297E	C	C		8	Cancer Gene	19	58213427	58213427	144	0.0555555555555556	NA	NA	NA			12			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF154&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,58213427,C,C&fts=all">p.G297E</a>
ZNF496	Missense_Mutation	p.A530V	G	G		8	Cancer Gene	1	247463996	247463996	154	0.0649350649350649	NA	NA	NA			36			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF496&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,247463996,G,G&fts=all">p.A530V</a>
ZNF536	Missense_Mutation	p.H765Y	C	C		8	Cancer Gene	19	31025876	31025876	171	0.0292397660818713	NA	NA	NA			182			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF536&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,31025876,C,C&fts=all">p.H765Y</a>
ZNF561	Missense_Mutation	p.S197F	G	G		8	Cancer Gene	19	9721540	9721540	263	0.0684410646387833	NA	NA	NA			14			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF561&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,9721540,G,G&fts=all">p.S197F</a>
ZNF568	Nonsense_Mutation	p.R491*	C	C	rs199774103	8	Cancer Gene	19	37441526	37441526	291	0.0893470790378007	NA	NA	NA			29			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF568&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,37441526,C,C&fts=all">p.R491*</a>
ZNF583	Missense_Mutation	p.S337L	C	C		8	Cancer Gene	19	56935037	56935037	233	0.0944206008583691	NA	NA	NA			26			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF583&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,56935037,C,C&fts=all">p.S337L</a>
ZNF606	Missense_Mutation	p.H618Y	G	G		8	Cancer Gene	19	58490196	58490196	292	0.0616438356164384	NA	NA	NA			26			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF606&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,58490196,G,G&fts=all">p.H618Y</a>
ZNF616	Nonsense_Mutation	p.Q100*	G	G		8	Cancer Gene	19	52620119	52620119	358	0.0195530726256983	NA	NA	NA			48			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF616&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,52620119,G,G&fts=all">p.Q100*</a>
ZNF626	Missense_Mutation	p.E226G	T	T	rs199934829	8	Cancer Gene	19	20808006	20808006	238	0.0210084033613445	NA	NA	NA			6			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF626&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,20808006,T,T&fts=all">p.E226G</a>
ZNF711	Missense_Mutation	p.D58N	G	G		8	Cancer Gene	X	84510357	84510357	246	0.121951219512195	NA	NA	NA			28			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF711&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,84510357,G,G&fts=all">p.D58N</a>
ZNF714	Missense_Mutation	p.P143L	C	C		8	Cancer Gene	19	21299898	21299898	119	0.0672268907563025	NA	NA	NA			18			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF714&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,21299898,C,C&fts=all">p.P143L</a>
ZNF746	Nonsense_Mutation	p.R38*	G	G		8	Cancer Gene	7	149191507	149191507	222	0.0540540540540541	NA	NA	NA			34			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF746&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,149191507,G,G&fts=all">p.R38*</a>
ZNF750	Missense_Mutation	p.S554L	G	G		8	Cancer Gene	17	80788529	80788529	170	0.0294117647058824	NA	NA	NA		p.S554L(1)	31			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF750&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,80788529,G,G&fts=all">p.S554L</a>
ZNF763	Missense_Mutation	p.E82K	G	G		8	Cancer Gene	19	12088983	12088983	476	0.0714285714285714	NA	NA	NA			15	KRAB. {ECO:0000255|PROSITE- ProRule:PRU00119}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF763&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,12088983,G,G&fts=all">p.E82K</a>
ZNF80	Missense_Mutation	p.G26E	C	C		8	Cancer Gene	3	113955845	113955845	278	0.10431654676259	NA	NA	NA			32			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF80&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,113955845,C,C&fts=all">p.G26E</a>
ZNF804A	Missense_Mutation	p.E111K	G	G		8	Cancer Gene	2	185798405	185798405	179	0.111731843575419	NA	NA	NA			146			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF804A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,185798405,G,G&fts=all">p.E111K</a>
ZNF804A	Missense_Mutation	p.E575K	G	G		8	Cancer Gene	2	185801846	185801846	225	0.04	NA	NA	NA		p.E575K(1)	146			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF804A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,185801846,G,G&fts=all">p.E575K</a>
ZSCAN5B	Missense_Mutation	p.H333Y	G	G		8	Cancer Gene	19	56701687	56701687	236	0.0296610169491525	NA	NA	NA			37			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZSCAN5B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,56701687,G,G&fts=all">p.H333Y</a>
AC005013.5	lincRNA		G	G		10	SNP	7	28996597	28996597	14	0.285714285714286	NA	NA	NA						MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AC005013.5&recr=Open">Click here</a>	
ANKS1B	Missense_Mutation	p.T773A	T	T		10	SNP	12	99640082	99640082	62	0.0645161290322581	NA	NA	NA			70			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANKS1B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,99640082,T,T&fts=all">p.T773A</a>
AOC1	Missense_Mutation	p.E157K	G	G		10	SNP	7	150554027	150554027	157	0.089171974522293	NA	NA	NA						MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AOC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,150554027,G,G&fts=all">p.E157K</a>
AP5Z1	Missense_Mutation	p.L347F	C	C		10	SNP	7	4825222	4825222	28	0.178571428571429	NA	NA	NA						MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AP5Z1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,4825222,C,C&fts=all">p.L347F</a>
BOD1L1	Missense_Mutation	p.R1364K	C	C		10	SNP	4	13604433	13604433	234	0.0555555555555556	NA	NA	NA						MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BOD1L1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,13604433,C,C&fts=all">p.R1364K</a>
BRINP2	Missense_Mutation	p.R420Q	G	G		10	SNP	1	177249571	177249571	243	0.0781893004115226	NA	NA	NA						MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BRINP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,177249571,G,G&fts=all">p.R420Q</a>
BRINP3	Missense_Mutation	p.E590K	C	C		10	SNP	1	190067681	190067681	514	0.0875486381322957	NA	NA	NA						MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BRINP3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,190067681,C,C&fts=all">p.E590K</a>
COLGALT2	Nonsense_Mutation	p.R222*	G	G	rs373361853	10	SNP	1	183938571	183938571	159	0.0817610062893082	NA	NA	NA						MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COLGALT2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,183938571,G,G&fts=all">p.R222*</a>
CPED1	Missense_Mutation	p.G493E	G	G		10	SNP	7	120770249	120770249	515	0.0776699029126214	NA	NA	NA						MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CPED1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,120770249,G,G&fts=all">p.G493E</a>
FAM208A	Missense_Mutation	p.R1414Q	C	C		10	SNP	3	56658933	56658933	335	0.017910447761194	NA	NA	NA			32			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM208A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,56658933,C,C&fts=all">p.R1414Q</a>
FAM217A	Missense_Mutation	p.H126Y	G	G	rs151055241	10	SNP	6	4070081	4070081	307	0.0195439739413681	NA	NA	NA						MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM217A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,4070081,G,G&fts=all">p.H126Y</a>
FAXC	Missense_Mutation	p.L392R	A	A		10	SNP	6	99729095	99729095	239	0.0334728033472803	NA	NA	NA						MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAXC&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,99729095,A,A&fts=all">p.L392R</a>
KMT2A	Missense_Mutation	p.V2789I	G	G		10	SNP	11	118374972	118374972	262	0.0458015267175573	NA	NA	NA						MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KMT2A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,118374972,G,G&fts=all">p.V2789I</a>
KMT2B	Missense_Mutation	p.P274L	C	C		10	SNP	19	36211070	36211070	30	0.133333333333333	NA	NA	NA						MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KMT2B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,36211070,C,C&fts=all">p.P274L</a>
LINC00922	lincRNA		G	G		10	SNP	16	65319348	65319348	109	0.073394495412844	NA	NA	NA						MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LINC00922&recr=Open">Click here</a>	
MROH2B	Missense_Mutation	p.P1461L	G	G		10	SNP	5	41000422	41000422	67	0.0597014925373134	NA	NA	NA						MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MROH2B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,41000422,G,G&fts=all">p.P1461L</a>
MVB12A	Missense_Mutation	p.L209F	C	C		10	SNP	19	17534593	17534593	97	0.11340206185567	NA	NA	NA				Interaction with TSG101, VPS37B and VPS28.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MVB12A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,17534593,C,C&fts=all">p.L209F</a>
NOP9	Missense_Mutation	p.T135P	A	A		10	SNP	14	24769769	24769769	909	0.0451045104510451	NA	NA	NA						MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NOP9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,24769769,A,A&fts=all">p.T135P</a>
NPAP1	Missense_Mutation	p.A278V	C	C		10	SNP	15	24921847	24921847	116	0.0689655172413793	NA	NA	NA						MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NPAP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,24921847,C,C&fts=all">p.A278V</a>
NXPE1	Missense_Mutation	p.G140R	C	C		10	SNP	11	114398613	114398613	164	0.0304878048780488	NA	NA	NA						MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NXPE1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,114398613,C,C&fts=all">p.G140R</a>
RP11-407N17.3	Missense_Mutation	p.L1075V	T	T		10	SNP	14	39790206	39790206	364	0.0686813186813187	NA	NA	NA						MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP11-407N17.3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,39790206,T,T&fts=all">p.L1075V</a>
SLC9C2	Missense_Mutation	p.T561A	T	T		10	SNP	1	173505063	173505063	392	0.0561224489795918	NA	NA	NA						MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC9C2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,173505063,T,T&fts=all">p.T561A</a>
SLC9C2	Missense_Mutation	p.S167F	G	G		10	SNP	1	173556827	173556827	167	0.0958083832335329	NA	NA	NA						MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC9C2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,173556827,G,G&fts=all">p.S167F</a>
TENM1	Missense_Mutation	p.S134F	G	G		10	SNP	X	124029907	124029907	361	0.127423822714681	NA	NA	NA				Teneurin N-terminal. {ECO:0000255|PROSITE-ProRule:PRU00694}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TENM1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,124029907,G,G&fts=all">p.S134F</a>
TENM2	Missense_Mutation	p.P886S	C	C		10	SNP	5	167627058	167627058	53	0.113207547169811	NA	NA	NA						MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TENM2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,167627058,C,C&fts=all">p.P886S</a>
TENM2	Missense_Mutation	p.P886L	C	C		10	SNP	5	167627059	167627059	53	0.113207547169811	NA	NA	NA						MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TENM2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,167627059,C,C&fts=all">p.P886L</a>
TENM3	Missense_Mutation	p.E1105K	G	G		10	SNP	4	183659631	183659631	299	0.040133779264214	NA	NA	NA						MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TENM3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,183659631,G,G&fts=all">p.E1105K</a>
TENM3	Missense_Mutation	p.G1443R	G	G		10	SNP	4	183675847	183675847	115	0.0347826086956522	NA	NA	NA						MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TENM3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,183675847,G,G&fts=all">p.G1443R</a>
TMEM237	Missense_Mutation	p.S408L	G	G		10	SNP	2	202488982	202488982	235	0.0297872340425532	NA	NA	NA			7			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM237&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,202488982,G,G&fts=all">p.S408L</a>
TSIX	lincRNA		C	C		10	SNP	X	73043792	73043792	38	0.105263157894737	NA	NA	NA						MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TSIX&recr=Open">Click here</a>	
UNC79	Missense_Mutation	p.P2042S	C	C		10	SNP	14	94128962	94128962	175	0.0571428571428571	NA	NA	NA			118			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UNC79&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,94128962,C,C&fts=all">p.P2042S</a>
XIST	lincRNA		G	G		10	SNP	X	73070850	73070850	75	0.08	NA	NA	NA						MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XIST&recr=Open">Click here</a>	
ZFP69B	Missense_Mutation	p.S124F	C	C		10	SNP	1	40923046	40923046	178	0.101123595505618	NA	NA	NA				KRAB. {ECO:0000255|PROSITE- ProRule:PRU00119}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZFP69B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,40923046,C,C&fts=all">p.S124F</a>
ZNF225	Missense_Mutation	p.E460K	G	G		10	SNP	19	44636145	44636145	222	0.0540540540540541	NA	NA	NA			16			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF225&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,44636145,G,G&fts=all">p.E460K</a>
AARSD1	Silent	p.I328I	G	G		11	Filtered Calls	17	41105765	41105765	191	0.109947643979058	NA	NA	NA			17			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AARSD1&recr=Open">Click here</a>	
ABCA10	Silent	p.F347F	G	G		11	Filtered Calls	17	67197775	67197775	203	0.0689655172413793	NA	NA	NA			81			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCA10&recr=Open">Click here</a>	
ABCA6	Intron		A	A		11	Filtered Calls	17	67077292	67077292	269	0.0855018587360595	NA	NA	NA			82			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCA6&recr=Open">Click here</a>	
ABCA8	Intron		G	G		11	Filtered Calls	17	66865923	66865923	412	0.0752427184466019	NA	NA	NA			83			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCA8&recr=Open">Click here</a>	
ABCC3	Intron		C	C		11	Filtered Calls	17	48755445	48755445	194	0.0618556701030928	NA	NA	NA			33			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCC3&recr=Open">Click here</a>	
ABCC9	Silent	p.I1077I	G	G		11	Filtered Calls	12	21997715	21997715	341	0.032258064516129	NA	NA	NA			118	ABC transmembrane type-1 2. {ECO:0000255|PROSITE-ProRule:PRU00441}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCC9&recr=Open">Click here</a>	
ABCG1	Silent	p.I421I	C	C		11	Filtered Calls	21	43710198	43710198	267	0.0636704119850187	NA	NA	NA			29	ABC transmembrane type-2.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCG1&recr=Open">Click here</a>	
ABCG5	Intron		C	C		11	Filtered Calls	2	44053560	44053560	178	0.050561797752809	NA	NA	NA		p.V245V(1)	33			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCG5&recr=Open">Click here</a>	
ABL2	Silent	p.S968S	G	G		11	Filtered Calls	1	179077498	179077498	182	0.0934065934065934	NA	NA	NA			65	Pro-rich.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABL2&recr=Open">Click here</a>	
ACBD3	Silent	p.G268G	C	C		11	Filtered Calls	1	226346984	226346984	417	0.052757793764988	NA	NA	NA			20	Gln-rich.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACBD3&recr=Open">Click here</a>	
ACOT13	5'Flank		G	G		11	Filtered Calls	6	24666977	24666977	526	0.0114068441064639	NA	NA	NA			1			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACOT13&recr=Open">Click here</a>	
ACSBG1	Silent	p.S53S	G	G		11	Filtered Calls	15	78500417	78500417	63	0.111111111111111	NA	NA	NA			37			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACSBG1&recr=Open">Click here</a>	
ACTR1B	Intron		G	G		11	Filtered Calls	2	98275949	98275949	324	0.0925925925925926	NA	NA	NA			15			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACTR1B&recr=Open">Click here</a>	
ACY3	Intron		C	C		11	Filtered Calls	11	67413368	67413368	118	0.0338983050847458	NA	NA	NA			8			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACY3&recr=Open">Click here</a>	
ADAM2	Intron		C	C		11	Filtered Calls	8	39645654	39645654	447	0.0693512304250559	NA	NA	NA		p.W253*(1)	53			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAM2&recr=Open">Click here</a>	
ADAM30	Silent	p.Q459Q	C	C		11	Filtered Calls	1	120437583	120437583	241	0.0871369294605809	NA	NA	NA			38	Disintegrin. {ECO:0000255|PROSITE- ProRule:PRU00068}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAM30&recr=Open">Click here</a>	
ADAMTS18	Silent	p.S785S	G	G	rs267604649	11	Filtered Calls	16	77353923	77353923	121	0.0413223140495868	NA	NA	NA		p.S785S(1)	118	Spacer.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAMTS18&recr=Open">Click here</a>	
ADAMTS20	Intron		G	G		11	Filtered Calls	12	43862511	43862511	160	0.0875	NA	NA	NA			95			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAMTS20&recr=Open">Click here</a>	
ADCY10	Silent	p.G904G	C	C		11	Filtered Calls	1	167815227	167815227	169	0.0650887573964497	NA	NA	NA			63			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADCY10&recr=Open">Click here</a>	
ADCYAP1R1	Intron		G	G		11	Filtered Calls	7	31121374	31121374	326	0.0276073619631902	NA	NA	NA			35			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADCYAP1R1&recr=Open">Click here</a>	
ADH1A	Silent	p.I220I	G	G		11	Filtered Calls	4	100203671	100203671	904	0.0221238938053097	NA	NA	NA			25			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADH1A&recr=Open">Click here</a>	
AFAP1L2	Intron		G	G		11	Filtered Calls	10	116060456	116060456	102	0.0490196078431373	NA	NA	NA			21			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AFAP1L2&recr=Open">Click here</a>	
AHNAK2	Intron		T	T		11	Filtered Calls	14	105407142	105407142	89	0.0898876404494382	NA	NA	NA			33			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AHNAK2&recr=Open">Click here</a>	
AHNAK2	Intron		G	G		11	Filtered Calls	14	105412650	105412650	232	0.0818965517241379	NA	NA	NA			33			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AHNAK2&recr=Open">Click here</a>	
AKNA	Silent	p.P1036P	G	G	rs200232041	11	Filtered Calls	9	117113252	117113252	77	0.0779220779220779	NA	NA	NA			51			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AKNA&recr=Open">Click here</a>	
AKNAD1	Silent	p.P553P	C	C	rs143487473	11	Filtered Calls	1	109377556	109377556	277	0.0216606498194946	NA	NA	NA			32			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AKNAD1&recr=Open">Click here</a>	
ALDH3A1	5'UTR		C	C		11	Filtered Calls	17	19651652	19651652	88	0.125	NA	NA	NA			13			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ALDH3A1&recr=Open">Click here</a>	
AMIGO1	Silent	p.L91L	G	G		11	Filtered Calls	1	110051264	110051264	89	0.0561797752808989	NA	NA	NA			16			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AMIGO1&recr=Open">Click here</a>	
ANK3	Silent	p.F3254F	A	A		11	Filtered Calls	10	61830877	61830877	444	0.0698198198198198	NA	NA	NA			196			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANK3&recr=Open">Click here</a>	
ANK3	Silent	p.D2450D	G	G		11	Filtered Calls	10	61833289	61833289	452	0.0132743362831858	NA	NA	NA			196			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANK3&recr=Open">Click here</a>	
ANKHD1	Intron		C	C		11	Filtered Calls	5	139915133	139915133	115	0.0347826086956522	NA	NA	NA			60			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANKHD1&recr=Open">Click here</a>	
ANKMY1	Intron		C	C	rs145888118	11	Filtered Calls	2	241468548	241468548	241	0.0539419087136929	NA	NA	NA			30			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANKMY1&recr=Open">Click here</a>	
ANKRD30A	Silent	p.V1034V	T	T		11	Filtered Calls	10	37507910	37507910	145	0.0827586206896552	NA	NA	NA			158			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANKRD30A&recr=Open">Click here</a>	
ANXA6	Silent	p.T466T	G	G		11	Filtered Calls	5	150498901	150498901	220	0.0227272727272727	NA	NA	NA			12			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANXA6&recr=Open">Click here</a>	
APCS	Silent	p.R165R	G	G		11	Filtered Calls	1	159558321	159558321	145	0.0620689655172414	NA	NA	NA			20	Pentaxin.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+APCS&recr=Open">Click here</a>	
ARHGAP4	Intron		G	G		11	Filtered Calls	X	153184516	153184516	65	0.153846153846154	NA	NA	NA			14			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARHGAP4&recr=Open">Click here</a>	
ASB1	Silent	p.F119F	C	C		11	Filtered Calls	2	239353148	239353148	133	0.0902255639097744	NA	NA	NA			8			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ASB1&recr=Open">Click here</a>	
ATF7IP2	Silent	p.P522P	C	C	rs372769529	11	Filtered Calls	16	10574752	10574752	445	0.0674157303370786	NA	NA	NA			3			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATF7IP2&recr=Open">Click here</a>	
ATP1A4	Silent	p.F1005F	C	C	rs200363709	11	Filtered Calls	1	160156111	160156111	492	0.0833333333333333	NA	NA	NA			75			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATP1A4&recr=Open">Click here</a>	
ATP8B4	Silent	p.V175V	G	G		11	Filtered Calls	15	50288938	50288938	204	0.122549019607843	NA	NA	NA			73			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATP8B4&recr=Open">Click here</a>	
AWAT2	Silent	p.F19F	G	G		11	Filtered Calls	X	69269726	69269726	53	0.132075471698113	NA	NA	NA			9			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AWAT2&recr=Open">Click here</a>	
AXDND1	Silent	p.R562R	G	G		11	Filtered Calls	1	179414227	179414227	322	0.0683229813664596	NA	NA	NA			59			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AXDND1&recr=Open">Click here</a>	
BASP1	Silent	p.S219S	C	C		11	Filtered Calls	5	17275982	17275982	111	0.036036036036036	NA	NA	NA			9			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BASP1&recr=Open">Click here</a>	
BBX	Intron		C	C		11	Filtered Calls	3	107497206	107497206	272	0.0955882352941176	NA	NA	NA			49			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BBX&recr=Open">Click here</a>	
BCKDK	Intron		C	C		11	Filtered Calls	16	31120826	31120826	57	0.087719298245614	NA	NA	NA			2			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BCKDK&recr=Open">Click here</a>	
BCL9L	5'UTR		G	G		11	Filtered Calls	11	118769201	118769201	79	0.10126582278481	NA	NA	NA			56			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BCL9L&recr=Open">Click here</a>	
BIN1	Intron		C	C		11	Filtered Calls	2	127826494	127826494	116	0.0689655172413793	NA	NA	NA			24			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BIN1&recr=Open">Click here</a>	
BMX	Silent	p.S54S	C	C		11	Filtered Calls	X	15527475	15527475	124	0.169354838709677	NA	NA	NA			30	PH. {ECO:0000255|PROSITE- ProRule:PRU00145}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BMX&recr=Open">Click here</a>	
BOD1	Intron		G	G		11	Filtered Calls	5	173036246	173036246	180	0.0944444444444444	NA	NA	NA			7			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BOD1&recr=Open">Click here</a>	
BPTF	Intron		A	A		11	Filtered Calls	17	65862815	65862815	94	0.074468085106383	NA	NA	NA			78			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BPTF&recr=Open">Click here</a>	
BRAT1	Silent	p.A164A	G	G	rs375295992	11	Filtered Calls	7	2583535	2583535	60	0.1	NA	NA	NA			23			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BRAT1&recr=Open">Click here</a>	
BRPF1	Silent	p.K710K	G	G		11	Filtered Calls	3	9784774	9784774	126	0.150793650793651	NA	NA	NA			49	Bromo. {ECO:0000255|PROSITE- ProRule:PRU00035}.|Interaction with MEAF6 and ING5.|Required for RUNX1 and RUNX2 transcriptional activation.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BRPF1&recr=Open">Click here</a>	
BTNL8	Silent	p.L297L	C	C		11	Filtered Calls	5	180374727	180374727	652	0.0843558282208589	NA	NA	NA			28	B30.2/SPRY. {ECO:0000255|PROSITE- ProRule:PRU00548}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BTNL8&recr=Open">Click here</a>	
C12orf55	Silent	p.V2600V	G	G		11	Filtered Calls	12	97147636	97147636	354	0.0649717514124294	NA	NA	NA			NA			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C12orf55&recr=Open">Click here</a>	
C16orf46	Silent	p.S109S	G	G		11	Filtered Calls	16	81095627	81095627	131	0.0534351145038168	NA	NA	NA			18			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C16orf46&recr=Open">Click here</a>	
C16orf89	Silent	p.G319G	C	C		11	Filtered Calls	16	5105254	5105254	31	0.129032258064516	NA	NA	NA			12			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C16orf89&recr=Open">Click here</a>	
C1orf101	Silent	p.S638S	C	C		11	Filtered Calls	1	244736038	244736038	337	0.0504451038575668	NA	NA	NA			36			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C1orf101&recr=Open">Click here</a>	
C1orf177	Silent	p.P289P	G	G	rs372749723	11	Filtered Calls	1	55279591	55279591	283	0.0636042402826855	NA	NA	NA			17			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C1orf177&recr=Open">Click here</a>	
C20orf196	Silent	p.Q127Q	G	G		11	Filtered Calls	20	5843872	5843872	118	0.0593220338983051	NA	NA	NA			9			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C20orf196&recr=Open">Click here</a>	
C2orf78	Silent	p.G266G	G	G		11	Filtered Calls	2	74041304	74041304	339	0.0766961651917404	NA	NA	NA			34			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C2orf78&recr=Open">Click here</a>	
C3	Intron		G	G		11	Filtered Calls	19	6702597	6702597	117	0.102564102564103	NA	NA	NA			72			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C3&recr=Open">Click here</a>	
C9orf135	Intron		T	T		11	Filtered Calls	9	72459429	72459429	363	0.0798898071625344	NA	NA	NA			7			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C9orf135&recr=Open">Click here</a>	
C9orf142	Silent	p.L121L	C	C		11	Filtered Calls	9	139887635	139887635	95	0.0736842105263158	NA	NA	NA			NA			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C9orf142&recr=Open">Click here</a>	
CACNA1A	Silent	p.P128P	C	C		11	Filtered Calls	19	13565936	13565936	474	0.0464135021097046	NA	NA	NA			42			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA1A&recr=Open">Click here</a>	
CACNA1E	Silent	p.I1359I	C	C		11	Filtered Calls	1	181725179	181725179	98	0.0612244897959184	NA	NA	NA			204			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA1E&recr=Open">Click here</a>	
CACNA1G	Intron		G	G		11	Filtered Calls	17	48695298	48695298	133	0.0526315789473684	NA	NA	NA			47			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA1G&recr=Open">Click here</a>	
CACNA1G	Silent	p.F1778F	C	C		11	Filtered Calls	17	48695665	48695665	195	0.0820512820512821	NA	NA	NA			47			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA1G&recr=Open">Click here</a>	
CACNG6	Intron		C	C		11	Filtered Calls	19	54502877	54502877	724	0.0400552486187845	NA	NA	NA			15			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNG6&recr=Open">Click here</a>	
CAPN13	Silent	p.G454G	C	C		11	Filtered Calls	2	30966332	30966332	593	0.0623946037099494	NA	NA	NA			30			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CAPN13&recr=Open">Click here</a>	
CARS	Silent	p.D702D	G	G		11	Filtered Calls	11	3028152	3028152	395	0.0177215189873418	NA	NA	NA			31			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CARS&recr=Open">Click here</a>	
CAT	Silent	p.F356F	T	T		11	Filtered Calls	11	34482809	34482809	326	0.0828220858895705	NA	NA	NA			26			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CAT&recr=Open">Click here</a>	
CATSPERB	Intron		G	G		11	Filtered Calls	14	92077025	92077025	105	0.0571428571428571	NA	NA	NA			54			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CATSPERB&recr=Open">Click here</a>	
CCDC146	Intron		C	C		11	Filtered Calls	7	76923968	76923968	127	0.062992125984252	NA	NA	NA			34			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC146&recr=Open">Click here</a>	
CCER1	Silent	p.K282K	C	C		11	Filtered Calls	12	91347674	91347674	505	0.0831683168316832	NA	NA	NA			NA	Glu-rich.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCER1&recr=Open">Click here</a>	
CCL5	Intron		G	G		11	Filtered Calls	17	34199477	34199477	355	0.0845070422535211	NA	NA	NA			3			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCL5&recr=Open">Click here</a>	
CCP110	Intron		T	T		11	Filtered Calls	16	19556108	19556108	306	0.042483660130719	NA	NA	NA			21			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCP110&recr=Open">Click here</a>	
CD300LB	Silent	p.I55I	G	G		11	Filtered Calls	17	72522203	72522203	326	0.0460122699386503	NA	NA	NA			21	Ig-like V-type.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CD300LB&recr=Open">Click here</a>	
CD36	Intron		A	A		11	Filtered Calls	7	80295812	80295812	203	0.0985221674876847	NA	NA	NA			21			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CD36&recr=Open">Click here</a>	
CD4	Intron		T	T	rs201308520	11	Filtered Calls	12	6909463	6909463	167	0.0838323353293413	NA	NA	NA			23			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CD4&recr=Open">Click here</a>	
CD84	Silent	p.E158E	C	C		11	Filtered Calls	1	160523851	160523851	225	0.08	NA	NA	NA			24	Ig-like C2-type.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CD84&recr=Open">Click here</a>	
CDCA2	Silent	p.L408L	T	T		11	Filtered Calls	8	25341583	25341583	294	0.0136054421768707	NA	NA	NA			35			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDCA2&recr=Open">Click here</a>	
CDH7	Intron		C	C		11	Filtered Calls	18	63511311	63511311	335	0.0597014925373134	NA	NA	NA			80			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDH7&recr=Open">Click here</a>	
CDH8	Silent	p.V139V	C	C		11	Filtered Calls	16	61935213	61935213	282	0.0354609929078014	NA	NA	NA			112	Cadherin 1. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDH8&recr=Open">Click here</a>	
CDH9	Intron		T	T		11	Filtered Calls	5	26889940	26889940	161	0.0372670807453416	NA	NA	NA			137			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDH9&recr=Open">Click here</a>	
CDKL5	Silent	p.S257S	C	C		11	Filtered Calls	X	18613494	18613494	190	0.0789473684210526	NA	NA	NA		p.S257S(1)	44	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDKL5&recr=Open">Click here</a>	
CELSR2	Intron		C	C		11	Filtered Calls	1	109812445	109812445	273	0.0732600732600733	NA	NA	NA			82			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CELSR2&recr=Open">Click here</a>	
CES2	Silent	p.F178F	C	C		11	Filtered Calls	16	66973180	66973180	329	0.0364741641337386	NA	NA	NA			12			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CES2&recr=Open">Click here</a>	
CFB	Silent	p.L166L	C	C		11	Filtered Calls	6	31905151	31905151	443	0.108352144469526	NA	NA	NA			21	Sushi 3. {ECO:0000255|PROSITE- ProRule:PRU00302}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CFB&recr=Open">Click here</a>	
CFH	Intron		T	T		11	Filtered Calls	1	196706142	196706142	144	0.0763888888888889	NA	NA	NA			101			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CFH&recr=Open">Click here</a>	
CHGB	Silent	p.E309E	G	G		11	Filtered Calls	20	5903717	5903717	94	0.0531914893617021	NA	NA	NA			47			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHGB&recr=Open">Click here</a>	
CHIA	Silent	p.Y34Y	C	C		11	Filtered Calls	1	111854858	111854858	181	0.0386740331491713	NA	NA	NA			23			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHIA&recr=Open">Click here</a>	
CHMP4C	Silent	p.L79L	C	C		11	Filtered Calls	8	82665345	82665345	333	0.0570570570570571	NA	NA	NA			10	Intramolecular interaction with C- terminus. {ECO:0000250}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHMP4C&recr=Open">Click here</a>	
CLCA1	Intron		C	C		11	Filtered Calls	1	86947885	86947885	117	0.0512820512820513	NA	NA	NA			38			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLCA1&recr=Open">Click here</a>	
CLEC3A	Intron		C	C		11	Filtered Calls	16	78061998	78061998	242	0.0578512396694215	NA	NA	NA			18			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLEC3A&recr=Open">Click here</a>	
CLIC4	Intron		C	C	rs199510855	11	Filtered Calls	1	25166341	25166341	187	0.0855614973262032	NA	NA	NA			6			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLIC4&recr=Open">Click here</a>	
CNKSR2	Silent	p.P286P	G	G		11	Filtered Calls	X	21534650	21534650	290	0.148275862068966	NA	NA	NA			61	PDZ. {ECO:0000255|PROSITE- ProRule:PRU00143}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNKSR2&recr=Open">Click here</a>	
CNTD1	IGR		G	G	rs140668306	11	Filtered Calls	17	40963741	40963741	412	0.128640776699029	NA	NA	NA			10			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNTD1&recr=Open">Click here</a>	
COCH	Silent	p.L37L	A	A		11	Filtered Calls	14	31349668	31349668	104	0.0576923076923077	NA	NA	NA			19	LCCL. {ECO:0000255|PROSITE- ProRule:PRU00123}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COCH&recr=Open">Click here</a>	
COL14A1	Silent	p.G1337G	G	G		11	Filtered Calls	8	121298143	121298143	223	0.0493273542600897	NA	NA	NA			119			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL14A1&recr=Open">Click here</a>	
COL15A1	Silent	p.T1249T	C	C		11	Filtered Calls	9	101829259	101829259	219	0.0730593607305936	NA	NA	NA			107	Nonhelical region 10 (NC10).		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL15A1&recr=Open">Click here</a>	
COLGALT2	Silent	p.L240L	G	G		11	Filtered Calls	1	183938517	183938517	239	0.0669456066945607	NA	NA	NA			NA			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COLGALT2&recr=Open">Click here</a>	
CPD	Silent	p.S970S	C	C		11	Filtered Calls	17	28776607	28776607	523	0.0630975143403442	NA	NA	NA			36	Carboxypeptidase-like 3.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CPD&recr=Open">Click here</a>	
CRHR2	Intron		C	C		11	Filtered Calls	7	30701765	30701765	112	0.0625	NA	NA	NA			28			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CRHR2&recr=Open">Click here</a>	
CRIPAK	Silent	p.L291L	C	C		11	Filtered Calls	4	1389170	1389170	539	0.0371057513914657	NA	NA	NA			35			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CRIPAK&recr=Open">Click here</a>	
CSF2RB	Intron		C	C		11	Filtered Calls	22	37326409	37326409	282	0.0921985815602837	NA	NA	NA			42			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSF2RB&recr=Open">Click here</a>	
CSMD1	Silent	p.R1229R	C	C		11	Filtered Calls	8	3165973	3165973	76	0.0657894736842105	NA	NA	NA			25	Sushi 7. {ECO:0000255|PROSITE- ProRule:PRU00302}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSMD1&recr=Open">Click here</a>	
CTC-241N9.1	IGR		C	C		11	Filtered Calls	5	179290547	179290547	104	0.0769230769230769	NA	NA	NA			NA			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CTC-241N9.1&recr=Open">Click here</a>	
CTCF	Silent	p.T421T	C	C		11	Filtered Calls	16	67655400	67655400	333	0.024024024024024	NA	NA	NA			79			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CTCF&recr=Open">Click here</a>	
CTRC	Silent	p.A140A	C	C		11	Filtered Calls	1	15769977	15769977	337	0.0356083086053412	NA	NA	NA			13	Peptidase S1. {ECO:0000255|PROSITE- ProRule:PRU00274}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CTRC&recr=Open">Click here</a>	
CUBN	Intron		G	G		11	Filtered Calls	10	17152908	17152908	244	0.0614754098360656	NA	NA	NA			241			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CUBN&recr=Open">Click here</a>	
CUL9	Silent	p.L349L	C	C		11	Filtered Calls	6	43153989	43153989	179	0.0782122905027933	NA	NA	NA			92			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CUL9&recr=Open">Click here</a>	
CXCR1	Silent	p.K318K	C	C		11	Filtered Calls	2	219028981	219028981	203	0.0492610837438424	NA	NA	NA			13			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CXCR1&recr=Open">Click here</a>	
CYP11A1	IGR		C	C		11	Filtered Calls	15	74627455	74627455	194	0.0876288659793814	NA	NA	NA			20			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP11A1&recr=Open">Click here</a>	
CYP19A1	Intron		G	G		11	Filtered Calls	15	51534958	51534958	41	0.121951219512195	NA	NA	NA			33			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP19A1&recr=Open">Click here</a>	
CYP2C9	Intron		C	C		11	Filtered Calls	10	96748601	96748601	440	0.0795454545454545	NA	NA	NA			34			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP2C9&recr=Open">Click here</a>	
CYP4A11	Intron		C	C		11	Filtered Calls	1	47399613	47399613	68	0.0735294117647059	NA	NA	NA			36			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP4A11&recr=Open">Click here</a>	
CYP4B1	Intron		C	C		11	Filtered Calls	1	47283712	47283712	197	0.0761421319796954	NA	NA	NA			36			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP4B1&recr=Open">Click here</a>	
DDX23	Silent	p.S63S	G	G		11	Filtered Calls	12	49239377	49239377	338	0.0798816568047337	NA	NA	NA			36	Arg-rich.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DDX23&recr=Open">Click here</a>	
DEDD2	Silent	p.P185P	G	G		11	Filtered Calls	19	42713886	42713886	278	0.0431654676258993	NA	NA	NA			5			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DEDD2&recr=Open">Click here</a>	
DEFB112	Silent	p.S23S	G	G		11	Filtered Calls	6	50016296	50016296	379	0.079155672823219	NA	NA	NA			19			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DEFB112&recr=Open">Click here</a>	
DEFB124	Intron		G	G		11	Filtered Calls	20	30053477	30053477	165	0.109090909090909	NA	NA	NA			NA			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DEFB124&recr=Open">Click here</a>	
DGKB	Silent	p.L544L	G	G		11	Filtered Calls	7	14613980	14613980	223	0.0403587443946188	NA	NA	NA			72	DAGKc. {ECO:0000255|PROSITE- ProRule:PRU00783}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DGKB&recr=Open">Click here</a>	
DGKG	Silent	p.S156S	G	G		11	Filtered Calls	3	186006575	186006575	648	0.123456790123457	NA	NA	NA			42	Poly-Ser.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DGKG&recr=Open">Click here</a>	
DGKI	Intron		G	G	rs554311762	11	Filtered Calls	7	137363406	137363406	194	0.0360824742268041	NA	NA	NA			84			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DGKI&recr=Open">Click here</a>	
DIP2B	Silent	p.D983D	T	T		11	Filtered Calls	12	51112589	51112589	108	0.111111111111111	NA	NA	NA			60			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DIP2B&recr=Open">Click here</a>	
DMBT1	Silent	p.V237V	G	G	rs538862158	11	Filtered Calls	10	124339125	124339125	783	0.0676883780332056	NA	NA	NA			72	SRCR 2. {ECO:0000255|PROSITE- ProRule:PRU00196}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DMBT1&recr=Open">Click here</a>	
DMGDH	Silent	p.S661S	G	G		11	Filtered Calls	5	78324305	78324305	264	0.0568181818181818	NA	NA	NA			34			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DMGDH&recr=Open">Click here</a>	
DNAAF2	Silent	p.P651P	T	T	rs34352773	11	Filtered Calls	14	50094784	50094784	40	0.125	NA	NA	NA			5			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAAF2&recr=Open">Click here</a>	
DNAH5	Silent	p.I2064I	G	G		11	Filtered Calls	5	13830192	13830192	170	0.0294117647058824	NA	NA	NA			378	AAA 1. {ECO:0000250}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH5&recr=Open">Click here</a>	
DNAH9	Silent	p.F1142F	C	C		11	Filtered Calls	17	11583146	11583146	399	0.0601503759398496	NA	NA	NA			290	Stem. {ECO:0000250}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH9&recr=Open">Click here</a>	
DNAJC5B	Intron		C	C		11	Filtered Calls	8	66992606	66992606	301	0.0730897009966777	NA	NA	NA			20			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAJC5B&recr=Open">Click here</a>	
DPM1	Intron		G	G		11	Filtered Calls	20	49552806	49552806	70	0.0571428571428571	NA	NA	NA			7			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DPM1&recr=Open">Click here</a>	
DSCAM	Silent	p.L1993L	G	G	rs190494751	11	Filtered Calls	21	41385021	41385021	162	0.0802469135802469	NA	NA	NA			142			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DSCAM&recr=Open">Click here</a>	
DSCAM	Intron		G	G		11	Filtered Calls	21	41385317	41385317	94	0.0957446808510638	NA	NA	NA			142			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DSCAM&recr=Open">Click here</a>	
DSG3	Silent	p.V52V	G	G		11	Filtered Calls	18	29037027	29037027	371	0.0889487870619946	NA	NA	NA			62	Cadherin 1. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DSG3&recr=Open">Click here</a>	
DSG3	Silent	p.I412I	C	C		11	Filtered Calls	18	29044310	29044310	297	0.0740740740740741	NA	NA	NA			62	Cadherin 4. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DSG3&recr=Open">Click here</a>	
DSG4	Silent	p.T552T	G	G		11	Filtered Calls	18	28986059	28986059	256	0.0859375	NA	NA	NA			70			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DSG4&recr=Open">Click here</a>	
DSP	Silent	p.Y2547Y	C	C		11	Filtered Calls	6	7585136	7585136	220	0.0272727272727273	NA	NA	NA			101	Globular 2.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DSP&recr=Open">Click here</a>	
DTX3L	Silent	p.L11L	C	C		11	Filtered Calls	3	122283306	122283306	62	0.193548387096774	NA	NA	NA			24			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DTX3L&recr=Open">Click here</a>	
DUOX2	Silent	p.L1396L	G	G		11	Filtered Calls	15	45387686	45387686	184	0.0652173913043478	NA	NA	NA			63			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DUOX2&recr=Open">Click here</a>	
DXO	5'Flank		A	A		11	Filtered Calls	6	31940094	31940094	296	0.0371621621621622	NA	NA	NA			NA			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DXO&recr=Open">Click here</a>	
DZIP1	Silent	p.T97T	G	G		11	Filtered Calls	13	96293855	96293855	209	0.0813397129186603	NA	NA	NA			38			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DZIP1&recr=Open">Click here</a>	
EFCAB3	Intron		T	T		11	Filtered Calls	17	60484385	60484385	283	0.0848056537102474	NA	NA	NA			17			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EFCAB3&recr=Open">Click here</a>	
EFCAB5	Silent	p.Q870Q	G	G		11	Filtered Calls	17	28386592	28386592	340	0.0852941176470588	NA	NA	NA			43	EF-hand. {ECO:0000255|PROSITE- ProRule:PRU00448}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EFCAB5&recr=Open">Click here</a>	
EIF2AK4	Silent	p.I1226I	T	T		11	Filtered Calls	15	40301916	40301916	443	0.0112866817155756	NA	NA	NA			40	Histidyl-tRNA synthetase-like.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EIF2AK4&recr=Open">Click here</a>	
EIF4B	Silent	p.E616E	A	A		11	Filtered Calls	12	53434004	53434004	141	0.0851063829787234	NA	NA	NA			22			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EIF4B&recr=Open">Click here</a>	
ERCC6L2	Intron		C	C		11	Filtered Calls	9	98660125	98660125	382	0.0392670157068063	NA	NA	NA			NA			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ERCC6L2&recr=Open">Click here</a>	
ERO1LB	Silent	p.D336D	A	A		11	Filtered Calls	1	236389613	236389613	313	0.0798722044728434	NA	NA	NA			23			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ERO1LB&recr=Open">Click here</a>	
ESRP2	Silent	p.Q306Q	C	C		11	Filtered Calls	16	68266310	68266310	99	0.0707070707070707	NA	NA	NA			16	RRM 1.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ESRP2&recr=Open">Click here</a>	
ETAA1	Intron		T	T		11	Filtered Calls	2	67630112	67630112	171	0.0701754385964912	NA	NA	NA			33			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ETAA1&recr=Open">Click here</a>	
EVPL	Silent	p.R1561R	C	C		11	Filtered Calls	17	74004603	74004603	23	0.173913043478261	NA	NA	NA			54	Central fibrous rod domain.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EVPL&recr=Open">Click here</a>	
F13A1	Intron		G	G		11	Filtered Calls	6	6267054	6267054	434	0.0161290322580645	NA	NA	NA			62			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+F13A1&recr=Open">Click here</a>	
FAM120A	Silent	p.F857F	C	C		11	Filtered Calls	9	96320195	96320195	52	0.134615384615385	NA	NA	NA			34	RNA binding.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM120A&recr=Open">Click here</a>	
FAM178A	Silent	p.V1000V	A	A		11	Filtered Calls	10	102706861	102706861	455	0.0791208791208791	NA	NA	NA			NA			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM178A&recr=Open">Click here</a>	
FAM3D	Intron		G	G		11	Filtered Calls	3	58620103	58620103	103	0.058252427184466	NA	NA	NA			3			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM3D&recr=Open">Click here</a>	
FAM49A	Silent	p.L20L	G	G		11	Filtered Calls	2	16769330	16769330	170	0.0411764705882353	NA	NA	NA			23			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM49A&recr=Open">Click here</a>	
FAT3	Silent	p.F1359F	C	C		11	Filtered Calls	11	92523300	92523300	328	0.0274390243902439	NA	NA	NA			85	Cadherin 12. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAT3&recr=Open">Click here</a>	
FAT4	Silent	p.I841I	C	C		11	Filtered Calls	4	126240089	126240089	340	0.0411764705882353	NA	NA	NA			355	Cadherin 8. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAT4&recr=Open">Click here</a>	
FBLN2	Intron		C	C		11	Filtered Calls	3	13672822	13672822	26	0.115384615384615	NA	NA	NA			24			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FBLN2&recr=Open">Click here</a>	
FBLN2	Silent	p.I1168I	C	C		11	Filtered Calls	3	13679227	13679227	32	0.1875	NA	NA	NA			24	Domain III.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FBLN2&recr=Open">Click here</a>	
FBN3	Silent	p.F1017F	G	G		11	Filtered Calls	19	8188379	8188379	33	0.121212121212121	NA	NA	NA			132	EGF-like 12; calcium-binding. {ECO:0000255|PROSITE-ProRule:PRU00076}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FBN3&recr=Open">Click here</a>	
FCGBP	Intron		C	C		11	Filtered Calls	19	40360846	40360846	129	0.0852713178294574	NA	NA	NA			165			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FCGBP&recr=Open">Click here</a>	
FCGBP	Intron		C	C		11	Filtered Calls	19	40360847	40360847	129	0.0930232558139535	NA	NA	NA			165			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FCGBP&recr=Open">Click here</a>	
FCHSD1	IGR		C	C		11	Filtered Calls	5	141019490	141019490	244	0.0942622950819672	NA	NA	NA			24			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FCHSD1&recr=Open">Click here</a>	
FCHSD2	Silent	p.L461L	C	C		11	Filtered Calls	11	72553801	72553801	161	0.0434782608695652	NA	NA	NA			22			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FCHSD2&recr=Open">Click here</a>	
FGA	Silent	p.S572S	G	G		11	Filtered Calls	4	155506865	155506865	304	0.0328947368421053	NA	NA	NA			73			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FGA&recr=Open">Click here</a>	
FLII	Intron		G	G		11	Filtered Calls	17	18156780	18156780	170	0.0764705882352941	NA	NA	NA			32			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FLII&recr=Open">Click here</a>	
FRAS1	IGR		C	C		11	Filtered Calls	4	79369328	79369328	87	0.0689655172413793	NA	NA	NA			103			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FRAS1&recr=Open">Click here</a>	
FREM2	Silent	p.T3013T	G	G		11	Filtered Calls	13	39454453	39454453	204	0.053921568627451	NA	NA	NA			148			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FREM2&recr=Open">Click here</a>	
FRYL	Intron		G	G		11	Filtered Calls	4	48592856	48592856	189	0.0582010582010582	NA	NA	NA			91			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FRYL&recr=Open">Click here</a>	
FSTL4	Silent	p.I716I	G	G		11	Filtered Calls	5	132535168	132535168	120	0.05	NA	NA	NA			23			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FSTL4&recr=Open">Click here</a>	
FSTL4	Intron		T	T		11	Filtered Calls	5	132763405	132763405	139	0.0575539568345324	NA	NA	NA			23			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FSTL4&recr=Open">Click here</a>	
FSTL5	Intron		G	G		11	Filtered Calls	4	162463851	162463851	186	0.0752688172043011	NA	NA	NA			91			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FSTL5&recr=Open">Click here</a>	
FYN	Intron		G	G		11	Filtered Calls	6	112015824	112015824	513	0.037037037037037	NA	NA	NA			30			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FYN&recr=Open">Click here</a>	
GABRA3	Silent	p.V309V	G	G	rs199793732	11	Filtered Calls	X	151366109	151366109	104	0.173076923076923	NA	NA	NA			37			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GABRA3&recr=Open">Click here</a>	
GALNT2	Silent	p.V298V	C	C		11	Filtered Calls	1	230385006	230385006	185	0.0378378378378378	NA	NA	NA			32			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GALNT2&recr=Open">Click here</a>	
GANC	Silent	p.P566P	C	C		11	Filtered Calls	15	42622827	42622827	309	0.087378640776699	NA	NA	NA			23			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GANC&recr=Open">Click here</a>	
GANC	Silent	p.S788S	C	C		11	Filtered Calls	15	42640360	42640360	184	0.0869565217391304	NA	NA	NA			23			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GANC&recr=Open">Click here</a>	
GAS7	Intron		A	A		11	Filtered Calls	17	9872982	9872982	106	0.10377358490566	NA	NA	NA			39			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GAS7&recr=Open">Click here</a>	
GCN1L1	Silent	p.F2385F	G	G		11	Filtered Calls	12	120572384	120572384	109	0.0642201834862385	NA	NA	NA			94			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GCN1L1&recr=Open">Click here</a>	
GFRAL	Silent	p.L394L	C	C		11	Filtered Calls	6	55266648	55266648	296	0.0236486486486486	NA	NA	NA		p.L394L(1)	48			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GFRAL&recr=Open">Click here</a>	
GH2	Intron		C	C		11	Filtered Calls	17	61958073	61958073	246	0.0487804878048781	NA	NA	NA			24			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GH2&recr=Open">Click here</a>	
GIMAP8	Silent	p.T557T	G	G	rs557029400	11	Filtered Calls	7	150174541	150174541	239	0.0920502092050209	NA	NA	NA			62	AIG1-type G 3.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GIMAP8&recr=Open">Click here</a>	
GLRB	Silent	p.V130V	G	G		11	Filtered Calls	4	158057713	158057713	351	0.037037037037037	NA	NA	NA			27			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GLRB&recr=Open">Click here</a>	
GLT8D2	Silent	p.V111V	C	C		11	Filtered Calls	12	104393244	104393244	207	0.0434782608695652	NA	NA	NA			16			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GLT8D2&recr=Open">Click here</a>	
GMFG	Silent	p.F68F	G	G	rs370207146	11	Filtered Calls	19	39820263	39820263	62	0.0806451612903226	NA	NA	NA			10	ADF-H. {ECO:0000255|PROSITE- ProRule:PRU00599}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GMFG&recr=Open">Click here</a>	
GMPR2	IGR		C	C		11	Filtered Calls	14	24709626	24709626	170	0.0352941176470588	NA	NA	NA			12			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GMPR2&recr=Open">Click here</a>	
GON4L	Silent	p.F988F	G	G		11	Filtered Calls	1	155736300	155736300	233	0.0858369098712446	NA	NA	NA			45			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GON4L&recr=Open">Click here</a>	
GOT1L1	Silent	p.L278L	C	C		11	Filtered Calls	8	37793317	37793317	143	0.104895104895105	NA	NA	NA			14			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GOT1L1&recr=Open">Click here</a>	
GPR1	Silent	p.F101F	G	G		11	Filtered Calls	2	207041669	207041669	230	0.0478260869565217	NA	NA	NA			18			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR1&recr=Open">Click here</a>	
GPR111	Silent	p.S569S	C	C		11	Filtered Calls	6	47650206	47650206	177	0.0564971751412429	NA	NA	NA			29			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR111&recr=Open">Click here</a>	
GPR119	Silent	p.V93V	G	G		11	Filtered Calls	X	129519143	129519143	194	0.11340206185567	NA	NA	NA			11			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR119&recr=Open">Click here</a>	
GPR133	Silent	p.F93F	C	C		11	Filtered Calls	12	131488807	131488807	76	0.0657894736842105	NA	NA	NA			67			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR133&recr=Open">Click here</a>	
GPR158	Silent	p.F345F	C	C		11	Filtered Calls	10	25684866	25684866	188	0.0478723404255319	NA	NA	NA			119			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR158&recr=Open">Click here</a>	
GPR37L1	Silent	p.S297S	C	C	rs558768667	11	Filtered Calls	1	202097129	202097129	113	0.0619469026548673	NA	NA	NA			18			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR37L1&recr=Open">Click here</a>	
GPR98	Silent	p.V2922V	G	G		11	Filtered Calls	5	90004668	90004668	343	0.0524781341107872	NA	NA	NA			269	Calx-beta 20. {ECO:0000255}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR98&recr=Open">Click here</a>	
GRIK3	Silent	p.F479F	G	G		11	Filtered Calls	1	37307430	37307430	271	0.044280442804428	NA	NA	NA			89			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRIK3&recr=Open">Click here</a>	
GRIP1	Intron		C	C		11	Filtered Calls	12	66909391	66909391	518	0.0598455598455598	NA	NA	NA			50			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRIP1&recr=Open">Click here</a>	
GSTA2	Intron		G	G		11	Filtered Calls	6	52616517	52616517	254	0.0905511811023622	NA	NA	NA			16			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GSTA2&recr=Open">Click here</a>	
GTF3C2	Intron		G	G		11	Filtered Calls	2	27566020	27566020	112	0.0982142857142857	NA	NA	NA			38			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GTF3C2&recr=Open">Click here</a>	
HAAO	Silent	p.I160I	G	G		11	Filtered Calls	2	42997287	42997287	64	0.078125	NA	NA	NA			11			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HAAO&recr=Open">Click here</a>	
HACL1	Intron		C	C		11	Filtered Calls	3	15628055	15628055	427	0.0398126463700234	NA	NA	NA			16			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HACL1&recr=Open">Click here</a>	
HAP1	Silent	p.A637A	G	G		11	Filtered Calls	17	39881058	39881058	259	0.0965250965250965	NA	NA	NA			21			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HAP1&recr=Open">Click here</a>	
HFM1	Silent	p.I844I	G	G		11	Filtered Calls	1	91788652	91788652	365	0.0219178082191781	NA	NA	NA			75	SEC63.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HFM1&recr=Open">Click here</a>	
HIPK1	Silent	p.A1101A	C	C		11	Filtered Calls	1	114515804	114515804	261	0.0421455938697318	NA	NA	NA			39			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HIPK1&recr=Open">Click here</a>	
HMCN1	Intron		C	C		11	Filtered Calls	1	186051991	186051991	159	0.157232704402516	NA	NA	NA			308			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HMCN1&recr=Open">Click here</a>	
HOXD4	Silent	p.F17F	C	C		11	Filtered Calls	2	177016412	177016412	182	0.0934065934065934	NA	NA	NA		p.F17L(1)	9			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HOXD4&recr=Open">Click here</a>	
HOXD9	Silent	p.E346E	G	G		11	Filtered Calls	2	176988882	176988882	216	0.0787037037037037	NA	NA	NA		p.E336D(1)	10			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HOXD9&recr=Open">Click here</a>	
HPN	Intron		C	C		11	Filtered Calls	19	35551081	35551081	216	0.0324074074074074	NA	NA	NA			19			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HPN&recr=Open">Click here</a>	
HS3ST4	Silent	p.N318N	C	C		11	Filtered Calls	16	26147152	26147152	457	0.0634573304157549	NA	NA	NA			15			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HS3ST4&recr=Open">Click here</a>	
HS3ST4	Silent	p.I324I	C	C		11	Filtered Calls	16	26147170	26147170	475	0.0336842105263158	NA	NA	NA			15			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HS3ST4&recr=Open">Click here</a>	
HSD17B13	Intron		G	G		11	Filtered Calls	4	88238381	88238381	194	0.0567010309278351	NA	NA	NA			8			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HSD17B13&recr=Open">Click here</a>	
HSPA8	Silent	p.A142A	A	A		11	Filtered Calls	11	122930962	122930962	335	0.116417910447761	NA	NA	NA			36			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HSPA8&recr=Open">Click here</a>	
IFT122	Silent	p.V355V	C	C		11	Filtered Calls	3	129195562	129195562	192	0.0833333333333333	NA	NA	NA			52			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IFT122&recr=Open">Click here</a>	
IFT122	Silent	p.L1113L	C	C		11	Filtered Calls	3	129236383	129236383	146	0.10958904109589	NA	NA	NA			52			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IFT122&recr=Open">Click here</a>	
IGHD6-19	RNA		G	G		11	Filtered Calls	14	106357584	106357584	108	0.0648148148148148	NA	NA	NA			NA			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGHD6-19&recr=Open">Click here</a>	
IGHV1-24	RNA		C	C		11	Filtered Calls	14	106733294	106733294	432	0.0509259259259259	NA	NA	NA			NA			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGHV1-24&recr=Open">Click here</a>	
IGHV3-74	RNA		C	C	rs370151646	11	Filtered Calls	14	107218946	107218946	280	0.0464285714285714	NA	NA	NA			NA			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGHV3-74&recr=Open">Click here</a>	
IGHV3-74	RNA		C	C		11	Filtered Calls	14	107219083	107219083	445	0.0337078651685393	NA	NA	NA			NA			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGHV3-74&recr=Open">Click here</a>	
IGKV1-8	RNA		C	C		11	Filtered Calls	2	89292043	89292043	403	0.0645161290322581	NA	NA	NA			NA			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGKV1-8&recr=Open">Click here</a>	
IGLV1-36	RNA		G	G		11	Filtered Calls	22	22786631	22786631	247	0.0526315789473684	NA	NA	NA			NA			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGLV1-36&recr=Open">Click here</a>	
IKBKAP	Intron		G	G	rs371793321	11	Filtered Calls	9	111681638	111681638	115	0.0521739130434783	NA	NA	NA			53			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IKBKAP&recr=Open">Click here</a>	
IL16	Silent	p.S1083S	C	C		11	Filtered Calls	15	81593784	81593784	219	0.0547945205479452	NA	NA	NA			57	Interaction with HTLV-1 tax.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IL16&recr=Open">Click here</a>	
IL17RA	3'UTR		C	C		11	Filtered Calls	22	17578740	17578740	130	0.0769230769230769	NA	NA	NA			30			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IL17RA&recr=Open">Click here</a>	
IL18RAP	Intron		G	G		11	Filtered Calls	2	103040376	103040376	216	0.0509259259259259	NA	NA	NA			37			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IL18RAP&recr=Open">Click here</a>	
IMMP2L	Intron		T	T		11	Filtered Calls	7	110764714	110764714	228	0.0570175438596491	NA	NA	NA			14			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IMMP2L&recr=Open">Click here</a>	
IPO11	Silent	p.T840T	C	C		11	Filtered Calls	5	61857022	61857022	250	0.072	NA	NA	NA			30			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IPO11&recr=Open">Click here</a>	
IRAK1	Intron		G	G		11	Filtered Calls	X	153282099	153282099	39	0.128205128205128	NA	NA	NA			25			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IRAK1&recr=Open">Click here</a>	
IRAK1	Intron		G	G		11	Filtered Calls	X	153282100	153282100	37	0.135135135135135	NA	NA	NA			25			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IRAK1&recr=Open">Click here</a>	
ITGA9	Silent	p.S728S	C	C		11	Filtered Calls	3	37778424	37778424	151	0.0794701986754967	NA	NA	NA			44			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITGA9&recr=Open">Click here</a>	
ITGAE	Intron		G	G		11	Filtered Calls	17	3657223	3657223	92	0.0869565217391304	NA	NA	NA			41			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITGAE&recr=Open">Click here</a>	
ITGAL	Intron		T	T		11	Filtered Calls	16	30490792	30490792	78	0.0641025641025641	NA	NA	NA			76			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITGAL&recr=Open">Click here</a>	
ITGAL	Intron		C	C		11	Filtered Calls	16	30531174	30531174	524	0.0324427480916031	NA	NA	NA			76			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITGAL&recr=Open">Click here</a>	
IZUMO2	Intron		G	G		11	Filtered Calls	19	50661516	50661516	204	0.0245098039215686	NA	NA	NA			7			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IZUMO2&recr=Open">Click here</a>	
JAG1	Silent	p.K154K	C	C		11	Filtered Calls	20	10639348	10639348	162	0.0864197530864197	NA	NA	NA			44			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+JAG1&recr=Open">Click here</a>	
KBTBD12	Intron		C	C		11	Filtered Calls	3	127642834	127642834	204	0.0931372549019608	NA	NA	NA			13			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KBTBD12&recr=Open">Click here</a>	
KBTBD8	Silent	p.A501A	C	C		11	Filtered Calls	3	67058506	67058506	359	0.064066852367688	NA	NA	NA			20			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KBTBD8&recr=Open">Click here</a>	
KCNA5	Silent	p.L145L	C	C		11	Filtered Calls	12	5153748	5153748	90	0.0888888888888889	NA	NA	NA			52			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNA5&recr=Open">Click here</a>	
KCNA5	Silent	p.I495I	C	C		11	Filtered Calls	12	5154798	5154798	195	0.0820512820512821	NA	NA	NA			52			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNA5&recr=Open">Click here</a>	
KCNAB1	Silent	p.T151T	C	C	rs377242869	11	Filtered Calls	3	156181515	156181515	316	0.0158227848101266	NA	NA	NA			28			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNAB1&recr=Open">Click here</a>	
KCND2	Silent	p.C529C	C	C		11	Filtered Calls	7	120385953	120385953	317	0.0410094637223975	NA	NA	NA			75			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCND2&recr=Open">Click here</a>	
KCNH1	Silent	p.F522F	G	G		11	Filtered Calls	1	210977405	210977405	110	0.0454545454545455	NA	NA	NA			68			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNH1&recr=Open">Click here</a>	
KCNK5	Silent	p.K436K	C	C		11	Filtered Calls	6	39158858	39158858	42	0.142857142857143	NA	NA	NA			19			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNK5&recr=Open">Click here</a>	
KCNK5	Silent	p.I308I	G	G		11	Filtered Calls	6	39159242	39159242	313	0.0255591054313099	NA	NA	NA			19			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNK5&recr=Open">Click here</a>	
KCNK5	Silent	p.I167I	G	G		11	Filtered Calls	6	39162078	39162078	140	0.0357142857142857	NA	NA	NA			19			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNK5&recr=Open">Click here</a>	
KCNQ5	Intron		G	G		11	Filtered Calls	6	73839564	73839564	47	0.127659574468085	NA	NA	NA			57			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNQ5&recr=Open">Click here</a>	
KCNT2	Silent	p.L935L	A	A		11	Filtered Calls	1	196250097	196250097	171	0.0760233918128655	NA	NA	NA			97			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNT2&recr=Open">Click here</a>	
KCTD16	Silent	p.S49S	C	C		11	Filtered Calls	5	143586424	143586424	141	0.0425531914893617	NA	NA	NA			21	BTB.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCTD16&recr=Open">Click here</a>	
KDM5A	Silent	p.C1166C	G	G		11	Filtered Calls	12	417052	417052	520	0.0134615384615385	NA	NA	NA			77			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KDM5A&recr=Open">Click here</a>	
KIAA0100	Intron		G	G		11	Filtered Calls	17	26942823	26942823	73	0.150684931506849	NA	NA	NA			68			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA0100&recr=Open">Click here</a>	
KIAA0895	Silent	p.F104F	G	G		11	Filtered Calls	7	36396613	36396613	251	0.107569721115538	NA	NA	NA			26			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA0895&recr=Open">Click here</a>	
KIF26B	Silent	p.V451V	G	G		11	Filtered Calls	1	245765881	245765881	73	0.0547945205479452	NA	NA	NA			51	Kinesin motor. {ECO:0000255|PROSITE- ProRule:PRU00283}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIF26B&recr=Open">Click here</a>	
KLHDC7A	Silent	p.F274F	C	C		11	Filtered Calls	1	18808297	18808297	197	0.0253807106598985	NA	NA	NA			22			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KLHDC7A&recr=Open">Click here</a>	
KLHL5	Silent	p.V12V	T	T		11	Filtered Calls	4	39064170	39064170	380	0.0394736842105263	NA	NA	NA			29			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KLHL5&recr=Open">Click here</a>	
KMT2D	5'Flank		G	G	rs201218526	11	Filtered Calls	12	49434056	49434056	67	0.0895522388059701	NA	NA	NA			NA			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KMT2D&recr=Open">Click here</a>	
KRT7	Intron		C	C		11	Filtered Calls	12	52635248	52635248	110	0.0636363636363636	NA	NA	NA			14			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KRT7&recr=Open">Click here</a>	
KRTAP10-5	Silent	p.V19V	C	C		11	Filtered Calls	21	46000399	46000399	182	0.043956043956044	NA	NA	NA			14			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KRTAP10-5&recr=Open">Click here</a>	
KRTAP12-2	Silent	p.L104L	G	G		11	Filtered Calls	21	46086494	46086494	112	0.0803571428571429	NA	NA	NA			5	23 X 5 AA approximate repeats.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KRTAP12-2&recr=Open">Click here</a>	
KRTAP13-2	Silent	p.S114S	C	C	rs143178819	11	Filtered Calls	21	31744190	31744190	92	0.0760869565217391	NA	NA	NA			21			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KRTAP13-2&recr=Open">Click here</a>	
KRTAP24-1	Silent	p.Q62Q	T	T		11	Filtered Calls	21	31655065	31655065	220	0.05	NA	NA	NA			14			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KRTAP24-1&recr=Open">Click here</a>	
KRTDAP	Silent	p.S13S	G	G		11	Filtered Calls	19	35981306	35981306	251	0.0717131474103586	NA	NA	NA			6			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KRTDAP&recr=Open">Click here</a>	
LAD1	Intron		C	C		11	Filtered Calls	1	201352195	201352195	323	0.0247678018575851	NA	NA	NA			19			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LAD1&recr=Open">Click here</a>	
LCTL	Silent	p.G209G	G	G		11	Filtered Calls	15	66853422	66853422	175	0.0514285714285714	NA	NA	NA			32			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LCTL&recr=Open">Click here</a>	
LEFTY2	Silent	p.A290A	A	A		11	Filtered Calls	1	226125372	226125372	46	0.108695652173913	NA	NA	NA			16			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LEFTY2&recr=Open">Click here</a>	
LGI1	Silent	p.V457V	C	C		11	Filtered Calls	10	95557257	95557257	174	0.103448275862069	NA	NA	NA			29			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LGI1&recr=Open">Click here</a>	
LILRA2	Silent	p.Q445Q	G	G		11	Filtered Calls	19	55098783	55098783	89	0.0674157303370786	NA	NA	NA			50			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LILRA2&recr=Open">Click here</a>	
LINGO4	Silent	p.L233L	C	C		11	Filtered Calls	1	151774482	151774482	125	0.072	NA	NA	NA			21			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LINGO4&recr=Open">Click here</a>	
LONP2	Intron		C	C		11	Filtered Calls	16	48290512	48290512	369	0.024390243902439	NA	NA	NA			31			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LONP2&recr=Open">Click here</a>	
LRRC37B	Intron		C	C		11	Filtered Calls	17	30348398	30348398	191	0.0523560209424084	NA	NA	NA			29			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRRC37B&recr=Open">Click here</a>	
LRRC37B	Silent	p.L209L	C	C		11	Filtered Calls	17	30349038	30349038	196	0.0561224489795918	NA	NA	NA			29			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRRC37B&recr=Open">Click here</a>	
LRRK2	Intron		T	T		11	Filtered Calls	12	40758638	40758638	62	0.0645161290322581	NA	NA	NA			181			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRRK2&recr=Open">Click here</a>	
LST3	Intron		C	C		11	Filtered Calls	12	21032488	21032488	358	0.0782122905027933	NA	NA	NA			NA			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LST3&recr=Open">Click here</a>	
LYSMD4	Intron		A	A		11	Filtered Calls	15	100271390	100271390	218	0.0963302752293578	NA	NA	NA			10			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LYSMD4&recr=Open">Click here</a>	
LYST	Silent	p.A1168A	G	G		11	Filtered Calls	1	235967855	235967855	325	0.0646153846153846	NA	NA	NA			162			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LYST&recr=Open">Click here</a>	
MAGEA1	Silent	p.E86E	C	C		11	Filtered Calls	X	152482753	152482753	127	0.0866141732283465	NA	NA	NA			19			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAGEA1&recr=Open">Click here</a>	
MAGEB2	Silent	p.S131S	C	C	rs139272287	11	Filtered Calls	X	30237090	30237090	62	0.145161290322581	NA	NA	NA			23	MAGE. {ECO:0000255|PROSITE- ProRule:PRU00127}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAGEB2&recr=Open">Click here</a>	
MAGI1	Silent	p.Y138Y	G	G		11	Filtered Calls	3	65607663	65607663	115	0.0347826086956522	NA	NA	NA			51	Guanylate kinase-like. {ECO:0000255|PROSITE-ProRule:PRU00100}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAGI1&recr=Open">Click here</a>	
MAGI2	Silent	p.I991I	G	G		11	Filtered Calls	7	77764396	77764396	212	0.117924528301887	NA	NA	NA			84	PDZ 5. {ECO:0000255|PROSITE- ProRule:PRU00143}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAGI2&recr=Open">Click here</a>	
MAK	Intron		C	C		11	Filtered Calls	6	10802120	10802120	407	0.0687960687960688	NA	NA	NA			22			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAK&recr=Open">Click here</a>	
MAP2K5	Silent	p.S35S	C	C	rs41306690	11	Filtered Calls	15	67835778	67835778	163	0.0613496932515337	NA	NA	NA			16	OPR.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAP2K5&recr=Open">Click here</a>	
MAP3K7CL	5'UTR		C	C	rs201466305	11	Filtered Calls	21	30464886	30464886	230	0.0478260869565217	NA	NA	NA			NA			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAP3K7CL&recr=Open">Click here</a>	
MATN2	Intron		C	C		11	Filtered Calls	8	99015882	99015882	172	0.0406976744186047	NA	NA	NA			31			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MATN2&recr=Open">Click here</a>	
MAVS	Silent	p.T54T	C	C		11	Filtered Calls	20	3838326	3838326	197	0.0609137055837563	NA	NA	NA			14	CARD.|Required for interaction with NLRX1.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAVS&recr=Open">Click here</a>	
MCTP2	Intron		C	C		11	Filtered Calls	15	94882510	94882510	280	0.0642857142857143	NA	NA	NA			49			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MCTP2&recr=Open">Click here</a>	
MDN1	Intron		A	A		11	Filtered Calls	6	90374194	90374194	385	0.0337662337662338	NA	NA	NA			218			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MDN1&recr=Open">Click here</a>	
MED23	Silent	p.L1026L	G	G		11	Filtered Calls	6	131915393	131915393	318	0.0377358490566038	NA	NA	NA			44			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MED23&recr=Open">Click here</a>	
MEF2D	Intron		G	G		11	Filtered Calls	1	156449145	156449145	53	0.113207547169811	NA	NA	NA			15			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MEF2D&recr=Open">Click here</a>	
MERTK	Silent	p.E952E	A	A		11	Filtered Calls	2	112786297	112786297	44	0.0909090909090909	NA	NA	NA			46			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MERTK&recr=Open">Click here</a>	
MET	Silent	p.L851L	C	C		11	Filtered Calls	7	116403238	116403238	220	0.0454545454545455	NA	NA	NA			233	Arg/Glu-rich.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MET&recr=Open">Click here</a>	
MGAM	Silent	p.F1030F	C	C	rs372534153	11	Filtered Calls	7	141752715	141752715	180	0.0333333333333333	NA	NA	NA			13			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MGAM&recr=Open">Click here</a>	
MICAL2	Silent	p.F823F	C	C	rs201474826	11	Filtered Calls	11	12263892	12263892	108	0.0833333333333333	NA	NA	NA			47			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MICAL2&recr=Open">Click here</a>	
MIR516B2	RNA		C	C		11	Filtered Calls	19	54230181	54230181	494	0.0526315789473684	NA	NA	NA			NA			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MIR516B2&recr=Open">Click here</a>	
MIR521-1	RNA		G	G		11	Filtered Calls	19	54254487	54254487	523	0.0745697896749522	NA	NA	NA			NA			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MIR521-1&recr=Open">Click here</a>	
MIR654	RNA		T	T		11	Filtered Calls	14	101507737	101507737	346	0.0722543352601156	NA	NA	NA			NA			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MIR654&recr=Open">Click here</a>	
MLH3	Silent	p.L1203L	C	C		11	Filtered Calls	14	75505077	75505077	423	0.0567375886524823	NA	NA	NA			44			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MLH3&recr=Open">Click here</a>	
MLIP	Silent	p.T104T	G	G	rs202026457	11	Filtered Calls	6	53989363	53989363	262	0.0610687022900763	NA	NA	NA			34			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MLIP&recr=Open">Click here</a>	
MLYCD	Silent	p.I261I	C	C		11	Filtered Calls	16	83941872	83941872	186	0.043010752688172	NA	NA	NA			12	Catalytic domain.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MLYCD&recr=Open">Click here</a>	
MMP16	Silent	p.E202E	C	C		11	Filtered Calls	8	89180001	89180001	237	0.0590717299578059	NA	NA	NA			81			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MMP16&recr=Open">Click here</a>	
MMP17	Silent	p.I185I	C	C		11	Filtered Calls	12	132325250	132325250	153	0.0588235294117647	NA	NA	NA			5			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MMP17&recr=Open">Click here</a>	
MR1	Silent	p.V291V	C	C		11	Filtered Calls	1	181021639	181021639	91	0.120879120879121	NA	NA	NA			18	Alpha-3.|Ig-like C1-type.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MR1&recr=Open">Click here</a>	
MRGBP	Silent	p.F105F	C	C		11	Filtered Calls	20	61429983	61429983	608	0.0756578947368421	NA	NA	NA			NA			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MRGBP&recr=Open">Click here</a>	
MRPS9	Silent	p.L38L	T	T		11	Filtered Calls	2	105654662	105654662	45	0.0888888888888889	NA	NA	NA			18			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MRPS9&recr=Open">Click here</a>	
MSN	Silent	p.H179H	C	C		11	Filtered Calls	X	64951038	64951038	21	0.285714285714286	NA	NA	NA			43	FERM. {ECO:0000255|PROSITE- ProRule:PRU00084}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MSN&recr=Open">Click here</a>	
MSX2	IGR		G	G		11	Filtered Calls	5	174156392	174156392	117	0.0341880341880342	NA	NA	NA			10			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MSX2&recr=Open">Click here</a>	
MUC16	Silent	p.S12846S	G	G		11	Filtered Calls	19	9013852	9013852	98	0.0612244897959184	NA	NA	NA			590			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC16&recr=Open">Click here</a>	
MUT	Silent	p.F308F	G	G		11	Filtered Calls	6	49421457	49421457	461	0.108459869848156	NA	NA	NA			30			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUT&recr=Open">Click here</a>	
MXRA5	Silent	p.F1418F	G	G		11	Filtered Calls	X	3239472	3239472	53	0.113207547169811	NA	NA	NA			157			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MXRA5&recr=Open">Click here</a>	
MYH3	Silent	p.L916L	G	G	rs201383580	11	Filtered Calls	17	10543054	10543054	461	0.06941431670282	NA	NA	NA			83			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYH3&recr=Open">Click here</a>	
MYH4	Silent	p.G712G	G	G		11	Filtered Calls	17	10358969	10358969	289	0.0795847750865052	NA	NA	NA			149	Myosin motor.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYH4&recr=Open">Click here</a>	
MYH8	Silent	p.L1906L	C	C		11	Filtered Calls	17	10293867	10293867	383	0.0731070496083551	NA	NA	NA			134			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYH8&recr=Open">Click here</a>	
MYL10	Silent	p.L215L	G	G		11	Filtered Calls	7	101256793	101256793	248	0.0443548387096774	NA	NA	NA			12	EF-hand 3. {ECO:0000255|PROSITE- ProRule:PRU00448}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYL10&recr=Open">Click here</a>	
MYO5B	Silent	p.F180F	G	G	rs370497980	11	Filtered Calls	18	47527697	47527697	236	0.0932203389830508	NA	NA	NA			87	Myosin motor.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO5B&recr=Open">Click here</a>	
MYO9A	Silent	p.T828T	A	A		11	Filtered Calls	15	72227720	72227720	407	0.0737100737100737	NA	NA	NA			88	Myosin motor.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO9A&recr=Open">Click here</a>	
NALCN	Intron		G	G	rs369043342	11	Filtered Calls	13	101833451	101833451	232	0.0689655172413793	NA	NA	NA			177			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NALCN&recr=Open">Click here</a>	
NBEAL2	Intron		C	C		11	Filtered Calls	3	47032699	47032699	32	0.1875	NA	NA	NA			51			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NBEAL2&recr=Open">Click here</a>	
NCF4	Silent	p.F73F	C	C	rs373041130	11	Filtered Calls	22	37261062	37261062	197	0.0253807106598985	NA	NA	NA			16	PX. {ECO:0000255|PROSITE- ProRule:PRU00147}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NCF4&recr=Open">Click here</a>	
NCOA1	Silent	p.F1008F	C	C		11	Filtered Calls	2	24952507	24952507	253	0.0632411067193676	NA	NA	NA			53			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NCOA1&recr=Open">Click here</a>	
NCOA6	Silent	p.N1062N	G	G	rs370847683	11	Filtered Calls	20	33330874	33330874	321	0.0373831775700935	NA	NA	NA			107	NCOA1-binding region.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NCOA6&recr=Open">Click here</a>	
NEUROD4	Silent	p.S8S	C	C		11	Filtered Calls	12	55420247	55420247	198	0.0505050505050505	NA	NA	NA			41			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NEUROD4&recr=Open">Click here</a>	
NFS1	Intron		G	G		11	Filtered Calls	20	34268805	34268805	119	0.0588235294117647	NA	NA	NA			18			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NFS1&recr=Open">Click here</a>	
NGF	Silent	p.I14I	G	G		11	Filtered Calls	1	115829375	115829375	171	0.0409356725146199	NA	NA	NA			13			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NGF&recr=Open">Click here</a>	
NLK	Intron		C	C		11	Filtered Calls	17	26459636	26459636	43	0.0930232558139535	NA	NA	NA			14			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLK&recr=Open">Click here</a>	
NLRC5	Silent	p.K1751K	G	G		11	Filtered Calls	16	57113473	57113473	242	0.0247933884297521	NA	NA	NA			75			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLRC5&recr=Open">Click here</a>	
NLRP8	Silent	p.T359T	G	G		11	Filtered Calls	19	56466501	56466501	247	0.0283400809716599	NA	NA	NA			35	NACHT. {ECO:0000255|PROSITE- ProRule:PRU00136}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLRP8&recr=Open">Click here</a>	
NLRP9	Silent	p.L806L	C	C		11	Filtered Calls	19	56226504	56226504	148	0.0405405405405405	NA	NA	NA			74			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLRP9&recr=Open">Click here</a>	
NMS	Intron		C	C		11	Filtered Calls	2	101098736	101098736	262	0.0458015267175573	NA	NA	NA			14			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NMS&recr=Open">Click here</a>	
NMUR1	Silent	p.L355L	G	G		11	Filtered Calls	2	232389970	232389970	134	0.0522388059701493	NA	NA	NA			24			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NMUR1&recr=Open">Click here</a>	
NMUR2	Silent	p.F131F	G	G		11	Filtered Calls	5	151784282	151784282	158	0.0443037974683544	NA	NA	NA			44			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NMUR2&recr=Open">Click here</a>	
NNT	Silent	p.G669G	C	C		11	Filtered Calls	5	43653263	43653263	121	0.0495867768595041	NA	NA	NA			51			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NNT&recr=Open">Click here</a>	
NOL7	Intron		C	C		11	Filtered Calls	6	13616688	13616688	397	0.035264483627204	NA	NA	NA			5			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NOL7&recr=Open">Click here</a>	
NOL8	Silent	p.V337V	T	T		11	Filtered Calls	9	95077896	95077896	86	0.0581395348837209	NA	NA	NA			16			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NOL8&recr=Open">Click here</a>	
NPC1	Intron		G	G		11	Filtered Calls	18	21140454	21140454	146	0.089041095890411	NA	NA	NA			38			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NPC1&recr=Open">Click here</a>	
NPC1L1	Silent	p.P584P	G	G		11	Filtered Calls	7	44575957	44575957	156	0.0705128205128205	NA	NA	NA			57			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NPC1L1&recr=Open">Click here</a>	
NPY2R	Silent	p.I313I	C	C		11	Filtered Calls	4	156136030	156136030	201	0.0796019900497512	NA	NA	NA		p.I313I(1)	36			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NPY2R&recr=Open">Click here</a>	
NRAP	Silent	p.V873V	G	G		11	Filtered Calls	10	115381778	115381778	143	0.048951048951049	NA	NA	NA			95			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NRAP&recr=Open">Click here</a>	
NRDE2	Silent	p.F712F	G	G		11	Filtered Calls	14	90756658	90756658	159	0.0566037735849057	NA	NA	NA			NA			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NRDE2&recr=Open">Click here</a>	
NRK	Silent	p.F1171F	C	C		11	Filtered Calls	X	105179175	105179175	297	0.117845117845118	NA	NA	NA			76			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NRK&recr=Open">Click here</a>	
NRXN1	Silent	p.L343L	G	G	rs373580355	11	Filtered Calls	2	50850658	50850658	333	0.0810810810810811	NA	NA	NA			58	Laminin G-like 2. {ECO:0000255|PROSITE- ProRule:PRU00122}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NRXN1&recr=Open">Click here</a>	
NSUN5	Silent	p.F30F	G	G		11	Filtered Calls	7	72722698	72722698	125	0.064	NA	NA	NA			8			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NSUN5&recr=Open">Click here</a>	
NUP188	Silent	p.L448L	C	C		11	Filtered Calls	9	131742957	131742957	232	0.0387931034482759	NA	NA	NA			60			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NUP188&recr=Open">Click here</a>	
NXN	Silent	p.L253L	G	G	rs200533384	11	Filtered Calls	17	722740	722740	161	0.0745341614906832	NA	NA	NA			13	Thioredoxin. {ECO:0000255|PROSITE- ProRule:PRU00691}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NXN&recr=Open">Click here</a>	
OBP2A	Silent	p.E141E	A	A		11	Filtered Calls	9	138440588	138440588	223	0.0762331838565022	NA	NA	NA			11			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OBP2A&recr=Open">Click here</a>	
OBSCN	Intron		C	C	rs550508890	11	Filtered Calls	1	228482125	228482125	192	0.0260416666666667	NA	NA	NA			223			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OBSCN&recr=Open">Click here</a>	
OPN5	Silent	p.I215I	C	C	rs141504571	11	Filtered Calls	6	47763188	47763188	247	0.109311740890688	NA	NA	NA			29			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OPN5&recr=Open">Click here</a>	
OR10G9	Silent	p.I245I	C	C	rs192757687	11	Filtered Calls	11	123894454	123894454	368	0.0543478260869565	NA	NA	NA			61			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR10G9&recr=Open">Click here</a>	
OR10H4	Silent	p.F169F	C	C		11	Filtered Calls	19	16060324	16060324	487	0.082135523613963	NA	NA	NA			17			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR10H4&recr=Open">Click here</a>	
OR10R2	Silent	p.I278I	C	C		11	Filtered Calls	1	158450501	158450501	192	0.0625	NA	NA	NA			41			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR10R2&recr=Open">Click here</a>	
OR13C3	Silent	p.S97S	A	A		11	Filtered Calls	9	107298804	107298804	177	0.0395480225988701	NA	NA	NA			19			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR13C3&recr=Open">Click here</a>	
OR14A16	Silent	p.V99V	G	G		11	Filtered Calls	1	247978735	247978735	166	0.102409638554217	NA	NA	NA			45			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR14A16&recr=Open">Click here</a>	
OR14K1	Silent	p.F60F	C	C		11	Filtered Calls	1	247902096	247902096	211	0.0616113744075829	NA	NA	NA			27			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR14K1&recr=Open">Click here</a>	
OR2B6	Silent	p.L47L	A	A		11	Filtered Calls	6	27925159	27925159	524	0.0248091603053435	NA	NA	NA			19			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR2B6&recr=Open">Click here</a>	
OR2B6	Silent	p.L69L	G	G		11	Filtered Calls	6	27925225	27925225	399	0.0576441102756892	NA	NA	NA			19			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR2B6&recr=Open">Click here</a>	
OR2G2	Silent	p.I16I	C	C		11	Filtered Calls	1	247751709	247751709	209	0.0909090909090909	NA	NA	NA			45			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR2G2&recr=Open">Click here</a>	
OR2J3	5'Flank		G	G		11	Filtered Calls	6	29079665	29079665	294	0.0340136054421769	NA	NA	NA			24			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR2J3&recr=Open">Click here</a>	
OR2T1	Silent	p.I212I	C	C		11	Filtered Calls	1	248569931	248569931	158	0.0569620253164557	NA	NA	NA			39			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR2T1&recr=Open">Click here</a>	
OR2T4	Silent	p.V62V	C	C		11	Filtered Calls	1	248525068	248525068	337	0.142433234421365	NA	NA	NA			56			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR2T4&recr=Open">Click here</a>	
OR2V2	Silent	p.L186L	T	T		11	Filtered Calls	5	180582498	180582498	550	0.0927272727272727	NA	NA	NA			20			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR2V2&recr=Open">Click here</a>	
OR2W5	RNA		T	T		11	Filtered Calls	1	247654962	247654962	216	0.0833333333333333	NA	NA	NA			39			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR2W5&recr=Open">Click here</a>	
OR4C13	Silent	p.V133V	C	C		11	Filtered Calls	11	49974373	49974373	183	0.0655737704918033	NA	NA	NA			43			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR4C13&recr=Open">Click here</a>	
OR51A4	Silent	p.I222I	G	G		11	Filtered Calls	11	4967665	4967665	90	0.0888888888888889	NA	NA	NA			29			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR51A4&recr=Open">Click here</a>	
OR51V1	Silent	p.I97I	G	G		11	Filtered Calls	11	5221640	5221640	82	0.0975609756097561	NA	NA	NA			39			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR51V1&recr=Open">Click here</a>	
OR5H15	Silent	p.T167T	C	C		11	Filtered Calls	3	97888044	97888044	211	0.123222748815166	NA	NA	NA			35			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR5H15&recr=Open">Click here</a>	
OR5T1	Silent	p.L142L	C	C		11	Filtered Calls	11	56043540	56043540	584	0.0821917808219178	NA	NA	NA			43			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR5T1&recr=Open">Click here</a>	
OR6C2	IGR		G	G		11	Filtered Calls	12	55846947	55846947	95	0.0631578947368421	NA	NA	NA			23			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR6C2&recr=Open">Click here</a>	
OR6C6	Silent	p.F71F	G	G		11	Filtered Calls	12	55688804	55688804	145	0.0758620689655172	NA	NA	NA			20			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR6C6&recr=Open">Click here</a>	
OR6K3	Silent	p.I155I	G	G		11	Filtered Calls	1	158687441	158687441	151	0.0662251655629139	NA	NA	NA			41			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR6K3&recr=Open">Click here</a>	
OR9A2	Silent	p.I194I	G	G		11	Filtered Calls	7	142723638	142723638	313	0.0415335463258786	NA	NA	NA			25			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR9A2&recr=Open">Click here</a>	
OTUD3	Intron		C	C		11	Filtered Calls	1	20220854	20220854	149	0.087248322147651	NA	NA	NA			9			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OTUD3&recr=Open">Click here</a>	
PANK2	Intron		C	C		11	Filtered Calls	20	3870386	3870386	63	0.0952380952380952	NA	NA	NA			15			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PANK2&recr=Open">Click here</a>	
PARD3	Silent	p.P1319P	G	G		11	Filtered Calls	10	34400211	34400211	101	0.0693069306930693	NA	NA	NA			63			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PARD3&recr=Open">Click here</a>	
PARVB	Silent	p.F275F	C	C		11	Filtered Calls	22	44553954	44553954	159	0.0880503144654088	NA	NA	NA			25	CH 2. {ECO:0000255|PROSITE- ProRule:PRU00044}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PARVB&recr=Open">Click here</a>	
PAX6	Intron		G	G		11	Filtered Calls	11	31823332	31823332	115	0.0434782608695652	NA	NA	NA			35			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PAX6&recr=Open">Click here</a>	
PCDHA10	Silent	p.V358V	G	G		11	Filtered Calls	5	140236707	140236707	200	0.08	NA	NA	NA			79	Cadherin 4. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHA10&recr=Open">Click here</a>	
PCDHA13	Silent	p.I48I	C	C		11	Filtered Calls	5	140261997	140261997	149	0.0671140939597315	NA	NA	NA			95	Cadherin 1. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHA13&recr=Open">Click here</a>	
PCDHA13	Intron		C	C		11	Filtered Calls	5	140308613	140308613	234	0.0683760683760684	NA	NA	NA			95			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHA13&recr=Open">Click here</a>	
PCDHA13	Intron		C	C	rs549238768	11	Filtered Calls	5	140346796	140346796	66	0.106060606060606	NA	NA	NA			95			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHA13&recr=Open">Click here</a>	
PCDHB12	Silent	p.E387E	G	G		11	Filtered Calls	5	140589640	140589640	113	0.0530973451327434	NA	NA	NA			83	Cadherin 4. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHB12&recr=Open">Click here</a>	
PCDHB12	Silent	p.I389I	C	C	rs267600438	11	Filtered Calls	5	140589646	140589646	109	0.0458715596330275	NA	NA	NA		p.I389I(1)	83	Cadherin 4. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHB12&recr=Open">Click here</a>	
PCDHGA1	Silent	p.Q55Q	A	A		11	Filtered Calls	5	140710416	140710416	227	0.0484581497797357	NA	NA	NA			78	Cadherin 1. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHGA1&recr=Open">Click here</a>	
PCDHGA4	Silent	p.F215F	C	C		11	Filtered Calls	5	140735412	140735412	41	0.0975609756097561	NA	NA	NA			5	Cadherin 2. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHGA4&recr=Open">Click here</a>	
PCSK5	Silent	p.G1647G	G	G		11	Filtered Calls	9	78965799	78965799	385	0.051948051948052	NA	NA	NA			55	CRM (Cys-rich motif).		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCSK5&recr=Open">Click here</a>	
PDE1B	Intron		G	G		11	Filtered Calls	12	54971247	54971247	404	0.0742574257425743	NA	NA	NA			31			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDE1B&recr=Open">Click here</a>	
PDE3B	Silent	p.L334L	T	T		11	Filtered Calls	11	14793504	14793504	282	0.074468085106383	NA	NA	NA			39			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDE3B&recr=Open">Click here</a>	
PDGFRB	Silent	p.I214I	G	G		11	Filtered Calls	5	149513561	149513561	180	0.0722222222222222	NA	NA	NA			75	Ig-like C2-type 3.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDGFRB&recr=Open">Click here</a>	
PDZD7	Silent	p.I284I	G	G		11	Filtered Calls	10	102781570	102781570	250	0.072	NA	NA	NA			22	PDZ 2. {ECO:0000255|PROSITE- ProRule:PRU00143}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDZD7&recr=Open">Click here</a>	
PDZK1IP1	Intron		G	G		11	Filtered Calls	1	47650779	47650779	147	0.0680272108843537	NA	NA	NA			3			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDZK1IP1&recr=Open">Click here</a>	
PEX5	Silent	p.S228S	C	C		11	Filtered Calls	12	7354878	7354878	182	0.0604395604395604	NA	NA	NA			21			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PEX5&recr=Open">Click here</a>	
PFAS	Silent	p.N1159N	T	T		11	Filtered Calls	17	8171945	8171945	124	0.137096774193548	NA	NA	NA			35	Glutamine amidotransferase type-1.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PFAS&recr=Open">Click here</a>	
PHAX	Silent	p.A157A	C	C		11	Filtered Calls	5	125939636	125939636	247	0.097165991902834	NA	NA	NA			8	Necessary for interaction with CBP80. {ECO:0000250}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PHAX&recr=Open">Click here</a>	
PHF3	Silent	p.F1274F	C	C		11	Filtered Calls	6	64421083	64421083	200	0.08	NA	NA	NA			75			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PHF3&recr=Open">Click here</a>	
PIK3AP1	Silent	p.R106R	C	C	rs369999871	11	Filtered Calls	10	98469436	98469436	178	0.0730337078651685	NA	NA	NA			52	Necessary and sufficent to mediate inhibition of NF-kappa-B downstream of activated TLRs; may mediate interaction with MYD88 and TIRAP. {ECO:0000250}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PIK3AP1&recr=Open">Click here</a>	
PIK3C2B	Intron		G	G	rs373022234	11	Filtered Calls	1	204429674	204429674	154	0.0909090909090909	NA	NA	NA			52			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PIK3C2B&recr=Open">Click here</a>	
PILRB	Silent	p.L61L	T	T		11	Filtered Calls	7	99956429	99956429	104	0.0673076923076923	NA	NA	NA			13	Ig-like V-type.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PILRB&recr=Open">Click here</a>	
PLB1	Intron		C	C		11	Filtered Calls	2	28849288	28849288	160	0.04375	NA	NA	NA			69			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLB1&recr=Open">Click here</a>	
PLG	Silent	p.N533N	C	C		11	Filtered Calls	6	161155038	161155038	145	0.0413793103448276	NA	NA	NA			59	Kringle 5. {ECO:0000255|PROSITE- ProRule:PRU00121}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLG&recr=Open">Click here</a>	
PLK2	Silent	p.I646I	G	G		11	Filtered Calls	5	57750530	57750530	182	0.115384615384615	NA	NA	NA			26	POLO box 2. {ECO:0000255|PROSITE- ProRule:PRU00154}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLK2&recr=Open">Click here</a>	
PLXNA4	Intron		A	A		11	Filtered Calls	7	132174043	132174043	120	0.0833333333333333	NA	NA	NA			45			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLXNA4&recr=Open">Click here</a>	
PML	Intron		C	C		11	Filtered Calls	15	74328030	74328030	173	0.0867052023121387	NA	NA	NA			31			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PML&recr=Open">Click here</a>	
POFUT2	Intron		C	C		11	Filtered Calls	21	46687479	46687479	199	0.0402010050251256	NA	NA	NA			20			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+POFUT2&recr=Open">Click here</a>	
POLE	Silent	p.I2199I	G	G	rs147611144	11	Filtered Calls	12	133202291	133202291	206	0.0485436893203883	NA	NA	NA			89			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+POLE&recr=Open">Click here</a>	
POLR3C	Silent	p.F366F	G	G		11	Filtered Calls	1	145597027	145597027	281	0.0498220640569395	NA	NA	NA			25			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+POLR3C&recr=Open">Click here</a>	
POTEA	RNA		G	G		11	Filtered Calls	8	43147793	43147793	163	0.0429447852760736	NA	NA	NA			46			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+POTEA&recr=Open">Click here</a>	
POU6F2	Silent	p.E482E	G	G		11	Filtered Calls	7	39500189	39500189	82	0.0853658536585366	NA	NA	NA			42	POU-specific. {ECO:0000255|PROSITE- ProRule:PRU00530}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+POU6F2&recr=Open">Click here</a>	
PPARD	Silent	p.L350L	C	C		11	Filtered Calls	6	35392526	35392526	110	0.118181818181818	NA	NA	NA			23	Ligand-binding.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPARD&recr=Open">Click here</a>	
PPEF2	Silent	p.R702R	C	C		11	Filtered Calls	4	76781976	76781976	196	0.0306122448979592	NA	NA	NA			50	EF-hand 3. {ECO:0000255|PROSITE- ProRule:PRU00448}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPEF2&recr=Open">Click here</a>	
PPFIA3	Intron		C	C		11	Filtered Calls	19	49642915	49642915	115	0.121739130434783	NA	NA	NA			35			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPFIA3&recr=Open">Click here</a>	
PPIP5K2	Silent	p.Y692Y	C	C		11	Filtered Calls	5	102503789	102503789	376	0.0265957446808511	NA	NA	NA			42			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPIP5K2&recr=Open">Click here</a>	
PPP2R2B	Silent	p.I387I	G	G		11	Filtered Calls	5	145969681	145969681	431	0.0324825986078886	NA	NA	NA			32			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPP2R2B&recr=Open">Click here</a>	
PPP2R3A	Intron		C	C		11	Filtered Calls	3	135745667	135745667	154	0.0974025974025974	NA	NA	NA			31			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPP2R3A&recr=Open">Click here</a>	
PPP3R2	Silent	p.F85F	G	G		11	Filtered Calls	9	104356958	104356958	193	0.0829015544041451	NA	NA	NA			22	EF-hand 2. {ECO:0000255|PROSITE- ProRule:PRU00448}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPP3R2&recr=Open">Click here</a>	
PRAMEF1	Silent	p.F263F	C	C		11	Filtered Calls	1	12854565	12854565	422	0.0473933649289099	NA	NA	NA			35			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRAMEF1&recr=Open">Click here</a>	
PRDM1	Intron		A	A		11	Filtered Calls	6	106547430	106547430	254	0.078740157480315	NA	NA	NA			94			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRDM1&recr=Open">Click here</a>	
PRDM9	Intron		G	G		11	Filtered Calls	5	23509710	23509710	178	0.0280898876404494	NA	NA	NA			172			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRDM9&recr=Open">Click here</a>	
PRDM9	Intron		C	C		11	Filtered Calls	5	23522402	23522402	258	0.0775193798449612	NA	NA	NA			172			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRDM9&recr=Open">Click here</a>	
PREPL	5'UTR		G	G		11	Filtered Calls	2	44573495	44573495	323	0.0464396284829721	NA	NA	NA			33			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PREPL&recr=Open">Click here</a>	
PREX2	Intron		C	C		11	Filtered Calls	8	69018554	69018554	339	0.0206489675516224	NA	NA	NA			178			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PREX2&recr=Open">Click here</a>	
PRKAA2	Intron		C	C		11	Filtered Calls	1	57161842	57161842	348	0.0488505747126437	NA	NA	NA			23			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRKAA2&recr=Open">Click here</a>	
PRKACA	Intron		G	G		11	Filtered Calls	19	14217561	14217561	202	0.0396039603960396	NA	NA	NA			16			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRKACA&recr=Open">Click here</a>	
PRKAR1A	Intron		C	C		11	Filtered Calls	17	66533674	66533674	113	0.0884955752212389	NA	NA	NA			31			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRKAR1A&recr=Open">Click here</a>	
PROKR1	Silent	p.I101I	C	C	rs144978946	11	Filtered Calls	2	68873256	68873256	334	0.0538922155688623	NA	NA	NA			35			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PROKR1&recr=Open">Click here</a>	
PROKR2	Silent	p.F333F	G	G	rs138101742	11	Filtered Calls	20	5282842	5282842	334	0.0359281437125748	NA	NA	NA			53			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PROKR2&recr=Open">Click here</a>	
PRPF19	Intron		G	G		11	Filtered Calls	11	60669945	60669945	135	0.0592592592592593	NA	NA	NA			22			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRPF19&recr=Open">Click here</a>	
PRR11	Intron		T	T		11	Filtered Calls	17	57278918	57278918	246	0.0691056910569106	NA	NA	NA			16			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRR11&recr=Open">Click here</a>	
PSG5	Intron		G	G		11	Filtered Calls	19	43687579	43687579	171	0.087719298245614	NA	NA	NA			35			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PSG5&recr=Open">Click here</a>	
PTCHD2	Silent	p.F1318F	C	C		11	Filtered Calls	1	11596518	11596518	135	0.0592592592592593	NA	NA	NA			76			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTCHD2&recr=Open">Click here</a>	
PTH2R	Silent	p.E512E	G	G		11	Filtered Calls	2	209358267	209358267	113	0.0442477876106195	NA	NA	NA			43			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTH2R&recr=Open">Click here</a>	
PTPN21	Silent	p.S797S	C	C		11	Filtered Calls	14	88945384	88945384	94	0.0425531914893617	NA	NA	NA			45			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPN21&recr=Open">Click here</a>	
PTPRJ	Silent	p.V1243V	C	C	rs141257303	11	Filtered Calls	11	48185941	48185941	89	0.0561797752808989	NA	NA	NA			52	Substrate binding. {ECO:0000250}.|Tyrosine-protein phosphatase. {ECO:0000255|PROSITE-ProRule:PRU00160}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPRJ&recr=Open">Click here</a>	
PTPRR	Silent	p.I41I	G	G	rs189132625	11	Filtered Calls	12	71158457	71158457	243	0.0534979423868313	NA	NA	NA			41			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPRR&recr=Open">Click here</a>	
PTX4	Silent	p.N65N	G	G		11	Filtered Calls	16	1537918	1537918	630	0.0111111111111111	NA	NA	NA			17			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTX4&recr=Open">Click here</a>	
RBL1	Intron		G	G		11	Filtered Calls	20	35689684	35689684	271	0.0848708487084871	NA	NA	NA			42			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RBL1&recr=Open">Click here</a>	
RELN	Silent	p.I1886I	G	G		11	Filtered Calls	7	103197563	103197563	155	0.0903225806451613	NA	NA	NA			227			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RELN&recr=Open">Click here</a>	
RELN	Silent	p.L349L	C	C		11	Filtered Calls	7	103338396	103338396	475	0.0610526315789474	NA	NA	NA			227			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RELN&recr=Open">Click here</a>	
RFC2	Silent	p.I206I	G	G	rs377300393	11	Filtered Calls	7	73654343	73654343	53	0.113207547169811	NA	NA	NA			8			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RFC2&recr=Open">Click here</a>	
RFPL3	Silent	p.V157V	G	G		11	Filtered Calls	22	32756423	32756423	299	0.0869565217391304	NA	NA	NA			15	B30.2/SPRY. {ECO:0000255|PROSITE- ProRule:PRU00548}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RFPL3&recr=Open">Click here</a>	
RFX6	Silent	p.L330L	C	C		11	Filtered Calls	6	117239217	117239217	631	0.03486529318542	NA	NA	NA			59			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RFX6&recr=Open">Click here</a>	
RGS3	Silent	p.C607C	C	C	rs551929417	11	Filtered Calls	9	116285272	116285272	353	0.0169971671388102	NA	NA	NA			48			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RGS3&recr=Open">Click here</a>	
RHAG	Intron		C	C		11	Filtered Calls	6	49583334	49583334	323	0.0340557275541796	NA	NA	NA			39			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RHAG&recr=Open">Click here</a>	
RHOBTB2	Silent	p.I291I	C	C		11	Filtered Calls	8	22864565	22864565	207	0.0289855072463768	NA	NA	NA			31	BTB 1. {ECO:0000255|PROSITE- ProRule:PRU00037}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RHOBTB2&recr=Open">Click here</a>	
RHOT1	Silent	p.T41T	C	C		11	Filtered Calls	17	30500876	30500876	521	0.0690978886756238	NA	NA	NA			28	Miro 1.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RHOT1&recr=Open">Click here</a>	
RIMS1	Silent	p.A237A	A	A		11	Filtered Calls	6	72889517	72889517	105	0.0476190476190476	NA	NA	NA			102			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RIMS1&recr=Open">Click here</a>	
RLF	Silent	p.S1678S	C	C	rs548524379	11	Filtered Calls	1	40705408	40705408	170	0.0941176470588235	NA	NA	NA			68			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RLF&recr=Open">Click here</a>	
RNF207	Intron		C	C		11	Filtered Calls	1	6270425	6270425	163	0.0552147239263804	NA	NA	NA			16			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RNF207&recr=Open">Click here</a>	
RP11-145E5.5	Intron		C	C		11	Filtered Calls	9	21974674	21974674	392	0.076530612244898	NA	NA	NA		p.0?(1315)|p.?(12)|p.0(1)|p.V28_V51del(1)	NA			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP11-145E5.5&recr=Open">Click here</a>	
RPH3A	Intron		C	C		11	Filtered Calls	12	113285493	113285493	185	0.0972972972972973	NA	NA	NA			47			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RPH3A&recr=Open">Click here</a>	
RYR3	Silent	p.L1985L	C	C		11	Filtered Calls	15	33988513	33988513	165	0.0848484848484849	NA	NA	NA			311	4 X approximate repeats.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RYR3&recr=Open">Click here</a>	
SALL1	5'Flank		C	C	rs556441449	11	Filtered Calls	16	51174819	51174819	296	0.0540540540540541	NA	NA	NA		p.A438A(1)	126			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SALL1&recr=Open">Click here</a>	
SAPCD1	5'Flank		C	C		11	Filtered Calls	6	31728457	31728457	283	0.0918727915194346	NA	NA	NA			NA			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SAPCD1&recr=Open">Click here</a>	
SAPCD1	Silent	p.E116E	G	G	rs149949398	11	Filtered Calls	6	31731933	31731933	200	0.065	NA	NA	NA			NA			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SAPCD1&recr=Open">Click here</a>	
SCAMP5	Silent	p.T143T	G	G		11	Filtered Calls	15	75310792	75310792	585	0.0632478632478632	NA	NA	NA			5			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCAMP5&recr=Open">Click here</a>	
SCAPER	Intron		T	T		11	Filtered Calls	15	76957986	76957986	99	0.0606060606060606	NA	NA	NA			39			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCAPER&recr=Open">Click here</a>	
SCARF1	Silent	p.E307E	T	T		11	Filtered Calls	17	1543831	1543831	36	0.138888888888889	NA	NA	NA			20	EGF-like 5. {ECO:0000255|PROSITE- ProRule:PRU00076}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCARF1&recr=Open">Click here</a>	
SCN4A	Intron		G	G	rs374039266	11	Filtered Calls	17	62026893	62026893	88	0.102272727272727	NA	NA	NA			101			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCN4A&recr=Open">Click here</a>	
SDE2	Silent	p.S170S	G	G		11	Filtered Calls	1	226180109	226180109	223	0.0358744394618834	NA	NA	NA			NA			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SDE2&recr=Open">Click here</a>	
SERINC2	Silent	p.L276L	C	C		11	Filtered Calls	1	31901872	31901872	371	0.0377358490566038	NA	NA	NA			12			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SERINC2&recr=Open">Click here</a>	
SERINC4	Intron		C	C		11	Filtered Calls	15	44089036	44089036	511	0.0919765166340509	NA	NA	NA			6			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SERINC4&recr=Open">Click here</a>	
SERPINA9	Silent	p.T129T	G	G		11	Filtered Calls	14	94935791	94935791	237	0.0506329113924051	NA	NA	NA			21			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SERPINA9&recr=Open">Click here</a>	
SERPINB11	RNA		G	G	rs367579501	11	Filtered Calls	18	61383346	61383346	109	0.0642201834862385	NA	NA	NA			6			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SERPINB11&recr=Open">Click here</a>	
SERTM1	5'UTR		C	C		11	Filtered Calls	13	37269208	37269208	166	0.0542168674698795	NA	NA	NA			NA			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SERTM1&recr=Open">Click here</a>	
SEZ6L	Silent	p.S336S	C	C		11	Filtered Calls	22	26692892	26692892	75	0.133333333333333	NA	NA	NA			80	CUB 1. {ECO:0000255|PROSITE- ProRule:PRU00059}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEZ6L&recr=Open">Click here</a>	
SHANK3	Silent	p.R526R	G	G		11	Filtered Calls	22	51142295	51142295	39	0.128205128205128	NA	NA	NA			8	SH3. {ECO:0000255|PROSITE- ProRule:PRU00192}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SHANK3&recr=Open">Click here</a>	
SHOX	Silent	p.F71F	C	C		11	Filtered Calls	X	591845	591845	163	0.0429447852760736	NA	NA	NA			13			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SHOX&recr=Open">Click here</a>	
SIPA1L1	Silent	p.F774F	C	C	rs374259672	11	Filtered Calls	14	72137902	72137902	515	0.0601941747572816	NA	NA	NA			78	Rap-GAP. {ECO:0000255|PROSITE- ProRule:PRU00165}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SIPA1L1&recr=Open">Click here</a>	
SLC10A7	Silent	p.F83F	G	G		11	Filtered Calls	4	147431136	147431136	233	0.0729613733905579	NA	NA	NA			16			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC10A7&recr=Open">Click here</a>	
SLC12A1	Silent	p.F388F	C	C		11	Filtered Calls	15	48527150	48527150	278	0.079136690647482	NA	NA	NA			59			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC12A1&recr=Open">Click here</a>	
SLC12A5	Intron		G	G		11	Filtered Calls	20	44684923	44684923	78	0.0769230769230769	NA	NA	NA			80			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC12A5&recr=Open">Click here</a>	
SLC16A7	Silent	p.S33S	C	C		11	Filtered Calls	12	60098681	60098681	180	0.0666666666666667	NA	NA	NA			30			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC16A7&recr=Open">Click here</a>	
SLC17A6	Silent	p.K469K	G	G		11	Filtered Calls	11	22398212	22398212	246	0.0853658536585366	NA	NA	NA			50			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC17A6&recr=Open">Click here</a>	
SLC22A13	Silent	p.I471I	C	C		11	Filtered Calls	3	38318469	38318469	36	0.305555555555556	NA	NA	NA			20			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC22A13&recr=Open">Click here</a>	
SLC22A3	Silent	p.F384F	C	C		11	Filtered Calls	6	160858107	160858107	410	0.0829268292682927	NA	NA	NA		p.F384F(1)	27			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC22A3&recr=Open">Click here</a>	
SLC35B1	Silent	p.T82T	G	G		11	Filtered Calls	17	47783659	47783659	98	0.0918367346938776	NA	NA	NA			7			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC35B1&recr=Open">Click here</a>	
SLC39A5	Silent	p.L389L	G	G		11	Filtered Calls	12	56630490	56630490	180	0.111111111111111	NA	NA	NA			27			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC39A5&recr=Open">Click here</a>	
SLC5A2	Silent	p.S262S	C	C		11	Filtered Calls	16	31498981	31498981	63	0.0634920634920635	NA	NA	NA			25			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC5A2&recr=Open">Click here</a>	
SLC6A2	Silent	p.F531F	C	C		11	Filtered Calls	16	55734053	55734053	128	0.0703125	NA	NA	NA			41			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC6A2&recr=Open">Click here</a>	
SLC6A4	Silent	p.F454F	G	G		11	Filtered Calls	17	28537620	28537620	233	0.0944206008583691	NA	NA	NA			25			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC6A4&recr=Open">Click here</a>	
SLC6A7	Silent	p.F75F	C	C		11	Filtered Calls	5	149576286	149576286	355	0.0957746478873239	NA	NA	NA			16			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC6A7&recr=Open">Click here</a>	
SLC9A2	Intron		C	C		11	Filtered Calls	2	103299712	103299712	248	0.0201612903225806	NA	NA	NA			42			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC9A2&recr=Open">Click here</a>	
SLCO2A1	Intron		C	C	rs142215026	11	Filtered Calls	3	133673940	133673940	104	0.192307692307692	NA	NA	NA			30			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLCO2A1&recr=Open">Click here</a>	
SLIT2	Intron		G	G		11	Filtered Calls	4	20541216	20541216	187	0.0481283422459893	NA	NA	NA			116			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLIT2&recr=Open">Click here</a>	
SLIT3	Intron		G	G		11	Filtered Calls	5	168149337	168149337	71	0.112676056338028	NA	NA	NA			100			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLIT3&recr=Open">Click here</a>	
SLITRK4	Silent	p.I13I	A	A		11	Filtered Calls	X	142718886	142718886	123	0.105691056910569	NA	NA	NA			60			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLITRK4&recr=Open">Click here</a>	
SMG7	IGR		G	G		11	Filtered Calls	1	183525375	183525375	164	0.0731707317073171	NA	NA	NA			46			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SMG7&recr=Open">Click here</a>	
SNAP91	Intron		T	T		11	Filtered Calls	6	84303465	84303465	198	0.0707070707070707	NA	NA	NA			37			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SNAP91&recr=Open">Click here</a>	
SNHG14	RNA		G	G		11	Filtered Calls	15	25328000	25328000	943	0.0699893955461294	NA	NA	NA			NA			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SNHG14&recr=Open">Click here</a>	
SNTG1	Intron		C	C		11	Filtered Calls	8	51571143	51571143	177	0.0677966101694915	NA	NA	NA			66			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SNTG1&recr=Open">Click here</a>	
SOCS7	Intron		C	C		11	Filtered Calls	17	36521233	36521233	131	0.099236641221374	NA	NA	NA		p.P334L(1)	9			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SOCS7&recr=Open">Click here</a>	
SORCS3	Silent	p.D324D	C	C		11	Filtered Calls	10	106802830	106802830	295	0.0644067796610169	NA	NA	NA			131			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SORCS3&recr=Open">Click here</a>	
SORT1	Silent	p.F592F	G	G		11	Filtered Calls	1	109867579	109867579	303	0.0264026402640264	NA	NA	NA			26			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SORT1&recr=Open">Click here</a>	
SOS1	Intron		A	A		11	Filtered Calls	2	39262458	39262458	110	0.0636363636363636	NA	NA	NA			75			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SOS1&recr=Open">Click here</a>	
SPARC	Intron		G	G		11	Filtered Calls	5	151052789	151052789	242	0.0537190082644628	NA	NA	NA			15			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPARC&recr=Open">Click here</a>	
SPATA18	Intron		C	C		11	Filtered Calls	4	52961040	52961040	256	0.0390625	NA	NA	NA			41			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPATA18&recr=Open">Click here</a>	
SPIC	Intron		C	C		11	Filtered Calls	12	101880110	101880110	310	0.0387096774193548	NA	NA	NA			22			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPIC&recr=Open">Click here</a>	
SPNS2	Silent	p.R167R	G	G		11	Filtered Calls	17	4428416	4428416	210	0.0428571428571429	NA	NA	NA			6			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPNS2&recr=Open">Click here</a>	
SPNS2	Intron		C	C	rs375044616	11	Filtered Calls	17	4433917	4433917	107	0.0654205607476635	NA	NA	NA			6			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPNS2&recr=Open">Click here</a>	
SPNS3	3'UTR		C	C	rs372872211	11	Filtered Calls	17	4391193	4391193	101	0.0891089108910891	NA	NA	NA			28			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPNS3&recr=Open">Click here</a>	
SPON1	RNA		G	G		11	Filtered Calls	11	14276233	14276233	150	0.0533333333333333	NA	NA	NA			21			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPON1&recr=Open">Click here</a>	
SPTA1	Intron		G	G		11	Filtered Calls	1	158587387	158587387	191	0.0732984293193717	NA	NA	NA			307			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPTA1&recr=Open">Click here</a>	
SPTA1	Intron		G	G		11	Filtered Calls	1	158612340	158612340	179	0.0279329608938547	NA	NA	NA			307			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPTA1&recr=Open">Click here</a>	
SPTLC2	Intron		G	G		11	Filtered Calls	14	78036861	78036861	298	0.0302013422818792	NA	NA	NA			19			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPTLC2&recr=Open">Click here</a>	
SRBD1	Silent	p.I773I	G	G		11	Filtered Calls	2	45645518	45645518	522	0.0555555555555556	NA	NA	NA			49			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SRBD1&recr=Open">Click here</a>	
SRBD1	Intron		A	A		11	Filtered Calls	2	45704124	45704124	222	0.0675675675675676	NA	NA	NA			49			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SRBD1&recr=Open">Click here</a>	
SRCAP	Silent	p.T197T	C	C		11	Filtered Calls	16	30718991	30718991	167	0.0958083832335329	NA	NA	NA			136			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SRCAP&recr=Open">Click here</a>	
SSUH2	Silent	p.R246R	C	C		11	Filtered Calls	3	8667297	8667297	244	0.0204918032786885	NA	NA	NA			NA			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SSUH2&recr=Open">Click here</a>	
STAT2	Intron		G	G		11	Filtered Calls	12	56743986	56743986	170	0.0294117647058824	NA	NA	NA			31			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STAT2&recr=Open">Click here</a>	
STK31	Silent	p.L842L	C	C		11	Filtered Calls	7	23827635	23827635	394	0.0304568527918782	NA	NA	NA			67	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STK31&recr=Open">Click here</a>	
STK4	Intron		T	T		11	Filtered Calls	20	43629027	43629027	191	0.0418848167539267	NA	NA	NA			20			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STK4&recr=Open">Click here</a>	
SYNE1	Silent	p.V6552V	G	G		11	Filtered Calls	6	152565708	152565708	225	0.0666666666666667	NA	NA	NA		p.V6552V(2)	524			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SYNE1&recr=Open">Click here</a>	
SYNE1	Intron		G	G	rs376033376	11	Filtered Calls	6	152777187	152777187	382	0.0287958115183246	NA	NA	NA			524			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SYNE1&recr=Open">Click here</a>	
TACC2	Intron		C	C		11	Filtered Calls	10	123987345	123987345	173	0.0404624277456647	NA	NA	NA			83			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TACC2&recr=Open">Click here</a>	
TAOK2	Intron		C	C		11	Filtered Calls	16	29998481	29998481	94	0.0531914893617021	NA	NA	NA			22			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TAOK2&recr=Open">Click here</a>	
TBX4	Silent	p.L415L	G	G		11	Filtered Calls	17	59560484	59560484	98	0.0816326530612245	NA	NA	NA			40			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TBX4&recr=Open">Click here</a>	
TDRD5	Intron		A	A		11	Filtered Calls	1	179621167	179621167	194	0.077319587628866	NA	NA	NA			77			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TDRD5&recr=Open">Click here</a>	
TEX14	Intron		G	G		11	Filtered Calls	17	56677033	56677033	131	0.0534351145038168	NA	NA	NA			81			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TEX14&recr=Open">Click here</a>	
THBS1	Silent	p.V49V	G	G		11	Filtered Calls	15	39874473	39874473	154	0.136363636363636	NA	NA	NA			53	Heparin-binding.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+THBS1&recr=Open">Click here</a>	
THNSL2	Silent	p.I130I	C	C		11	Filtered Calls	2	88474835	88474835	137	0.0802919708029197	NA	NA	NA			27			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+THNSL2&recr=Open">Click here</a>	
THPO	Intron		A	A		11	Filtered Calls	3	184093807	184093807	86	0.13953488372093	NA	NA	NA			16			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+THPO&recr=Open">Click here</a>	
THRB	Silent	p.R39R	C	C		11	Filtered Calls	3	24231731	24231731	244	0.10655737704918	NA	NA	NA			19	Modulating.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+THRB&recr=Open">Click here</a>	
THSD4	Silent	p.P612P	C	C		11	Filtered Calls	15	72030276	72030276	116	0.0344827586206897	NA	NA	NA			42			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+THSD4&recr=Open">Click here</a>	
TLDC2	Intron		C	C		11	Filtered Calls	20	35509163	35509163	167	0.0359281437125748	NA	NA	NA			NA			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TLDC2&recr=Open">Click here</a>	
TMC5	Silent	p.L425L	G	G		11	Filtered Calls	16	19475136	19475136	283	0.0353356890459364	NA	NA	NA			31			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMC5&recr=Open">Click here</a>	
TMEM106A	Silent	p.L186L	T	T		11	Filtered Calls	17	41368594	41368594	255	0.117647058823529	NA	NA	NA			11			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM106A&recr=Open">Click here</a>	
TMEM207	Silent	p.A12A	C	C	rs114031396	11	Filtered Calls	3	190167563	190167563	296	0.162162162162162	NA	NA	NA		p.A12A(1)	7			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM207&recr=Open">Click here</a>	
TMEM244	Silent	p.F111F	G	G		11	Filtered Calls	6	130152518	130152518	329	0.0577507598784195	NA	NA	NA			NA			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM244&recr=Open">Click here</a>	
TNFRSF10C	Silent	p.E181E	G	G		11	Filtered Calls	8	22974307	22974307	189	0.0846560846560847	NA	NA	NA			15			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNFRSF10C&recr=Open">Click here</a>	
TNN	Intron		C	C		11	Filtered Calls	1	175067460	175067460	414	0.0314009661835749	NA	NA	NA			156			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNN&recr=Open">Click here</a>	
TNXB	Silent	p.T3187T	G	G	rs376258289	11	Filtered Calls	6	32017243	32017243	204	0.0735294117647059	NA	NA	NA			8	Fibronectin type-III 23. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNXB&recr=Open">Click here</a>	
TNXB	Silent	p.G2340G	C	C		11	Filtered Calls	6	32030082	32030082	89	0.0561797752808989	NA	NA	NA			8	Fibronectin type-III 15. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNXB&recr=Open">Click here</a>	
TP63	Silent	p.L522L	C	C		11	Filtered Calls	3	189612096	189612096	170	0.111764705882353	NA	NA	NA			61			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TP63&recr=Open">Click here</a>	
TRAV27	RNA		G	G		11	Filtered Calls	14	22616358	22616358	116	0.0948275862068965	NA	NA	NA			NA			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRAV27&recr=Open">Click here</a>	
TRBV7-8	RNA		A	A		11	Filtered Calls	7	142099603	142099603	164	0.024390243902439	NA	NA	NA			NA			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRBV7-8&recr=Open">Click here</a>	
TREH	Silent	p.F200F	G	G		11	Filtered Calls	11	118532363	118532363	127	0.094488188976378	NA	NA	NA			13			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TREH&recr=Open">Click here</a>	
TRIM22	Silent	p.G353G	G	G		11	Filtered Calls	11	5730440	5730440	391	0.0639386189258312	NA	NA	NA			23	B30.2/SPRY. {ECO:0000255|PROSITE- ProRule:PRU00548}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRIM22&recr=Open">Click here</a>	
TRIM40	3'UTR		C	C		11	Filtered Calls	6	30115599	30115599	160	0.0375	NA	NA	NA			1			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRIM40&recr=Open">Click here</a>	
TRIM60	Silent	p.E12E	G	G		11	Filtered Calls	4	165961260	165961260	181	0.0386740331491713	NA	NA	NA			29			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRIM60&recr=Open">Click here</a>	
TRPM1	Silent	p.T1623T	A	A	rs199597272	11	Filtered Calls	15	31294034	31294034	167	0.0718562874251497	NA	NA	NA			99			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRPM1&recr=Open">Click here</a>	
TRPM6	Silent	p.F1055F	G	G		11	Filtered Calls	9	77397322	77397322	211	0.0710900473933649	NA	NA	NA			126			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRPM6&recr=Open">Click here</a>	
TRPV5	Intron		G	G		11	Filtered Calls	7	142627546	142627546	182	0.0769230769230769	NA	NA	NA			67			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRPV5&recr=Open">Click here</a>	
TSGA10IP	RNA		G	G		11	Filtered Calls	11	65715017	65715017	189	0.0423280423280423	NA	NA	NA			14			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TSGA10IP&recr=Open">Click here</a>	
TSPEAR	Intron		G	G		11	Filtered Calls	21	45959385	45959385	239	0.0669456066945607	NA	NA	NA			37			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TSPEAR&recr=Open">Click here</a>	
TTC18	5'UTR		C	C		11	Filtered Calls	10	75091023	75091023	271	0.0774907749077491	NA	NA	NA			34			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTC18&recr=Open">Click here</a>	
TTC23	Silent	p.V65V	G	G		11	Filtered Calls	15	99762055	99762055	219	0.0730593607305936	NA	NA	NA			16			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTC23&recr=Open">Click here</a>	
TTN	Silent	p.P10912P	C	C	rs368838709	11	Filtered Calls	2	179548796	179548796	276	0.0289855072463768	NA	NA	NA			1448	Glu-rich.|Pro-rich.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	
TTN	Intron		G	G		11	Filtered Calls	2	179615174	179615174	222	0.0540540540540541	NA	NA	NA			1448			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	
TTN	Silent	p.E1922E	C	C		11	Filtered Calls	2	179640825	179640825	438	0.091324200913242	NA	NA	NA			1448	Ig-like 9.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	
TXNDC16	Silent	p.I617I	G	G		11	Filtered Calls	14	52907434	52907434	163	0.0429447852760736	NA	NA	NA			21			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TXNDC16&recr=Open">Click here</a>	
TYROBP	Silent	p.F63F	G	G		11	Filtered Calls	19	36398388	36398388	170	0.0705882352941176	NA	NA	NA			8			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TYROBP&recr=Open">Click here</a>	
TYW1	Silent	p.R389R	A	A		11	Filtered Calls	7	66532283	66532283	349	0.0687679083094556	NA	NA	NA			46			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TYW1&recr=Open">Click here</a>	
UBN1	Intron		A	A		11	Filtered Calls	16	4909858	4909858	129	0.10077519379845	NA	NA	NA			38			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UBN1&recr=Open">Click here</a>	
UBR4	Silent	p.Y3682Y	G	G		11	Filtered Calls	1	19441909	19441909	84	0.0714285714285714	NA	NA	NA			171			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UBR4&recr=Open">Click here</a>	
UBR5	Silent	p.S2418S	G	G		11	Filtered Calls	8	103281295	103281295	339	0.0383480825958702	NA	NA	NA			124	PABC. {ECO:0000255|PROSITE- ProRule:PRU00641}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UBR5&recr=Open">Click here</a>	
UGT1A6	Intron		C	C		11	Filtered Calls	2	234652280	234652280	155	0.129032258064516	NA	NA	NA			22			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UGT1A6&recr=Open">Click here</a>	
UGT3A1	Silent	p.K94K	C	C		11	Filtered Calls	5	35965947	35965947	228	0.0307017543859649	NA	NA	NA			46			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UGT3A1&recr=Open">Click here</a>	
UIMC1	3'UTR		G	G		11	Filtered Calls	5	176332271	176332271	231	0.0216450216450216	NA	NA	NA			21			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UIMC1&recr=Open">Click here</a>	
UNC5D	Silent	p.N69N	C	C		11	Filtered Calls	8	35406913	35406913	216	0.0231481481481481	NA	NA	NA		p.N64N(1)	112	Ig-like.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UNC5D&recr=Open">Click here</a>	
UNC5D	Silent	p.K239K	G	G		11	Filtered Calls	8	35541211	35541211	98	0.0510204081632653	NA	NA	NA			112	Ig-like C2-type.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UNC5D&recr=Open">Click here</a>	
UQCRC2	Intron		C	C	rs376496884	11	Filtered Calls	16	21973773	21973773	237	0.0253164556962025	NA	NA	NA			15			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UQCRC2&recr=Open">Click here</a>	
USP15	Silent	p.F534F	C	C	rs370305930	11	Filtered Calls	12	62783429	62783429	628	0.054140127388535	NA	NA	NA			37	USP.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USP15&recr=Open">Click here</a>	
VAV1	Intron		C	C		11	Filtered Calls	19	6829794	6829794	220	0.0818181818181818	NA	NA	NA			62			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VAV1&recr=Open">Click here</a>	
VCAN	Intron		T	T		11	Filtered Calls	5	82836136	82836136	451	0.0421286031042129	NA	NA	NA			190			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VCAN&recr=Open">Click here</a>	
VIL1	Silent	p.F346F	C	C		11	Filtered Calls	2	219295537	219295537	79	0.0886075949367089	NA	NA	NA			41	Core.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VIL1&recr=Open">Click here</a>	
VRK3	Silent	p.S368S	G	G		11	Filtered Calls	19	50491742	50491742	137	0.0583941605839416	NA	NA	NA			23	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VRK3&recr=Open">Click here</a>	
VTCN1	Silent	p.V108V	C	C		11	Filtered Calls	1	117699317	117699317	224	0.0491071428571429	NA	NA	NA			12			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VTCN1&recr=Open">Click here</a>	
VTCN1	Intron		C	C		11	Filtered Calls	1	117699604	117699604	117	0.0341880341880342	NA	NA	NA			12			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VTCN1&recr=Open">Click here</a>	
VWA3B	Silent	p.K310K	G	G		11	Filtered Calls	2	98750344	98750344	508	0.0807086614173228	NA	NA	NA			70			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VWA3B&recr=Open">Click here</a>	
VWF	Silent	p.Y2483Y	G	G	rs369629756	11	Filtered Calls	12	6080864	6080864	138	0.0289855072463768	NA	NA	NA			129	VWFC 2. {ECO:0000255|PROSITE- ProRule:PRU00220}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VWF&recr=Open">Click here</a>	
VWF	Intron		A	A		11	Filtered Calls	12	6220139	6220139	182	0.0659340659340659	NA	NA	NA			129			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VWF&recr=Open">Click here</a>	
WDFY3	Silent	p.F3392F	G	G		11	Filtered Calls	4	85599404	85599404	230	0.0391304347826087	NA	NA	NA			134	Interaction with ATG5.|Interaction with SQSTM1.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WDFY3&recr=Open">Click here</a>	
WFDC3	Silent	p.S130S	G	G		11	Filtered Calls	20	44404063	44404063	467	0.0877944325481799	NA	NA	NA			5	WAP 3. {ECO:0000255|PROSITE- ProRule:PRU00722}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WFDC3&recr=Open">Click here</a>	
WFDC8	Silent	p.F25F	G	G		11	Filtered Calls	20	44190810	44190810	136	0.0441176470588235	NA	NA	NA			15			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WFDC8&recr=Open">Click here</a>	
WFS1	Silent	p.F329F	C	C		11	Filtered Calls	4	6302509	6302509	166	0.0301204819277108	NA	NA	NA			21			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WFS1&recr=Open">Click here</a>	
WWC2	Intron		C	C		11	Filtered Calls	4	184182060	184182060	73	0.0958904109589041	NA	NA	NA			32			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WWC2&recr=Open">Click here</a>	
XDH	Silent	p.Q680Q	C	C		11	Filtered Calls	2	31591467	31591467	408	0.0637254901960784	NA	NA	NA		p.Q680H(1)	74			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XDH&recr=Open">Click here</a>	
XIRP2	Intron		G	G		11	Filtered Calls	2	168103588	168103588	239	0.0418410041841004	NA	NA	NA			315			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XIRP2&recr=Open">Click here</a>	
XIRP2	Intron		C	C		11	Filtered Calls	2	168106458	168106458	398	0.0728643216080402	NA	NA	NA			315			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XIRP2&recr=Open">Click here</a>	
XKR4	IGR		C	C		11	Filtered Calls	8	56436110	56436110	475	0.0463157894736842	NA	NA	NA			34			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XKR4&recr=Open">Click here</a>	
YBEY	5'UTR		C	C		11	Filtered Calls	21	47706819	47706819	250	0.068	NA	NA	NA			9			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+YBEY&recr=Open">Click here</a>	
YEATS2	Silent	p.S216S	C	C		11	Filtered Calls	3	183442317	183442317	123	0.105691056910569	NA	NA	NA			49	YEATS. {ECO:0000255|PROSITE- ProRule:PRU00376}.		MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+YEATS2&recr=Open">Click here</a>	
ZCCHC4	5'UTR		G	G		11	Filtered Calls	4	25314426	25314426	450	0.0466666666666667	NA	NA	NA			9			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZCCHC4&recr=Open">Click here</a>	
ZFYVE28	Silent	p.F402F	G	G		11	Filtered Calls	4	2306861	2306861	103	0.0485436893203883	NA	NA	NA			31			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZFYVE28&recr=Open">Click here</a>	
ZNF35	IGR		C	C		11	Filtered Calls	3	44700938	44700938	130	0.130769230769231	NA	NA	NA			12			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF35&recr=Open">Click here</a>	
ZNF407	Silent	p.V1244V	C	C		11	Filtered Calls	18	72346707	72346707	125	0.096	NA	NA	NA			67			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF407&recr=Open">Click here</a>	
ZNF471	3'UTR		C	C		11	Filtered Calls	19	57036640	57036640	233	0.0386266094420601	NA	NA	NA			36			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF471&recr=Open">Click here</a>	
ZNF512B	Intron		C	C		11	Filtered Calls	20	62626766	62626766	131	0.0458015267175573	NA	NA	NA			33			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF512B&recr=Open">Click here</a>	
ZNF552	Silent	p.S248S	G	G		11	Filtered Calls	19	58319888	58319888	120	0.166666666666667	NA	NA	NA			11			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF552&recr=Open">Click here</a>	
ZNF570	Silent	p.I183I	C	C		11	Filtered Calls	19	37975073	37975073	464	0.0280172413793103	NA	NA	NA			27			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF570&recr=Open">Click here</a>	
ZNF571	Intron		G	G	rs140590185	11	Filtered Calls	19	38056630	38056630	187	0.112299465240642	NA	NA	NA			25			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF571&recr=Open">Click here</a>	
ZNF711	Silent	p.L722L	G	G		11	Filtered Calls	X	84526576	84526576	151	0.139072847682119	NA	NA	NA			28			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF711&recr=Open">Click here</a>	
ZNF74	3'UTR		C	C		11	Filtered Calls	22	20761208	20761208	94	0.074468085106383	NA	NA	NA			19			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF74&recr=Open">Click here</a>	
ZNF778	Silent	p.P229P	G	G	rs369672877	11	Filtered Calls	16	89293467	89293467	262	0.0190839694656489	NA	NA	NA			24			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF778&recr=Open">Click here</a>	
ZNF830	Silent	p.F209F	C	C		11	Filtered Calls	17	33289212	33289212	157	0.0636942675159236	NA	NA	NA			13			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF830&recr=Open">Click here</a>	
ZYG11B	Silent	p.T663T	A	A		11	Filtered Calls	1	53282246	53282246	527	0.0246679316888046	NA	NA	NA			30			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZYG11B&recr=Open">Click here</a>	
ZZEF1	Intron		C	C		11	Filtered Calls	17	3917381	3917381	85	0.0823529411764706	NA	NA	NA			84			MEL-IPI_Pat103-Tumor-SM-4CU6Q	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZZEF1&recr=Open">Click here</a>	
